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ANION CONDUCTING STATES OF EXCITATORY AMINO ACID TRANSPORTERS 
Christopher Brad Divito, Ph.D. 
University of Pittsburgh, 2013 
Excitatory amino acid transporters (EAATs) are secondary active, electrogenic transporters 
which translocate L-glutamate (glu) against its concentration gradient using the co-transport of 3 
Na+, 1 H+, and the counter-transport of 1 K+ ion. In addition, these carriers possess a 
thermodynamically uncoupled anion channel that fluxes Cl- but is promiscuous with several 
permeant anionic species. The roles of EAATs are to shape the spatio-temporal profile of 
released glu in both the synaptic cleft and extra-synaptic regions as well as maintaining a low 
ambient extracellular concentration of glu. This transport activity regulates activation of glu 
receptors and thus regulates excitatory neurotransmission.  
Using a combination of techniques, we were successful in identifying inward oriented 
transporter conformations which allow transitions to open channels states. This observation was 
enabled by our development of a novel method to isolate EAAT1 in the inward facing 
conformation. While constrained to these conformations, currents with the same macroscopic 
amplitudes as conducting states mediated by the outward facing, Na+ bound states were 
observed. The persistence of currents is indicative of a channel gating mechanism that is 
insensitive to transporter orientation and that the anion channel is open during the majority of 
the transport cycle. Additional conducting states allows for a larger contribution of the anion 
channel function of EAATs to shape cellular function then previously assumed. 
Next we investigated the gating mechanism of the anion channel. We assayed for the 
ability of Na+ to gate the anion channel in both glial (EAAT1 and EAAT2) and neuronal (EAAT3 
and EAAT4) isoforms. We discovered that the glial isoforms are not gated by Na+ but are leak 
v 
channels with an open probability and single channel conductance that is insensitive to Na+ 
concentrations. In contrast, neuronal EAAT isoforms EAAT3 and EAAT4 both display Na+ 
dependent channel activity. This is the first example of a significant functional difference 
between glial and neuronal transporter isoforms of the solute carrier 1 (SLC1) family. The 
research presented here allows for a greater understanding of low open probability channel 
states and the possible contributions of the EAAT anion channel to the functioning of the 
nervous system.  
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1. INTRODUCTION 
 
L-glutamate (glu) is the primary excitatory amino acid in the central nervous system. 
Dysfunction of glutamatergic signaling is related to many debilitating diseases (1), and therefore 
proper coordination and fidelity of release, activation, and reuptake of this neurotransmitter is 
paramount for total system homeostasis. Excitatory amino acid transporters (EAATs) are 
secondary active, electrogenic transport systems that couple the accumulation of glu into the 
cytoplasm to downhill movement of co-transported ions along their concentration gradient. 
Alteration of these ion gradients, such as during anoxic depolarization, halts or even reverses 
glu transport and can contribute to excitotoxic conditions (2-5). The roles of the EAATs have 
been studied intensely for the last 30 years and much insight has been gathered into their 
structure, function, localization, and how they regulate neurotransmission. EAATs regulate 
glutamatergic neurotransmission but the mechanism by which they accomplish this process is 
by a dynamic coupling of bioenergetics of the transport process and the localization of the 
transporters themselves. The consequence of this coupling is the creation of complex spatio-
temporal profiles for extracellular glu. Here we will review background information on the SLC1 
family of transporters including their function and structure and how these transporters regulate 
neurotransmission.  
1.1.1. Isoforms and Localization  
The solute carrier 1 (SLC1) family of neurotransmitter transporters is comprised of several 
solute carriers including the excitatory amino acid transporter (EAATs). The initial cloning of a 
glu carrier in the SLC1 family was performed in 1992 with the isolation of a 60 kDa protein from 
rat brain termed the glutamate/aspartate transporter (GLAST) (6). One month later, glutamate 
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Figure 1: Localization of EAATs in the synapse: Model of a basic synapse illustrating the 
localization of EAATs 1-4. EAAT1 (green) and EAAT2 (red) are localized to glial membranes. 
EAAT3 (blue) and EAAT4 (magenta) are localized to post-synaptic membranes.  Expression 
and function of a presynaptic carrier (grey) is unclear, but EAAT2 and EAAT3 isoforms have 
both been implicated. Structures are modeled as monomers of an archeal homolog of a glu 
transporter from Pyrococcus horikoshii (GltPh)  and were modified from (7). The GltPh pdb file 
1FXH was modified using pymol vs 1.3. 
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transporter 1 (GLT-1) from rat, and excitatory amino acid carrier 1 (EAAC1) from rabbit were 
both cloned (8,9). All of these carriers were described as Na+ and K+ dependent, SLC1 family 
members that accumulate glu and L- or D-aspartate (asp). Subsequently two novel human 
isoforms were cloned from the cerebellum and retina, excitatory amino acid transporter 4 
(EAAT4) and EAAT5, respectively (10,11). Human isoforms of GLAST, GLT-1, and EAAC1 
were also cloned and renamed EAAT1-3 to denote their human species of origin (12). EAAT1-5 
share an approximate 65% primary sequences homology between them.  The transporters can 
roughly be divided into two classes – astrocytic or neuronal (Figure 1).  EAATs 1 and 2 are 
found predominantly in astrocytes while EAAT3, EAAT4, and EAAT5 are neuronal. EAAT1 is 
enriched in cerebellar astrocytes but also found in astrocytes throughout the brain (6,13). 
EAAT2 is the most abundant glu transporter found in the brain and, by some estimates, 
accounts for ~90% of the total glu uptake in the brain (14,15). EAAT3 is most often described as 
a postsynaptic neuronal carrier with expressing ranging throughout the brain. EAAT4, like 
EAAT3, is also a neuronal transporter (16). While the Purkinje cell localization of EAAT4 is 
dramatic, this carrier is also found in other neurons at low levels (16,17). Expression of EAAT5 
is exclusively in the retina (11). Throughout this paper will refer to general properties of the 
carriers using their EAAT nomenclature unless specifically in reference to the non-human 
isoforms. Although basic properties of the various isoforms are largely similar, minor differences 
in their kinetics, localization, and regulation dramatically affect glutamatergic neurotransmission. 
 
1.2. MECHANISM OF TRANSPORT 
1.2.1. Characterization of Glu Transport  
Initial functional studies of glu translocation were done in rat brain synaptosomes and the 
translocation were described as Na+ and K+ dependent processes (18). Experiments controlling 
the transmembrane potential in synaptosomes demonstrated that accumulation of glu was also 
an electrogenic process. Initial electrophysiological recordings of glu carriers described the 
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electrogenic nature of the transport cycle and supported the basic findings of earlier biochemical 
studies. A large, rectifying inward current, between -160 and +80 mV, in response to 
extracellular glu addition was generated in whole cell patch recording of Müller glial cells (19). 
These currents were voltage and Na+ dependent and only responded to applications of D- and 
L-asp and L-glu but not D-glu, congruent with the initial characterizations of glu transport 
performed by Kanner’s group.  Early electrophysiological reports also corroborated conclusions 
from biochemical data when the dependence of transport on intracellular K+ was investigated by 
whole cell patch recordings from glia (20).  
The translocation of glu is a reversible cycle, and homoexchange of glu was 
characterized before the molecular identity of the EAATs were known (21,22). All experiments 
pointed to a relatively high affinity carrier which could translocate substrates in the low 
micromolar range. Work done on a bacterial homolog glu transporter from Bacillus 
stearothermophilus, GLTBs, demonstrated that electrogenic glu uptake was accompanied by a 
proton as well as a sodium ion (23), although confirmation of this proton co-transport was 
contentious and the possibility of OH- counter transport as the source of pH change associated 
with glu transport arose (24,25). The most accurate estimation of stoichiometry was 
demonstrated using a series of experiments controlling ion concentrations and measuring 
reversal potentials of transport as well as pre-steady state kinetic measurements using 
substrate concentration jumps  (26-28). From data presented in these studies, it can be 
concluded that EAATs likely function by transporting 1 glu with 3 Na+, 1 H+, and the counter 
transport of 1 K+ (Figure 2).  
 Initial investigations into the transport kinetics revealed that hyperpolarization of the 
membrane stimulated transport in a manner that was dependent on glu concentration. This led 
authors to propose that glu translocation was the rate limiting step of the transport cycle (29,30). 
It wasn’t until pre-steady state kinetics were investigated using a photo-releasable glu analog 
that a detailed study of initial glu binding and translocations steps were possible (27). Glu  
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Figure 2: EAATs are secondary, electrogenic transporters. 4-state transport diagram 
depicting coupled stoichiometry of glu transport and ion movement. Transporters are displayed 
to represent the outward facing, HP2 open state (upper left), the outward facing, glu-bound, 
HP2 occluded state (upper right), the inward facing, HP1 occluded state (lower right), and the 
inward facing, HP1 open state (lower left). The structures used are adapted from the pdb files 
2NWW, 1FXH, and 3KBC of GltPh (7,31,32).    
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release on a sub-millisecond time scale revealed an initial transient electrogenic component 
which rapidly decayed down to a steady state level. This voltage and concentration dependent 
decay process is associated with the initial translocation of glu. Furthermore, these data can 
only be reconciled with a transport cycle with a rate limiting step not related to glu translocation 
but to the K+ mediated reorientation process. A rate limiting glu translocation would not produce 
the same transient components (33). Additionally, replacement of internal K+ with Cs+ 
dramatically affected cycling times, support that K+ interaction and reorientation are the late 
limiting steps of the transport cycle (34). The translocation of glu is dependent on the binding 
and co-transport of several cationic species. Na+ binding to the empty transporter has been 
shown to be a voltage dependent process, generating measureable capacitive currents (35,36). 
Since the steady state affinity of EAATs for glu is voltage independent although glu translocation 
generates net inward charge movements, then another voltage dependent process has to 
produce an equal and opposite charge movement. K+ reorientation has, therefore, been 
hypothesized to neutralize more than -1 elementary charge (33). To further test the hypothesis 
that co-transported cations are used to neutralize the endogenous charges present in the empty 
transporter (37), a combination of pre-steady state concentration and voltage jump experiments 
with computational modeling were used. These data led to the conclusion that the negative 
charge generated by the movement of the empty transport is, indeed, in part compensated by 
the binding and translocation of Na+, H+, and K+ ions (38). The compensation of endogenous 
transporter charges by ion binding, in addition to a defocused electric field and distribution of 
electrogenic steps, allows for a tightly regulated and energetically reasonable transport 
mechanism (Figure 2).  
1.2.2. Physiological Regulation of Transport  
The transport of glu against its concentration gradient is coupled to the downhill movement of 
co-transported ions with their gradient. Alterations of the ion gradients for Na+, H+, and K+ would, 
therefore, impact the ability for the EAATs to transport substrates. Evidence for reverse 
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transport came early when Kanner and Marva used vesicles from rat brain which were loaded 
with high internal Na+ and high extracellular K
+
 to efflux radiolabeled glu which had been loaded 
into the vesicle (22). In whole cell patch recording of Müller glial cells of the salamander retina, 
dialysis of the internal solution using a pipette solution containing Na+ and glu drove glu 
transporters in the reverse direction with the addition of extracellular K+ (39). The reversal of the 
transport cycle, or glutamate mediated efflux, has been demonstrated in a variety of glu 
transporters isoforms such as EAAT1 or EAAC1 (rat EAAT3), suggesting that reverse transport 
capability is intrinsic to the SLC1 family (40,41). During normal physiological conditions, it is 
unlikely that reverse transport occurs frequently enough to have a physiological consequence 
(42), yet during anoxic depolarization it has been suggested that glu efflux mediated by reversal 
of the EAAT transport cycle can mediate excitotoxic conditions (4). So how do the bioenergetics 
of transport influence glutamatergic neurotransmission? First, the coupled movement of three 
sodium ion indicates that glu can be concentrated inside a neuron or astrocyte with a 106 fold 
glu concentration difference or keep extracellular glu levels down to the low nanomolar 
concentration (26).  Additionally, under ambient conditions, the low affinity for Na+ and glu at the 
intracellular face of the transporter means that reverse transport would occur with a negligible 
frequency (36). During ischemic conditions, however, in which the Na+ and  K+ concentrations 
and transmembrane voltage are disturbed, a significant amount of glu has been demonstrated 
to be released through an EAAT mediated reverse transport process (4). Thus, the 
bioenergetics of glu transport tightly controls the rates and amount of neurotransmitter removal 
from the synaptic space. Because cessation of excitatory neurotransmission is dependent on 
the efficient removal of extracellular glu, the bioenergetics of EAAT transport contributes to the 
termination of glutamatergic neurotransmission in an essential manner.               
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Figure 3: EAATs mediate anion flux through multiple open states. A) 20 step state diagram 
depicting stable conformations of glu transport (black) and open channel states gated by either 
Na+ interaction (blue) or Na+ and glu interaction (red) associated with the outward facing 
conformations of the transport cycle. Inward facing open channel states have been removed for 
clarity. B) Demonstrative current-voltage relationship for an EAAT in response to extracellular 
application of Na+ + DL-threo-β-benzyloxyaspartate (DL-TBOA; black), Na+ alone (blue), or Na
+ 
+ 500 µM glu (red). Currents are representative of NO3 flux through EAAT4.    
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1.3. LIGAND-GATED ANION CHANNELS 
1.3.1. Characterization of Channel Activity 
In 1994, electrophysiological characterization of a novel EAAT cloned from cerebellar mRNA of 
humans, revealed a remarkable property of glu transporters (10). An EAAT-mediated Cl- flux 
which was Na+ and glu dependent but thermodynamically independent of the transport process 
was demonstrated (Figure 3). These data was the first to unambiguously reveal anion channel 
activity in the EAATs. Initial voltage clamp studies of the EAAT anion channel revealed several 
basic properties. First, the anion channel is promiscuous, with a permeability sequence 
generally following SCN- > ClO4
- > NO3
- > I- > Br- > Cl- > F- (43-45). Second, the interaction of 
substrates with EAATs elicits a robust anion current, but this anion flux occurs, with diminished 
amplitude, in the absence of substrates as well. This “leak” current was originally revealed by 
the loss of a tonic cellular conductance in the presence of inhibitors (46). Anion conductances in 
the absence of extracellular glu were substantiated by several groups (40,47,48). It was 
demonstrated that the leak current is actually dependent on extracellular Na+ (49) and indeed 
gated by Na+ interaction with the EAATs in the absence of glu (34,50). Stationary and non-
stationary noise analyses have been used to characterize channel properties mediated by Na+ 
and glu interaction (40,51-53). These data revealed that Na+ interaction with the EAATs 
mediates a low open probability and the open probability of the channel is increased upon glu 
binding subsequent to Na+, without a significant change in low (0.5-500 fS) single channel 
conductance. The physiological role or impact of these tonic anion fluxes in the absence of 
active transmission has yet to be examined in detail.  
 The mechanism by which substrate interaction with the EAATs gates the channel is still 
under investigation. Initial work by Vandenberg’s group using a series of point mutations 
between residues R90 and K114 of EAAT1 demonstrated that the D112A mutation significantly 
reduced glu gated anion current amplitudes yet strongly enhanced Na+ gated currents (54). 
These data suggest that D112 is involved in the ability of substrate to gate that the anion 
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channel. Similarly, when R388 in transmembrane domain 8 (TM8) is mutated to an acidic amino 
acid residue, substrate gated anion channel activity is completely abolished while current 
amplitudes in the presence of Na+ alone are enhanced several fold (Appendix D). Other 
residues have been implicated in the gating mechanism in addition to D112 and R388. 
Mutations of D272 (TM5), K384, and R385 (TM7) in hEAAT1 have all been demonstrated to 
increase channel activity after mutation to alanine (55). Only a handful of mutations have been 
demonstrated to alter channel activity, however non-mutational data have also contributed to 
our understanding of the mechanism of channel gating. Pre-steady state kinetics has been a 
powerful technique to study the initial steps in substrate interaction and channel activity. Laser 
pulse photolysis of caged glu was employed for a series of investigations to measure the initial 
kinetics of substrate binding, translocation, and substrate gating. These elegant experiments 
have lent great insight in the mechanism of transport and channel activity and have been 
thoroughly reviewed elsewhere (56,57).  
1.3.2. Role of the Chloride Channel in Regulating Synaptic Transmission 
The physiological role of a low conductance anion channel present in a family of 
neurotransmitter transporters remains elusive. One possible role for this ligand-gated channel is 
the stabilization of the membrane potential to offset the positive ion influx associated with 
electrogenic transport of substrates during neurotransmission (44). Veruki et al. (2006) used 
whole cell and paired recordings from rod bipolar cells and AII amacrine cells to demonstrate 
that glutamatergic activation of EAAT5 causes a membrane hyperpolarization which reduces 
subsequent transmitter release (58). These data demonstrate that anion flux through the EAATs 
is capable of regulating cellular excitability. Additional work demonstrated that EAAT5 mediated 
a large inhibitory current in response to bipolar cell depolarization, confirming a role for the 
EAAT mediated anion conductance in shaping neurotransmission (59).   
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1.4. STRUCTURE OF THE SLC1 FAMILY 
1.4.1. EAAT Topology 
Upon cloning of the first members of the SLC1 family, hydropathy plots gave initial insight into 
the secondary structure of these carriers. A bacterial SLC1 family member, the glutamate-
proton co-transporter (GltP) from E. coli, displayed 12 putative transmembrane domains (TM) 
with a cytoplasmic C-terminus (60). Topology models of GLT-1 and EAAC1 displayed 8 and 10 
transmembrane domains respectively, but both models contained a large glycosylated loop 
between TM3 and 4, an intracellular N-terminus, and a long, intracellular C-terminal tail (8,9). 
Structural experiments were used extensively by several groups in order to further refine the 
topology of the transporter during different conformational states. Rat membrane vesicles 
containing GLT-1 were probed for their sensitivity to trypsin digestion in the presence and 
absence of the GLT-1 inhibitor dihydrokainate (DHK) as well as the substrate glu. The 
difference in trypsin induced fragments with bound substrates and antagonist indicated at least 
two conformational states representing inhibitor stabilized, outward facing states and substrate 
induced, transporting states of GLT-1 (61). Additional topology models were proposed over the 
next few years including a refined 4 TM domain C-terminal region (62) and a possible β-sheet 
structure in the C-terminal transmembrane domains (63).  
In order to increase the resolution of the structural topology data, a method originally 
used to screen pore lining domains using modification of single cysteine residues was employed 
(64-66). Initial experiments employing cysteine mutagenesis based methods revealed a 
topology for GLT-1 with 8 TM domains and a reentrant loop (HP2) between TM 7 and 8 (67). 
Additional data using substituted cysteine accessibility method (SCAM) supported the presence 
of two reentrant loops, although disagreeing on their location in the c-terminal half of the 
transporter (68-70). The first accurate report of EAAT membrane topology came when 
Grunewald et al. (2000) performed SCAM experiments across residues 347 to 393 (71). The  
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Figure 4: General structure of the SLC1 family of transporters. A. Two-dimensional 
representation of the topology of the GltPh monomer colored with a rainbow pattern. B. (Left) 
Top-down view of the homotrimeric GltPh crystal from pdb file # 1FXH. Each monomer was 
colored with the same rainbow pattern as in A) using Pymol version 1.3. (Right) View of the 
same trimeric representation of the GltPh crystal structure from a horizontal or membrane view. 
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ability for only residues A364C and G365C (GLT-1) to be labeled by the extracellular application 
of the non-permeable MTSET, depicted another reentrant loop (HP1) located upstream of TM7. 
Currently the model for EAAT topology is 8 TM domains and 2 hairpin loops (HP1 and HP2); 
HP1 located between TM 6 and 7, and HP2 located between TM7 and 8 (Figure 4A).   
1.4.2. The Crystal Structure of an Archeal Homolog of Mammalian EAATs 
Work investigating the oligomerization of EAATs was incipient with exposing liposomes 
reconstituted from rat forebrain and cerebellum with chemical crosslinking reagents (72). These 
experiments, along with similar data from assays using heterologous expression of EAATs, 
support a homotrimeric organization of EAATs (73). However, the homotrimeric, quaternary 
structure of EAATs was disputed by freeze-fracture electron microscopy data which suggested 
a pentameric assembly (74). The first definitive picture of tertiary and quaternary structure came 
in 2004 when the crystal structure of an archeal homolog to the EAATs, GltPh was solved (7). 
The crystal architecture displayed 8 transmembrane domains and two hairpin loops located 
between TM6-7 and TM7-8, as previously described (71). The organization of the transporter in 
the membrane was that of a homotrimer with the subunit interface comprised of TM 2, 4, and 5 
regions (Figure 4B). The trimer shape of the GltPh crystal formed a bowl or extracellular solvent-
accessible basin and the co-crystallization of bound substrates confirmed the location of the 
hypothesized binding site. The binding site is adjacent to TM7, at the tips of HP2 and HP1 and 
the substrate was coordinated by several residues previously demonstrated to have a role in 
substrate interactions (28,75-78). The conformational state that seemed to be displayed by this 
snapshot was the outward conformation with the binding site occluded by HP2. Although the 
mutated archeal transporter used for crystallized was inactive, the resulting crystal structure was 
in strong congruence with structure-function data and served well to refine lingering questions in 
the field. To date, three more crystal structures have been solved using the archeal asp carrier 
GltPh. The location of the substrate-binding site was confirmed with investigations demonstrating 
that D394 in TM8 coordinates the amino group of asp or glu and R397 interacts with the side 
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chain carboxyl group. Additional structures demonstrated DL-TBOA bound states with slight 
differences in the location of HP2 suggested possible outward open states (31) (see also Figure 
2). One of the next structural developments depicted a possible inward-facing state. Through 
crosslinking of distal residues in HP2 and TM2, crystals were obtained and a transport 
mechanism was proposed to explain the transition of the previously described outward facing 
structures to the HP2/TM2 cross-linked structure. The model includes a substantial inward shift 
of TM3, TM6, HP1, TM7, HP2, and TM8, which was termed the translocation domain as it 
contained the HP2 and HP1 occluded, substrate binding site. This piston-like movement leaves 
both the translocation domain and TM1, TM2, TM4, and TM5, termed the scaffold domain, 
largely similar in conformation, when considered individually, albeit over an 18 Å inward shift of 
the substrate binding site (32).  
1.4.3. Structural Influences of the Trimeric Organization of EAATs in Glu Uptake 
Although many of the functional and structural features of the EAATs have been resolved, there 
may be other aspects of the structure which can influence carrier activity in unforeseen ways. 
Indeed it has been proposed that the bowl-like shape of the trimer may play a role in restricting 
glu diffusion after initial binding, thus helping to reduce effective glu release after initial binding 
events during synaptic transmission (79). Future work may further reveal aspect of how the 
quaternary structure of EAATs support their function roles in regulating excitatory 
neurotransmission. 
 
1.5. THE ROLE OF EAATS IN SYNAPTIC TRANSMISSION 
1.5.1. The Roles of EAATs in Glutamatergic Neurotransmission in the Hippocampus 
The role of EAATs is to control extracellular glu levels, both ambient and in response to 
exocytosis of neurotransmitter due to neuronal activity. Levels of ambient glu have been 
estimated as low as 25 nM and blocking the carriers with a specific antagonist causes a non-
linear rise in ambient levels, supporting the classic role of EAATs in maintaining low 
15 
 
extracellular glu concentrations (80). Synaptic concentrations of glu, after vesicular release from 
dissociated hippocampal neurons, were initially estimated to be in the millimolar range, 
approximately 1.0 - 1.5 mM (81). Early studies looked at the effect of EAAT blockade, or 
competition at the carrier binding site, on activation of post-synaptic ionotropic glu receptors 
(iGluRs) and indicated that loss of active transporters could increase the concentration of 
neurotransmitter in the synapse, observed as a slight, transient increase in mEPSC amplitudes 
(82) or as a decrease in decay rates of EPSCs (83). Through the delicate manipulation of α-
amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) kinetics with various 
pharmacology, it was demonstrated that in the first 100 µsec of glu release from the presynaptic 
terminal, EAATs act to reduce mEPSC amplitude and shorten rise times of the transient post 
synaptic currents (84). Since the transport cycle is significantly slower than this timing, 
approximately 15 - 90  s-1 (33,35), it was proposed that glu transporters act to buffer synaptic glu 
with a relatively high affinity binding interaction, yet the slow kinetics of transport allows for 
some unbinding of substrate before a substantial amount of glu can be transported (33). To 
support the hypothesis of rapid buffering, EAAT expression near the synapse would need to be 
at remarkably high levels. Indeed estimates for EAAT2 concentrations in hippocampal 
astrocytes are as high as 12,000/m3 and EAAC1 neuronal levels were estimated to be 130 
/m3 (14,85). Thus, EAATs can modulate the concentration of synaptic glu to some degree but 
also act to control the temporal profile of postsynaptic receptor activation and diffusion to 
perisynaptic regions as glu binds and unbinds rapidly to a high number of carriers.   
Diffusion accounts for much of the rapid decrease in synaptic levels of the 
neurotransmitter and elevated perisynaptic concentrations of glu can be detected for a 
sustained period of time (>10 msec). This sustained activation of peri-synaptic transporters has 
been demonstrated for EAAT expressing astrocytes in the CA1 region of the hippocampus with 
stimulation of Schaffer collaterals synapsing on CA1 pyramidal cells (48). These data 
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demonstrate that rapid clearance of synaptic glu is accomplished mainly through diffusion but a 
significant level of glu persists at the perisynaptic regions. This persistence of neurotransmitter 
is not due to heteroexchange functions of the EAATs (glu in - glu out) since application of the 
competitive transportable substrate threo-hydroxyaspartate (THA; a substrate which could 
induce heteroexchange for cytoplasmic glu) results in the same activation of iGluRs as does 
application of the non-transportable competitive inhibitor DL-threo-β-hydroxybenzoylaspartate 
(DL-TBOA; 86). The influence of EAAT-mediated glu buffering and transport capacity on 
hippocampal circuitry during high frequency stimulation was investigated (87). Synaptically 
evoked transporter currents (STCs) from CA1 region astrocytic carriers (EAAT1 and EAAT2) 
were not significantly altered after a series of stimulations at near-physiological temperatures 
arguing for a very capacious glu uptake system in the hippocampus. To further clarify the 
mechanism of glu removal surrounding the synapse (perisynaptic regions), Schaffer collatorals-
CA1 pyramidal cells synapses were exposed to a low affinity N-methyl-D-aspartate receptor 
(NMDAR) antagonist and the effects of TBOA blockade on NMDAR mediated EPSCs were 
measured (88). Results indicated that TBOA inhibition of the perisynaptic EAATs resulted in an 
increase in non-synaptically located, or distal, NMDAR activation. Additionally, replacement of 
internal cations in a post-synaptic neuron for NMDG+, effectively blocking transport, also 
significantly altered the activation of NMDARs suggesting a role for post-synaptic neuronal 
EAATs in limiting spillover activation from adjacent synapses, a role which was previously 
attributed predominately to the glial EAAT isoforms. Investigations using EAAC1 (mouse 
EAAT3) knock-out transgenic models refined the role of post-synaptic EAAC1 by speeding the 
decay constant of NMDAR activation in the presence of a low affinity antagonist, supporting the 
role these carrier play in modulating NDMAR activation, especially NR2B containing receptors, 
in perisynaptic spaces (89). This study, however, did not support the role of EAAC1 in limiting 
glu spillover to adjacent synapses. From these data, it is clear that EAATs not only modulate 
post-synaptic receptor activation but can regulate activation of ionotropic receptors located at 
17 
 
sites beyond the synaptic cleft. The distance that synaptically released glu can influence activity 
supports the need for a diverse and widely localized family of carriers.   
1.5.2. The Role of EAATs in the Cerebellum 
The role of glu transporters is similar for many brain regions although differences in expression 
pattern, synaptic architecture, and general features of circuitry all can influence glutamatergic 
neurotransmission. Due to the high concentration of EAAT4 (a higher affinity yet lower turnover 
rate isoform) expressed in the cerebellum, Otis et al. (1997) (90) investigated buffering of 
released glu from climbing fiber-Purkinje cell synapses (CF-PC). Results indicated some 
synaptic glu transporters as well as perisynaptic EAATs could rapidly buffer upwards of 22% of 
glu released from a single vesicle. In the cerebellar cortex, EAAT4 mimics the actions of EAAT3 
in the hippocampus by rapidly buffering synaptic glu. Although both EAAT3 and EAAT4 are 
expressed in CF synapses, investigations using EAAT3 and EAAT4 transgenic knockouts into 
the relative contribution of these two carriers in the CF synapse revealed a dominate role for 
EAAT4 as compared to EAAT3 in this system (91). To investigate the role of glial carriers 
(predominately EAAT1) in cerebellar excitatory neurotransmission, climbing fibers were 
stimulated and caused a rapid onset of EAAT transport currents in Bergmann glial cells which 
persisted for a prolonged period of time, supporting the notion of rapid escape of glu from the 
synapse and slow re-uptake once diffused to extrasynaptic regions (92).  
One of the most striking features of the CF-PC synapse is the concentrations of glu that 
are released following CF stimulation. CF-PC synapses have been thoroughly demonstrated to 
mediate multivesicular release and moderate firing rates induce a significant glu spillover (93). 
Spillover of glu causes activation of molecular layer interneurons (MLIs) and was observed in 
the cerebellum during activation of CF-PC synapses (94). This spillover mechanism is so 
profound that excitation of MLIs can mediate feed-forward inhibition and alter activity patterns in 
neighboring interneurons and Purkinje cells (95). Thus at the synaptic cleft, perisynaptic space, 
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and even at adjacent synapses glu transporters play vital roles in regulating the concentration of 
extracellular glu.   
1.5.3. EAATs Influence Activation of Metabotropic Glu Receptors and Synaptic Plasticity 
It is clear that glu transporters in conjunction with diffusion regulate the temporal and spatial 
pattern of glu after various modes of release. How does this spatial-temporal profile effect 
perisynaptic receptor activation and downstream processes such as synaptic plasticity? It has 
been observed that EAAC1 activity regulates NMDAR activation in the hippocampus but the 
consequences of ionotropic activation go beyond basic excitatory transmission. It is well 
demonstrated that activation of NMDAR (and some Ca2+ permeable AMPARs) can lead to 
several forms of synaptic plasticity (96-98). NMDAR activation is a key component to many 
alterations of synaptic strength. This alteration has been demonstrated to take various forms 
such as presynaptic alteration, typically reported as a difference in quanta,  as well as 
postsynaptic alterations such as changes in AMPAR surface expression (99-101). The extent to 
which EAAT3 limits activation of perisynaptic NMDARs is great enough to influence both LTP 
and LTD in the CA1 region of the hippocampus (89). Metabotropic GluRs (mGluRs) have a 
significant role in changes in synaptic strength in the CA1 region of the hippocampus (98,102). 
As we have described here, it is clear that EAATs mediate the ability for glu to activate 
perisynaptic receptors and as the affinity of many of the mGluRs for glu is lower as compared to 
iGluRs, the role of EAATs in regulating mGluR activation is pronounced. Indeed, inhibition of 
EAATs in the CA1 region of the hippocampus caused an enhancement of mGluR1α mediated 
currents in O-LM interneurons in that region (103). Likewise, application of TBOA to rat 
hippocampal slices altered the activation of mGluR5 and group III mGluRs supporting a general 
mechanism of EAATs regulating glu accessibility to any perisynaptically localized glu receptor 
(104). Thus, in the hippocampus, EAAT mediated regulation of receptor activation is a critical 
process that modulates not only fast excitatory neurotransmission but ionotropic and 
metabotropic regulation of synaptic function and strength.  
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The role of EAATs in modulating synaptic plasticity is not constrained to the 
hippocampus as demonstrated by investigations into the cerebellum. EAAT4 expression in the 
cerebellum is localized adjacent to the post-synaptic density (PSD) which overlaps with that of 
metabotropic glutamate receptors (mGluRs). Inhibition of post-synaptic EAAT4 (and EAAT3 to 
some extent) causes a significant enhancement of long-term depression (LTD) in PF-PC 
synapses through an mGluR dependent process (105,106).  Additionally, in CF-PC synapses 
the presence of a group 1 mGluR component is only observed when EAATs are inhibited 
(106,107). This mGluR activation has profound roles in CF associated LTD but also in synaptic 
pruning of multiple climbing fiber inputs to the PC early in development, and in general provides 
a CF-PF homosynaptic form of regulation tightly mediated by glu release and EAAT activity.  
Thus, one of the many roles of EAATs is to influence activation of mGluRs and subsequent 
synaptic functioning. Regional differences in the ability of Purkinje cells to be regulated through 
mGluR dependent activity are strongly controlled by the expression pattern of EAAT4 in the 
cerebellum (108). Another study demonstrated that LTD of PCs synapses results in a decrease 
in postsynaptic AMPAR expression and a concomitant persistent increase of post-synaptic 
EAAT4 currents (109). Thus, as synaptic strength is decreased by AMPAR trafficking, EAAT4 
levels likely increase to compensate for the decreased number of receptors by enhanced rapid 
buffering of glu and regulation of perisynaptic glu concentrations. Overall, these data presented 
here, and elsewhere, strongly support the role of glu carriers in shaping several aspects of 
neuronal functioning. 
 
1.6. CONCLUSION 
Glu transporters or EAATs regulate extracellular glu dynamics throughout the nervous system. 
The role of neuronal isoforms has expanded to included such processes as cysteine transport 
for glutathione synthesis (110,111) and glu uptake for GABA synthesis (112), but the prevailing 
hypothesis is that glial isoforms mediate the bulk of glu transport and have the greatest degree 
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of influence on extrasynaptic receptor activation. Excess glutamatergic signaling can lead to 
excitotoxic cell death and during ischemic conditions the transporters themselves become 
potent releasers of glu. The activities of EAATs are indicated in almost every process of 
neurotransmission and we are still trying to understand the roles of the chloride channel activity 
these transporters mediate. It is likely that the channel function of the EAATs can indeed 
regulate cellular activity either through offsetting inward positive charge movement associated 
with a high capacity transport mechanism or through acting as a classic ionotropic Cl- receptor. 
Indeed it is an exciting time to study this fascinating family of carriers and their roles in shaping 
glutamatergic neurotransmission.    
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2. INWARD FACING STATES OF EXCITATORY AMINO ACID TRANSPORTERS MEDIATE 
OPEN CHANNEL STATES 
 
2.1. INTRODUCTION 
L-glutamate (glu) is the major excitatory neurotransmitter in the brain. Synaptically released glu 
is rapidly buffered by binding to neuronal transporters although the majority of neurotransmitter 
diffuses and is cleared by glial and perisynaptic neuronal carriers (81,82,84). Dysfunction of 
excitatory amino acid transporters (EAATs) has been hypothesized to be pathogenic in 
Alzheimer’s disease, amyotrophic lateral sclerosis (ALS), Parkinson’s disease, and ischemia 
(1,113). In humans, a family of five glu transporters are responsible for the clearance of glu 
(114). EAATs are organized as homotrimers within the membrane and possess 8 
transmembrane domains (TM1-8) and 2 re-entrant  or hairpin loops (HP1 and HP2), (7). These 
secondary active, electrogenic carriers co-transport substrates with 2-3 Na+ and 1 H+ (26). After 
intracellular release of substrates, a K+ ion binds to the cytoplasmic facing transporter and 
allows for reorientation of the carrier in a rate-limiting  process (27,33). Glu binds to a 
transporter already bound with at least 1 Na+ ion, followed by H+ and the last Na+ ion(s) 
(27,35,50). The initial translocation of substrate generates approximately 2 inward charge 
movements and happens on a rapid time scale of 3-5 milliseconds (33). This leaves the 
transporter in the inward facing states for the majority of the transport cycle, ~ 15-30 msec.    
EAATs also possess a thermodynamically uncoupled anion conductance that is 
activated by ligand interactions (10,43,45). Modifying single cysteine mutants in HP2, a hairpin 
loop that serves as the external gate for substrate binding, locks the gate in the open position. 
This significantly disrupts glu transport capacity yet still allows for substrate binding and full 
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channel activity, thus supporting the hypothesis that distinct domains influence channel and 
transport function in the EAATs (115-117). These data demonstrate that gate modifications can 
restrict transporter conformation and can be used to study intact channel functionality.  
The EAAT associated anion channel is gated by initial Na+ interactions and the channel 
open probability is increased upon subsequent glu binding (46,50,52,53). Although, the channel 
activity during these first steps of the transport cycle has been thoroughly examined, a detailed 
investigation of channel activity mediated during other steps of the transport cycle, including 
steps where Na+ and/or glu ions remain bound to inward facing conformations, has not yet been 
performed in EAAT1. Experiments investigating the ability for glu to induce channel activity 
when applied to the intracellular face of the other EAAT isoforms using inside-out patch clamp 
recordings revealed that glu can induce significant anion flux (40,41,45). Recent results from 
combined experiments and modeling using EAAT4 indicate the possibility that all states in the 
transport cycle have an associated open channel state (118). To date, similar experiments have 
not been performed in EAAT1, thus it remains unclear if EAAT1 shares the same conducting 
states as the other isoforms.  
In the present study we developed an approach to restrict the transporter to inward 
facing states of the cycle by modifying the intracellular gate HP1 and then assaying for channel 
activity. Incubation of EAATs with high external K+ has been demonstrated to drive the carriers 
to the inward facing states where the transporter would need to rebind K+ or both Na+ and glu to 
reorient back to the outward facing states (20,22,39,119). Chemical modification of single 
cysteine mutants in the region of HP1 occur within the cytoplasm only when the carrier is 
inwardly oriented (120). After incubations with K+ conditions to drive the transporter to the 
inward facing state, modification of the exposed HP1 region restricts subsequent conformational 
changes, thus effectively trapping the carriers in an inward facing conformation. By chemically 
modifying L376C, a point mutation within HP1, we were able to use two electrode voltage clamp 
(TEVC) to observe an anion flux with similar properties to the outward, Na+ bound conducting 
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states. These novel data reveal anion conducting states during the glu transport cycle. Because 
the transporter spends the majority of the time in inward facing states, these findings highlight 
the potential of anion flux to contribute to neuronal function through prolonged channel activity.     
 
2.2. EXPERIMENTAL PROCEDURES 
2.2.1. Generation of Mutant EAAT Constructs and Cell Transfections  
Site directed mutagenesis was performed as previously described (116). Briefly, human CSLS 
EAAT1 constructs, in which all endogenous cysteine residues were mutated to serine, were 
used as a background for subsequent Quikchange (Stratagene) reactions to generate all 
cysteine point mutations used. All mutations were performed with the EAAT1 construct in the 
oocyte expression vector pOTV and were subsequently subcloned into pCDNA3.1 (rEAAT4) or 
pCMV5 (hEAAT1) using Kpn1 and Xba1 (New England Biolabs) restriction sites for mammalian 
expression. COS7 cells were transiently transfected using Lipofectamine 2000 (Invitrogen) two 
days prior to use for experiments. For oocyte experiments, stage VI oocytes were injected with 
10 ng of cRNA generated from EAAT1 pOTV constructs using mMessage mMachine T7 kit 
(Ambion) (10).   
2.2.2. Radiolabeled Glu Transport Assays 
Radiolabeled uptake assays were performed two days after transient transfection. 500 µM of 
either Na+ glu or K+ glu salts were mixed with 200 nM 3,4-3H-L-glu (Perkin Elmer) and applied to 
EAAT expressing COS-7 cells or Xenopus oocytes for 10 min. Cells were washed with 
phosphate buffered saline containing 1 mM MgCl2 and 0.1 mM CaCl2 (PBSCM) before and after 
glu incubations in COS-7 experiments. Oocytes were washed with ND96 buffer containing 96 
mM NaCl, 2 mM KCl, 1.8 mM MgCl2, 1 mM CaCl2, and 10 mM HEPES, pH 7.4. Various 
concentrations of N-ethylmaleimide (NEM) (Sigma-Aldrich) or (R)-(+)-N-(1-
Phenylethyl)maleimide (NPEM) (Sigma-Aldrich) were applied for various time points and then 
removed by washing immediately before addition of radiolabeled glu. Cells were lysed with 0.1 
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N NaOH and 1% SDS and liquid scintillation counting was used to record radiolabel 
accumulation in the cells. 
2.2.3. Cell Surface and Cysteine Targeted Biotinylations 
COS-7 were transiently transfected two days prior to experimentation. Cells were washed 3x 
with PBS before incubation with 80 µM maleimide-long arm-biotin (Vector Labs) or BCCM-Biotin 
(Pierce) for 40 min at 4OC. Reactions were quenched by addition of 100 mM L-glycine for 20 
min and cells were lysed before addition of EZ-link neutravidin agarose beads (Thermo 
Scientific). Western blots were run on a 8-16% tris-glycine gel (Invitrogen) and the transferred 
blot was probed using a lab-generated rabbit α hEAAT1 C-terminus antibody at a 1:1000 
dilution (68). Secondary antibodies, goat α rabbit conjugated to HRP, were used at a 1:5000 
dilution.  
2.2.4. Electrophysiology 
Two electrode voltage clamp recordings were performed using a Geneclamp 500 (Molecular 
Devices). Holding potential was set to -60 mV and 500 msec command ramps were performed 
from -120 mV to +60 mV. Current amplitudes used for data analysis were taken from the last 
100 msec of the ramp to ensure measurement of steady state conditions. Standard extracellular 
recording buffers used consisted of 96 mM NaNO3, 2 mM KCl, 1.8 mM MgCl2, 1 mM CaCl2, and 
10 mM HEPES, pH 7.4 (NaNO3 or high extracellular Na
+ buffer). Incubations with modification 
reagents were done with either  96 mM NaCl, 2 mM KCl, 1.8 mM MgCl2, 1 mM CaCl2, and 10 
mM HEPES, pH 7.4 (ND96), or  98 mM KCl, 1.8 mM MgCl2, 1 mM CaCl2, and 10 mM HEPES, 
pH 7.4 (K98 or high extracellular K+ buffer). Standard electrodes were pulled to a resistance of 
0.5 – 2 MΩ and were filled with 3 M KCl. A 3 M KCl salt bridge was used for all experiments and 
signals were filtered at 1 kHz with a low-pass Bessel filter and sampled at 50 kHz. All currents 
were recorded using pClamp10 software and digitized with a Digidata 1440A A/D converter 
(Molecular Devices). Modification of cys point mutations with permeable reagents used a 4 min 
perfusion of various concentrations of N-ethylmaleimide (NEM) or N-phenylethylmaleimide 
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(NPEM) in K98 or ND96 buffers with a gravity fed flow rate of ~ 5-10 ml/min unless otherwise 
noted. Post-modification washes consisted of ND96 for at least 2 min to ensure complete 
removal of reagents before recording. 
2.2.5. Homology and Kinetic Models  
Tertiary structural models of EAAT1 were generated using the software package Modeller 
version 9.11 (121).  First, the sequence for EAAT1 was aligned with the protein sequence of 
GltPh extracted from the coordinate files of the open (3KBC.pdb) or the closed (1XFH.pdb) 
structures obtained from the pdb repository (RCSB.org).  The alignments were accomplished 
using a combination of a Clustal algorithm and manual optimization in the MacVector software 
suite.  These alignments were then used by Modeller to thread the EAAT1 sequence on the 
published structures followed by optimization to satisfy spatial restraints. The PyMOL Molecular 
Graphics System, Version 1.5.0.4 (Schrödinger, LLC) was used to modify color and orient 
structures. Chembiodraw Version 13 (Perkin Elmer) was used to construct the state diagram. 
2.2.6. Data Analysis and Statistics 
Electrophysiology data were analyzed using Clampfit version 10.2 (Molecular Devices) and 
Prism version 5 (Graphpad). All other data were analyzed using Prism. To control for expression 
variability in the oocytes, TEVC data were normalized within each oocyte as indicated in the 
figures. Time course data was fit with a single exponential decay of  
          (                       )     
             
and was used to generate a time constant  . Kinetic curves of steady state current amplitudes at 
+60 mV in response to various concentrations of glu were fit with a Michaelis-Menten equation 
of  
                  
(       [   ])
(    [   ])
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Figure 5: Modification of L376C restricts the transporter to inward facing states. (A-D) 
Current-voltage relationships obtained from oocytes expressing EAAT1 L376C (A, B) or EAAT1 
CSLS (C, D) in response to a series of voltage ramps ranging from -120 mV to +60 mV. Each 
experimental group was perfused with NaNO3 + 500 µM L-glu (black squares), and NaNO3 + 
100 µM DL-TBOA (green triangles). 250 µM NEM was perfused for 4 min in the presence of 
high extracellular K+ buffer (A, C), or a high extracellular Na+ buffer (B, D). NaNO3 + 500 µM L-
glu applications were then repeated following NEM incubation (pink). Data are displayed as the 
mean and std dev. and was normalized to currents at + 60 mV for the unmodified L-glu 
response. (A-D) Data are an average of 20 individual cells for each condition from at least 3 
separate frogs. (E) Radiolabeled uptake assay of CSLS EAAT1 (white) and L376C (black) 
expressed in Xenopus oocytes. Conditions are a 4 min pre-incubation of either vehicle control, 
250 µM NEM in either high extracellular K+ buffer (K+) or high extracellular Na+ buffer (Na+), or 1 
mM MTSET in high extracellular K+ buffer (K+). Counts per min were normalized to vehicle 
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conditions. (F) Current amplitudes from varying concentrations of L-glu in L376C, pre- (black 
squares) and post- (pink squares) modification using a 250 µM NEM perfusion for 4 min. The 
currents were fit to a Michaelis-Menton equation as described in the experimental procedure. 
(E-F) Data are displayed as the mean and S.E.M. with an N of 8 for all conditions from 3 
separate frogs. Stars indicate statistical significant difference with a Bonferroni post-analysis 
after a significant 2-way ANOVA comparing isoform and condition.  
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All statistical analysis was done using a 2-way ANOVA comparing isoform/construct versus 
condition with an α = 0.05 (unless otherwise noted) and comparisons between conditions were 
made using a Bonferroni post-test analysis.           
 
2.3. RESULTS 
2.3.1. NEM Modification of L376C Captures the Inward Facing Conformations of the 
Transport Cycle 
To examine whether the inward facing states of EAAT1 can mediate anion channel activity, we 
used a cysteine modification strategy to trap or restrain transporters in the inward facing 
conformations. To capture carriers in these states, we modified a single cysteine point mutation, 
L376C, located in HP1. Modification consisted of a 4 min incubation of 250 µM NEM in 
conjunction with high external K+ to stabilize the inward facing conformations of the transport 
cycle or high extracellular Na+ buffers to stabilize the outward facing conformations.  After 
modification, we tested whether extracellularly applied substrates could still bind and gate the 
channel. We hypothesized that modification of the inward oriented transporter with an exposed 
HP1 could sterically hinder further conformational changes or the ability to reenter outward 
facing conformations of the transport cycle. Therefore, we would expect to see a decrease in glu 
induced current amplitudes subsequent to modification of HP1. Incubation of Xenopus oocytes 
expressing L376C EAAT1, with a high K+ extracellular solution (K+) containing 250 µM of the 
sulfhydryl-modifying reagent NEM, caused a 41.9 + 2.3% reduction (p < 0.001) in the amplitude 
of NO3 currents activated by 500 µM L-glu (Fig 5A). This modification was selective for the 
inward facing state of the transporter because incubation of NEM in high Na+-containing buffer 
ND96 (Na+), which stabilized the outward facing states in the absence of glu, did not alter glu-
induced NO3 current amplitudes at positive membrane potentials after modification (Fig 5B). We 
chose to highlight potentials at +60 mV because there are no significant contributions of 
currents generated by electrogenic glu transport to the macroscopic currents observed at this 
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potential. In addition, parallel incubations of CSLS EAAT1 controls with NEM in either K+ or Na+ 
based solutions did not alter glu-induced channel activity after exposure to NEM (Fig 5C, D). 
These results indicate that L376C undergoes partial modification when the carrier is inwardly 
oriented, due to K+ mediated reversal of the transport cycle, but this residue remains 
inaccessible when the carrier is in the outward facing- Na+ bound orientations. As hypothesized, 
there was a dramatic loss of extracellular substrate mediated channel activity after successful 
modification of L376C. Moreover, these results also suggest that the modification of HP1 
maintains the carrier in the inward conformation as there was a dramatic loss of current 
amplitudes mediated by extracellularly applied substrates. These results are consistent with a 
decreased number of transporters in the outward conformation necessary for interaction with 
extracellular substrates.  
Changes in glu induced current amplitudes after modification of L376C with NEM while 
the transporter is the inward conformation could be due to an unknown alteration to the anion 
pore. To test for a specific loss of anion flux or a loss in the number of transporter available for 
interaction with extracellular substrates, we assayed for a change in transport activity in L376C. 
Modification of L376C by NEM in high extracellular K+ buffers alters transport capacity as 
radiolabeled glu accumulation inside the cell was disrupted by 36.8 % + 8.5 % (p < 0.05) (Fig 
5E), indicating an effect beyond simple alteration of anion flux. Additionally, as a control for an 
unforeseen effect of mutation and/or modification of L376C on the structure of the transporter, 
we also tested whether a membrane impermeant sulfhydryl modification reagent applied to the 
L376C EAAT1 while the transporter is driven to the inward facing states using high extracellular 
K+ buffers could label the L376C residue. Oocytes preincubated with 1 mM MTSET in high K+ 
buffer displayed no significant effect on uptake, consistent with L376C only able to be labeled 
from the cytoplasmic face. We next examined whether the reduction in the glu induced current 
amplitudes after modification (Fig 5A) was due to a loss of glu mediated gating of the anion 
channel caused by changes to substrate recognition and binding. To address a possible change  
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Figure 6: Modification of L376C is time and concentration dependent (A) Current-voltage 
relationship of L376C pre and post exposure to 1 mM NEM for 4 min. Shown are NaNO3 
induced currents (grey circles), 500 µM L-glu induced currents (black squares), current in the 
presence of 100 µM DL-TBOA (green triangles), and glu induced current amplitudes post-NEM 
incubation (maroon squares). Data are presented as the mean and Std. dev. between 6 and 15 
oocytes from at least 3 distinct experiments. (B) CSLS or L376C EAAT1 current amplitudes 
from +60 mV quantitated in bar graph form. Conditions are NaNO3 + 500 µM L-glu (black), 
NaNO3 + 500 µM L-glu after a 4 min perfusion of 250 µM NEM (pink), after 500 µM NEM (red), 
or after 1 mM NEM (maroon). Data are normalized to the response elicited by unmodified 
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transporters exposed to glu (black). The dashed line indicated cellular current amplitudes 
elicited by NaNO3 application alone. Data are displayed as the mean and S.E.M. from between 
8 and 15 oocytes from 3 frogs (C) Time course of the loss of glu-gated anion current amplitudes 
at + 60 mV in CSLS (red squares) or L376C (red circles) transporters with exposure to 500 µM 
NEM for various times in high extracellular K+ buffer. Currents were normalized to the amplitude 
elicited by saturating glu concentrations before exposure to NEM. Data are represented by the 
mean and S.E.M. for an N of 6 and was fit with a single exponential decay according to the 
experimental procedures. The dashed line indicated cellular current amplitudes elicited by 
NaNO3 application alone. (D) Uptake of radiolabeled glu in CSLS (white) or L376C (black), with 
a 4 min preincubation of either high extracellular Na+ buffer alone (Vehicle), 1 mM NEM in high 
extracellular Na+ buffer (NEM (Na+)), 1 mM NEM in high extracellular K+ buffer (NEM (K+)), or 1 
mM MTSET in high extracellular K+ buffer (MTSET (K+)). Data are the mean and S.E.M. of 
between 8 -30 oocytes from > 3 frogs. (E) Current amplitudes of NaNO3 induced anion channel 
activity (grey) and in the presence of 100 µM DL-TBOA (green) pre (left) and post (right) 
exposure of L376C to 500 µM NEM for 6 min in high extracellular K+ buffer. Data are reported 
as the mean and S.E.M. of an N of 8 from at least three individual frogs. Stars indicate statistical 
significant difference with a Bonferroni post-analysis after a significant 2-way ANOVA comparing 
isoform and condition. (F) Representative western blot of COS-7 cells expressing either CSLS 
E1 or L376C proteins exposed to maleimide-biotin as described in the experimental procedure. 
Immunoreactivity was between 62 and 84 kDa as per previously described for EAAT1 (116). 
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in glu recognition, we assayed for the apparent affinity of glu for L376C EAAT1 before and after 
modification by NEM. Furthermore, the affinity for glu to gate the anion channel was not 
significantly altered by NEM modification of L376C. The KM of glu for gating of the anion 
channel, pre and post NEM modified L376C were 4.29 + 0.93 µM and 4.25 + 1.60 µM 
respectively, with a 37.7 % decrease in activity post-modification (Fig 5F), results congruent with 
loss of the number of transporters available for interaction with extracellular substrates. 
2.3.2. Modification of HP1 to Restrict Conformation is Time and Concentration 
Dependent  
The modification of HP1 using a 4 min perfusion of 250 µM NEM resulted in only a partial loss of 
subsequent glu induced currents (Fig 5A). If modification of L376C is indeed restricting the 
carrier to the inward facing state, then a complete loss of glu interaction after full modification of 
the transporter population would be observed, if the modification of L376C restricts further 
conformational changes of the transporters. Consistent with this hypothesis, the reduction of glu 
current amplitudes should be dependent on the concentration and time of NEM exposure. A 
representative I-V plot of the mean of responses to extracellular glu, pre- and post- modification 
using 1 mM NEM for 4 min, displays the complete loss of substrate interactions after complete 
modification of L376C in high extracellular K+ conditions (Fig 6A). When oocytes were exposed 
to either 500 µM or 1 mM NEM for 4 min, total cellular currents at +60 mV in the presence of glu 
were reduced by 56.5 + 3.1% and 75.9 + 2.4% respectively, as compared to the 30.4% reduction 
seen with a 4 min perfusion of 250 µM NEM in these experiments (p < 0.001; Fig 6B) . 
Modifications using 1 mM NEM for 4 min reduces glu induced currents to amplitudes observed 
for Na+ gated or leak currents (dashed line) suggesting a complete modification (Fig 6A and 
6B). To further characterize the modification reaction, 500 µM NEM was perfused onto oocytes 
for several time points in either ND96 or K98 extracellular solutions. The time course of NEM-
dependent reduction of glu induced currents in L376C followed a single exponential decay with  
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Figure 7: The inward facing conformations of EAAT1 have open channel states. (A) (left) 
Current amplitudes from +60 mV, displayed in bar graph form, of CSLS and L376C responses 
from perfusion of NaNO3 + 500 µM L-glu (black), 100 µM Dl-TBOA (green), and NaNO3 (grey). 
A 4min incubation of 250 µM NEM in high extracellular K+ buffer (K+) buffer was performed and 
then conditions retested, NaNO3 + 500 µM L-glu post NEM (pink) and NaNO3 post NEM (light 
blue). (right) Conditions are the same as in (left) except the 4 min perfusion of NEM was done in 
high extracellular Na+ buffer (Na+). Bar graphs are presented as the mean and S.E.M. of 
between 6 and 20 oocytes from > 3 frogs. (C) Current-voltage relationship from cellular 
responses between -150 mV to +60 mV to the application of 100 µM DL-TBOA (green 
triangles), NaNO3 (grey circles), NaNO3 + 500 µM L-glu (black squares), and NaNO3 post 
modification (light blue circles). Modification was a 4 min perfusion of 250 µM NEM in high 
extracellular K+ buffer (K+) buffer. I-V curve presented is the mean and std. dev. for an N of 15 
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from > 3 frogs. (D) Mean cellular current amplitudes of CSLS and L376C expressing oocytes (N 
of 8-15 oocytes from > 3 frogs) at +60 mV in the presence of NaNO3 alone after exposure to 
either vehicle controls (grey), 250 µM NEM (light blue), 500 µM NEM (blue), or 1 mM NEM (dark 
blue) for 4 min. (A-D) Stars indicate statistical significant difference with a Bonferroni post-
analysis after a significant 2-way ANOVA comparing isoform and condition. 
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a time constant of 2.41 + 0.57 min, consistent with a simple bimolecular reaction (Fig 6C). These 
simple reaction kinetics also support the idea that L376C is readily accessible in the K+ induced 
conformation and does not require more additional conformational changes in order to be 
modified as additional conformational changes would significantly alter the kinetics of the 
labeling reaction. Radiolabeled glu uptake was also impaired after modification with 1 mM NEM 
for 4 min in high K+ buffer, with 17.8 % + 2.7 % of transport activity remaining (p < 0.001). 
Additionally, Oocytes preincubated with 1 mM MTSET in high K+ buffer for 4 min displayed no 
significant effect on uptake, consistent with accessibility of L376C only from the cytoplasmic 
face (Fig 6D). To provide additional support for the total loss of substrate interaction observed 
after complete modification, saturating concentrations (100 µM) of the competitive antagonist 
DL-TBOA were applied before and after modification with 500 µM NEM in high extracellular K+ 
buffer for 4 min. Total cellular current amplitudes were reduced by 39.8 % + 3.8 % (p < 0.001) 
with antagonist application before modification, and no change in current amplitude was seen 
with TBOA exposure after modification, consistent with a loss of inhibitor interaction (Fig 6E). To 
further support the modification strategy, we attempted to selectively pull down inward facing 
conformational states of the transporter using biotin labeling of L376C under high extracellular 
K+ buffers. Western blot analysis of protein demonstrate our ability to selectively pull down 
inward facing L376C EAAT1 molecules using either BCCM-biotin or maleimide (long arm) biotin 
labeling of L376C under the high extracellular K+ conditions (Fig 6F). Incubation of cells with the 
same cysteine specific biotinylation reagents in high Na+ buffer did not enrich for biotinylated 
proteins. Thus the labeling of the mutant HP1 residue L376C allows for a continuous exposure 
of the biotin moiety to avidin conjugated beads. This supports the idea that HP1 persist in an 
exposed state after modification as we can capture inward facing transported with a biotin 
labeled HP1. All these data support that after modification of L376C, HP1 is constrained in an 
exposed state/s and limits subsequent conformational changes to the outward facing states, 
eliminating extracellular substrate or inhibitor interactions. 
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Figure 8: Modifications of HP1 residue A355C. (A) Current-voltage relationship of HP1 
mutant A355C perfused with NaNO3 + 500 µM L-glu (black squares), NaNO3 alone (grey 
circles), and NaNO3 + 100 µM DL-TBOA (green triangles). 250 µM NEM was perfused for 4 min 
in the presence of high extracellular K+ buffer. NaNO3 alone (light blue circles) and NaNO3 + 
500 µM L-glu (pink squares) applications were then repeated following NEM incubation. Data 
were normalized to currents at + 60 mV for the unmodified L-glu response. Data are shown as 
the mean and std. dev. of current amplitudes from 5 to 12 oocytes from > 3 experiments. (B) 
Current amplitudes at + 60 mV quantitated in bar graph form for A355C exposed to NEM 
incubations in either high extracellular Na+ buffer (Na+) or high extracellular K+ buffer (K+). 
Conditions displayed are NaNO3 + 500 µM L-glu pre- (black) and post- (pink) application of 250 
µM NEM for 4 min. The current response in the presence of NaNO3 alone pre- (grey) and post- 
(light blue) NEM application is also displayed. Dashed line indicated background oocytes 
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currents as revealed by application of 100 µM DL-TBOA. (C) Radiolabeled glu uptake assay of 
CSLS (white) and A355C (black) expressed in Xenopus oocytes. Conditions are a 4 min pre-
incubation of either vehicle control (ND96), 250 µM NEM in either ND96 (Na+) or K98 (K+), and 
1 mM MTSET in K98 (K+) followed by a 10 min incubation with 500 µM glu + 200 nM 
radiolabeled glu. Counts per minute were normalized to control conditions. (B) and (C) are 
depicted as the means and S.E.M. Data are an average of at least 20 individual oocytes for 
each condition from at least 3 separate frogs. Stars indicate statistical significant difference with 
a Bonferroni post-analysis after a significant 2-way ANOVA comparing salt and condition. 
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2.3.3. Inward Facing States Possess Anion Channel Activity  
The modification of HP1 after the carrier is in the inward facing states results in the capture of 
one or more inward states. We next used two electrode voltage clamp recordings (TEVC) to 
examine channel activity after HP1 modification. Application of 250 µM NEM for 4 min in high 
extracellular K+ buffer results in a significant reduction in extracellular glu interaction yet current 
amplitudes in NaNO3 alone were not altered with the carriers trapped in the inward facing state 
(Fig 7A, C). While the modification of HP1 is dependent on NEM in the presence of external K+, 
there is no significant difference in currents in the presence of NaNO3 alone in either L376C or 
CSLS when exposed to 250 µM NEM for 4 min in either high Na+ or high K
+
  buffers (Fig 7B). As 
complete modification of L376C requires higher concentrations of NEM or longer incubation 
times of the reagent (Fig 6A and 6C), NaNO3 induced current amplitudes were measured after 
exposing either L376C or CSLS expressing oocytes to 250 µM, 500 µM, or 1 mM NEM (Fig 7D). 
No significant change in EAAT1 currents in the absence of glu was observed indicating that the 
inward facing states of EAAT1 can mediate transitions to open channel states with macroscopic 
properties which mimics the outward facing, open states in the presence of NaNO3 alone. This 
is the first evidence for open channel states mediated by EAATs while biochemically restricted 
to the cytoplasmic facing conformations.    
2.3.4. Modification of HP1a Residue A355C Also Captures Inward Facing States 
In order to control for non-specific effects of L376C modification affecting channel properties 
through long range distortions, we repeated the basic phenomenon using another HP1 cysteine 
substitution mutant, A355C. This residue has also been previously demonstrated to be 
conformationally sensitive, with intracellular accessibility to reagents only during incubations in 
high extracellular K+ buffers (71,120). Modification of A355C expressing oocytes with 250 µM 
NEM for 4 min caused a 21.9% + 3.4% decrease in subsequent glu induced current amplitudes 
(p < 0.0001) (Fig 8A, B). Likewise, radiolabeled glu uptake was reduced by 50.1% + 12.4% (p < 
0.01) under the same experimental conditions (Fig 8C). As seen with L376C, application of  
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Figure 9: HP1 is readily accessible by the bulky modification reagent NPEM. (A) I-V plot of 
TEVC recordings of L376C exposed to a NaNO3 (grey circles) or NaNO3 + 500 µM L-glu (black 
squares) and after a 4 min incubation of 250 µM NPEM in high extracellular K+ buffers (K+), 
(light blue circles and pink squares, respectively). Data are shown as the mean and Std. dev. of 
an N of 6 oocytes from 3 frogs. (B, C) Bar graph of CSLS, L376C, and A355C current 
amplitudes at + 60 mV exposed to either NaNO3 + 500 µM L-glu (black), NaNO3 + 500 µM L-glu 
post NPEM exposure (pink), NaNO3 (grey), and NaNO3 post NPEM exposure (light blue). 
NPEM was perfused in high extracellular K+ buffers (B) or high extracellular Na+ buffers (C). (B) 
and (C) are reported as the mean and S.E.M. of 6 to 10 oocytes from at > 3 frogs. Stars indicate 
statistical significant difference with a Bonferroni post-analysis after a significant 2-way ANOVA 
comparing isoform and condition. 
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1mM MTSET in high external K+ buffers had no significant effects of transport activity 
suggesting that A355C is not modifiable from the extracellular milieu. These data are consistent 
with the hypothesis that HP1 dynamics are important for conformational changes subsequent to 
the inward facing states. Additionally, the effects of NEM on A355C support the interpretation 
that modification of HP1 limits subsequent conformational changes of the transporter and the 
effects of modification on accessibility to extracellular substrates is not due to other non-specific 
alteration in transporter structure since it would be highly improbable that modification of two 
distant residues would both lead to the same structural and functional aberrations.  
2.3.5. HP1 Accommodates Alternative Modification Reagents 
We next examined whether different modifying reagents might have distinct effects on the 
function of HP1 mutants after modification. We hypothesized that a larger modifying reagent 
may have less accessibility to HP1 and thus display a decreased change to glu induced current 
amplitudes after modification on HP1a (A355C) versus HP1b (L376C). (R)-(+)-N-(1-
Phenylethyl)maleimide (NPEM) is another sulfhydryl-reactive, membrane permeable reagent 
that when applied to either L376C or A355C caused an identical phenotype to that observed 
with NEM (Fig 9A). A 4 min exposure of 250 µM NPEM under high extracellular K+ buffers 
caused a 39.1% + 6.0% and a 38.4% + 5.6% decrease (p < 0.001) in saturating glu induced 
current amplitudes at +60 mV for L376C and A355C respectively (Fig 9B). As demonstrated 
with NEM modifications, labeling of HP1 residues with NPEM is dependent on extracellular K+ 
driving the transporter to the inward facing states because incubations conducted in high Na+ 
have no significant effect on transporter currents at +60 mV (Fig 9C). As both NEM and NPEM 
have similar effects on HP1 residues, these residues are readily accessed by both large and 
small reagents, consistent with the idea that the carrier resides in the inward conformation with 
HP1 possibly locked open after modification (32,122).  
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2.3.6. The EAAT1 Transport Cycle Depicting Open Channel States 
Our data presented here demonstrate that EAAT-associated anion conductances persist when 
the transporter is restricted to the inward facing states. The first crystal structure from 
Pyrococcus horikoshii (GltPh) likely depicts an outward-occluded state and illustrates a HP1 
domain embedded within transmembrane helices associated with transport function. Although 
residues of the HP1a/b loop can be modified by impermeant reagents in the outward 
conformations (122), residues buried lower in either HP1a or HP1b appear occluded in this 
structure. Interestingly, another crystal structure which was captured using HP2/TM2 
crosslinking depicts a cytoplasmically exposed HP1 where modifications of this structure would 
be predicted to occur readily. Human EAAT1 (hEAAT1) homology models based on the GltPh 
archeal asp transporter also illustrate these two distinct orientations of HP1 and support the 
changes in accessibility of this region in the outward and inward-oriented states (Fig 10A and B, 
respectively).  
Current models for open channel states occupied during the glu transport cycle rarely 
consider channel activity while in the inward facing state. Our model includes two new open 
states mediated by Na+ interaction in the cytoplasmic facing carrier (Fig 10C). These open 
channel states are likely identical to the open channel states seen in the outward, Na+-bound 
conformations. Additionally, these new open states are presumed to have the same unitary 
conductance and open probabilities because compensatory alterations in both parameters that 
generate the same net current amplitudes would be possible, although improbable.     
2.4.  DISCUSSION 
Here we describe a simple approach to conformationally restrain glu transporters into the inward 
facing states through modifying HP1 residues under high external K+ conditions. Under these 
conditions we readily observe a conductance state in the absence of glu that allows for currents 
similar in amplitude to the open channel states mediated by the outward facing conformations in 
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Figure 10: Model of hEAAT1 structures and proposed state diagram of general EAAT 
transport cycle including novel anion conducting states. (A) Homology model of hEAAT in 
the outward facing state based on the GltPh crystal structure from (7) (pdb file 3FXH). Helices 
are depicted in ribbon form (wheat) with a stick model of A355C and L376C (red) circled for 
easy of identification. (B) Homology model of hEAAT1 crystal structure in a proposed inward-
facing state adapted from (32) (pdb file 3KBC) color scheme is the same as in (A). (C) Kinetic 
diagram depicting substrate interactions and conformational states. Depicted are open channel 
states (*) in outward facing conformations in the absence of glu (grey), inward-facing open 
channel states in the absence of glu (blue), glu induced open channel states in outward facing 
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conformations (black), and inward facing open channel states mediated by glu interaction 
(fuchsia). Substrate binding order was adapted from (34). 
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the absence of glu. To our knowledge this is the first direct evidence for a conductance or open 
probability of the channel states mediated by the inward facing conformations seen during the 
transport cycle in the absence of glu. Since there are at least several inward facing states which 
are known to exist, it is not possible to ascertain which specific state or sub-states our 
modification restricts the transporter in. Nonetheless, these data supports that after modification 
of the carriers in the presence of high extracellular K+, the carriers are indeed inward facing for 
at least three reasons. First, it has been demonstrated by multiple groups that a high 
extracellular concentration of K+ will drive the reverse transport of glu but only in conditions 
where the intracellular composition of the cell has been altered to allow for reverse transport, i.e. 
high intracellular Na+ and glu concentrations (4,20,22,36). This is not the case for oocytes 
where reverse transport would be minimal due to the low intracellular concentrations of Na+ and 
the low affinity of the inward facing conformations of the transporters for glu (39,123). Therefore, 
a high extracellular concentration of K+ will allow the accumulation of carriers into the inward 
facing states, presumably in equilibrium between the inward open, K+ bound, Na+ bound, and 
Na+/glu bound states. It is under these states that modifications explored in the current study 
occur and thus it is likely that we have captured one or more of these states.  
Second, the lack of extracellular glu interactions is what functionally defines the 
occluded and inward facing states. As we have demonstrated here, after complete modification 
of HP1 residues, we no longer have extracellular accessibility of substrates to the transporter. 
Again, it is presumed that the transporters are mediating channel activity through interactions 
with substrates with the intracellular facing binding site or are alternatively observing novel 
gating mechanisms of the channel. Although these data presented here does not demonstrate 
the existence of inward facing, glu-induced conductances, these data do not preclude their 
existence. Indeed, it has been demonstrated using inside-out patches that intracellular glu can 
gate the anion conductance of transporters thus supporting the existence of inward-facing, glu-
gated anion conductance (41,45). Since intracellular concentrations of Na+ are low in the 
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oocyte, and the inward facing carrier’s affinity for glu is significantly reduced (27), it is likely that 
the fraction of glu-bound, inward oriented transporters is very low. This state may be such a low 
probability in our system that it would not significantly alter macroscopic current amplitudes over 
current amplitudes in the presence of Na+ alone. Thus, our model (Fig 10C), does depict glu 
induced open channel states in the cytoplasmic facing carriers (TI) as they have been 
demonstrated previously (36,41,45) although these glu induced, inward facing states are not 
observed in our experiments. 
Lastly, modification of EAAT reentrant loops and their relationship to channel activity has 
been previously examined. Modification of a cysteine point mutation V449C in HP2 has been 
reported to lock the transporter into the outward open conformation. Glu and TBOA binding from 
the extracellular space was not significantly altered nor was there any inhibition of channel 
function by the modification alone (115). These results have been demonstrated for several HP2 
point mutations as well suggesting that modifying the external gate in several residue positions 
in HP2 is sufficient to restrict the transporter into the outward open state (117,124). It is 
generally thought that HP1 functions in a manner analogous to HP2 (for a cogent argument, see 
(57)). Therefore, it is likely that an open, inward conformation is a low energy, stable state and 
that HP1 modification locks the transporter into the inward open state. Additionally, our rate of 
modification closely models a simple bimolecular reaction. These data would not have been 
observed if the transporter was undergoing additional conformational changes as a prerequisite 
for modification to occur. Additional conformational changes would have altered the order and 
the kinetics of the reactions and therefore would be observed in the experiments. Although 
these data do not rule out a possible unimolecular rearrangement of the transporter 
conformation after modification has occurred, we were able to isolate exposed, biotin modified 
L376C EAATs using an avidin capture as demonstrated in Fig 6F. These data all support the 
interpretation that we have likely captured inward-facing conformations of the transport cycle 
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through modification of HP1 while in the inward facing states, mediated by K+ induced 
reorientation of the EAATs.      
Bergles et al. (34) first described a kinetic model comprised of 15 individual states in the 
transport cycle. This diagram is a combination of data and modeling and 8 of those 15 states 
were described to have associated open channel states in which anions could permeate. The 
“leak” or Na+ gated channel state was attributed to the outward, 2 Na+ and H+ bound state. The 
only inward states described in this model to permit anion flux were the 2 Na+ bound state 
(Ti2Na), and the K
+ bound state (TiK). As many of these states, such as the TiK open channel 
state, were never directly examined, it is unclear which channel states exists for all EAAT 
isoforms (47). Recently, work from Kovermann et al. (2010) (125) and Machtens et al. (2001) 
(118) supports additional anion conducting states accessible during multiple conformations of 
the glu transport cycle. For rEAAT4, independent or mutually exclusive channel and transport 
states were assigned for all outward Na+ bound states as well as the TiNa and TiK states (125) 
(see Fig 10C). Additionally, experiments as well as simulations were combined in order to 
describe conducting states associated with other steps in the transport cycle. Our data support 
many of the interpretations of these groups, that multiple anion conducting states are mediated 
by inward-facing conformations. 
We have performed several assays in order to better describe the nature of this 
modification and its effects on function. L376C exposure to a low concentration of NEM in 
conjunction with high extracellular K+ buffers results in a loss of available carriers for 
extracellular substrate binding (reduced Vmax) with an unaltered binding mechanism (similar 
KM) (Fig 6B). These data are typical of reduced availability of extracellularly exposed 
transporters, but the available transporters still maintain an intact binding mechanism. If the 
modification of L376C was reducing surface transporter levels, then there would be a reduction 
in current amplitudes in the absence of glu, to a similar degree as observed for glu gated 
conductance post-modification. As displayed by Fig 7D, increasing the number of transporters 
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modified by increasing the concentration of NEM used in the experiment, never alters current 
amplitudes in the presence of NaNO3 alone.  
Mutations and modifications can yield effects through unforeseen alterations or long 
range effects and so we examined a different residue to test that our strategy for mediating 
inward facing states is valid. A355C is an HP1a residue and shows a conformation-dependent 
accessibility similar to L376C, which is located in HP1b. If L376C was perturbing the structure of 
EAAT1 through unusual means, then we might expect to see disparate results with other 
residues which are separated by even a moderate distance. This is not the case as A355C 
modifications using high external K+ buffers results in near identical channel phenotypes, 
supporting our interpretation of how HP1 modifications can affect transporter functionality. Our 
procedure is also robust in that it can accommodate at least 3 different modification reagents as 
well. NPEM has similar properties to NEM but possesses a large phenyl group. This could, in 
theory, have different accessibility to either L376 or A355 but our data shows identical results 
when compared to NEM-based modifications. A comparison of these data from NEM, NPEM, 
and maleimide-biotin modifications suggest that even modification of HP1 residues by NEM is 
sufficient to restrict further conformational change in EAAT1. This accommodating yet sensitive 
behavior of HP1 might suggest that an inward structure contains a more constricted 
environment surrounding HP1 than initially indicated from structural data depicting a dramatic 
cytoplasmic exposure of HP1 (Fig 10B), or possibly it could indicate a more dynamic role for 
HP1, then has previously been hypothesized (7,126,127). It is always a significant challenge is 
made structural interpretations based on functional data. Although we cannot definitively identify 
exactly what conformation of the transporter a modified L376C is in, our data all support the 
interpretation that a modified L376C is likely trapped in inward facing conformations of the 
transport cycle.     
Little is known about the how anion channel activity regulates neuronal functioning. 
Although strong evidence supports a role for EAAT5 regulating neuronal activity in the retina 
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(44,58,59), EAAT5 has some distinct properties compared to the other isoforms (128). 
Additional data will be required to establish the significance of EAAT mediated channel activity 
for the other isoforms. Here we describe a simple method to isolate inward facing conformations 
of the EAAT transport cycle, and using this approach we identified novel open channel states. 
An understanding of the contributions of these novel states to EAAT function should aid in 
efforts to establish the role of the anion channel in regulating neuronal or glial excitability and 
glu clearance.  
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3. THE DIFFERENCE IN THE Na+ DEPENDENCE OF ANION CHANNEL GATING 
BETWEEN NEURONAL AND GLIAL ISOFORMS OF GLUTAMATE TRANSPORTERS 
 
3.1. INTRODUCTION 
Excitatory amino acid transporters (EAATs) are a family of five carriers in the central nervous 
system (1). EAAT1 and 2 are located in glial, although there are some reports of neuronal 
expression of EAAT2 (6,8). EAAT3 is ubiquitously expressed in neurons and EAAT4 neuronal 
expression is extensive but most notable for its robust expression in the cerebellum (9,10,12). 
EAAT5 is exclusively expressed in neurons of the retina (11). Glial EAATs have been 
demonstrated to mediate the majority of L-glutamate (glu) transport and EAAT2 (GLT-1 in 
rodents) specifically is responsible for upwards of 90% of glu removal after synaptic release due 
to its high levels of expression in the glial membrane (14,85). Strong evidence supports the 
hypotheses that neuronal transporters such as EAAT3 and EAAT4 limit activation of peri- or 
extra- synaptic receptors through rapid buffering of synaptically released glutamate 
(82,84,88,89). This buffering activity has been demonstrated to affect processes such as 
synaptic plasticity through activation of N-methyl-D-aspartate receptors (NMDARs) or 
metabotropic glutamate receptors (mGluRs) (89,103,105,106,129).  
All members of the EAAT family function as secondary active, electrogenic transporters 
with the translocation of 1 glu molecule coupled to the co-transport of 3 Na+, 1 H+, and the 
counter-transport of 1 K+ ion (26,27). This coupling allows the net inward movement of 2 
positive charges with each glu molecular translocated into the cytoplasm. EAATs have a 
turnover rate of approximately 15-90 cycles per second across the isoforms (33,35). EAATs 
also possess a thermodynamically uncoupled anion conductance. This anion channel is 
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promiscuous with a permeability sequence generally following SCN- > ClO4
- > NO3
- > I- > Br- > 
Cl-. Contemporary data support that the anion channel is gated by the initial binding of Na+ and 
the open probability of the channel is subsequently increased upon glu interaction 
(49,50,53,130). Although a physiological role for the EAAT-mediated anion conductance has yet 
to be demonstrated in all isoforms, there are data which describe the significance of the EAAT5 
anion channel in regulating cellular activity in the retina (44). One elegant study has 
demonstrated that Cl- flux through EAAT5 regulates bipolar cell membrane potentials and 
modulates synaptic release rates (58). Additional data have substantiated the role of EAAT5 as 
a ligand gated ionotropic receptor (11,59,128) and together these data support the need for 
additional research in order to better address the roles of these channel activities.   
To date, only minor differences have been found between the 5 mammalian isoforms 
such as the affinity for glu (2.5 µM for EAAT4 to 97 µM for EAAT2) and the kinetics of transport 
(12,53,131,132). Any difference in the basic stoichiometry or number of open channel states 
has not been readily observed in previous studies (34,47,48,133). However, It has been 
suggested that EAAT2 may possess some additional conducting states compared to EAAT4 (or 
EAAT3) (34,47). These minor differences have not been attributed to any particular residues or 
structural disparities and are not know to mediate any significant difference in the regulation of 
glutamate in the synapse and beyond. Interestingly, no differences in function discovered thus 
far can be attributed to the difference in cell-type expression in vivo. Here we report that glial 
isoforms of glutamate transporters, EAAT1 and EAAT2, mediate Na+ independent open channel 
states or “leak” conductance states as compared to the classically Na+ dependent, neuronal 
isoforms EAAT3 and EAAT4. This is the first report to correlate a difference in anion channel 
gating mechanism by cell-type expression and ushers in a new avenue to study the relative 
roles of the various EAAT isoforms in shaping synaptic activity.         
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3.2. EXPERIMENTAL PROCEDURES 
3.2.1. Transfections in Mammalian Cell lines and cRNA Injections in Xenopus Oocytes 
Human EAAT1 (hEAAT1), hEAAT2, hEAAT3, or rat EAAT4 (rEAAT4) were subcloned into 
pcDNA3.1 (Invitrogen) using Kpn1 and XbaI restriction sites. rEAAT4 was used over hEAAT4 
due to significantly better expression in oocytes and only minor differences in primary sequence. 
tsA201 cells (European Collection of Cell Lines, ECACC) were transfected using Lipofectamine 
2000 (Invitrogen) or Fugene 6 (Promega) and incubated in DMEM with 10% FBS and pen/strep. 
pEGFP was used as a co-tranfection marker for electrophysiological recordings. 1 day before 
recording, cells were trypsinized and plated onto 12 mm coverslips for whole cell patch clamp 
experiments.  
For expression in Xenopus oocytes hEAAT1, hEAAT2, hEAAT3, and rEAAT4 were 
subcloned into pOTV using Kpn1 and XbaI restriction sites as previously described (36). 
Constructs were linearized with either SmaI (EAAT1-3) or BamHI (EAAT4). cRNA was made 
using mMessage mMachine T7 kit (Ambion) (5). 50 ul injection (10 ng total RNA) was delivered 
to each oocyte using a Nanoliter 2000 injection system (WPI). Oocytes were incubated at 18oC 
for 2 days after injection in 96 mM NaCl, 2 mM KCl, 1 mM CaCl2, 1.8 mM MgCl2, and 5 mM 
HEPES, pH 7.4 (ND96) containing 50 µg/ml pen/strep, 50 µg/ml of gentamycin, and 50 µM Na+ 
pyruvate.      
3.2.2. Radiolabeled Glu Transport Assays 
Radiolabeled uptake assays were performed two to three days after injection of cRNA. Oocytes 
were pre-incubated for 4 hours in either 96 mM NaNO3, 2 mM KNO3, 1 mM CaCl2, 1.8 mM 
MgCl2, and 5 mM HEPES, pH 7.4 (NaNO3), or 96 mM ChOH, 96 mM HNO3, 2 mM KNO3, 1 mM 
CaCl2, 1.8 mM MgCl2, and 5 mM HEPES, pH 7.4 (ChNO3) prior to transport assays. Oocytes 
were washed with either NaNO3 or ChNO3 and incubated with 10 µM glu with 200 nM 3,4-3H-L-
glu (Perkin Elmer) for 10 min in the appropriate buffers. All oocytes were washed three times 
with NaNO3 after glu incubations and were lysed with 0.1 N NaOH and 1% SDS before liquid 
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scintillation counting was used to record radiolabel accumulation of tritiated glu in individual 
cells. 
3.2.3. Two-Electrode Voltage Clamp Recordings 
Two electrode voltage clamp recordings (TEVC) were performed using a Geneclamp 500 
(Molecular Devices) on stage V-VI oocytes two days after injection of cRNA constructs. Holding 
potential was set to -60 mV and 500 msec voltage command ramps were performed from -120 
mV to +60 mV. Current amplitudes used for data analysis were taken from the last 100 msec of 
the ramp to ensure measurement of steady state conditions. Standard extracellular buffers used 
were either NaNO3, ChNO3, or 96 mM NMDG
+, 96 mM HNO3, 2 mM KNO3, 1 mM CaCl2, 1.8 
mM MgCl2, and 5 mM HEPES, pH 7.4 (NMDGNO3). Electrodes were pulled to a resistance of 
0.5 – 2 MΩ and were filled with 3 M KCl. A 3 M KCl salt bridge was used for all experiments. All 
currents were recorded using pClamp10 software with on-line filtering at 1 kHz using a Bessel 
filter and digitized with a Digidata 1440A A/D converter (Molecular Devices) at 50 Hz. 
3.2.4. Whole-Cell Patch Clamp Recordings 
Pipettes were pulled from borosilicate glass (Warner Instruments) and fire polished to a tip 
resistance of 2-5 MΩ Pipette solutions contained 115 mM CholineCl, 2 mM MgCl2, 5 mM EGTA, 
and 10 mM HEPES. pH was adjusted to 7.3 with 8.6 M CholineOH. Extracellular solutions 
contained 140 mM NaSCN, 4 mM KCl, 2 mM MgCl2, 2 mM CaCl2, and 10 mM HEPES, or 144 
mM KSCN, 2 mM MgCl2, 2 mM CaCl2, and 10 mM HEPES, unless otherwise noted.  pH was 
adjusted to 7.4 with 10 N NaOH. Whole-cell recordings were made from tsA201 cells 2-3 days 
after transfection with an Axopatch 200B amplifier (Molecular Devices) in voltage-clamp mode. 
Series resistance compensation was set to at least 85% in all experiments.  Signals were low-
pass filtered at 5 kHz (8-pole Bessel; Warner Instruments) and collected at a sampling 
frequency of 10 kHz. Recordings from cells where series resistance exceeded 20 MΩ or 
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currents exceeded -100 pA at -70 mV in the presence of 100 µM DL-TBOA were excluded from 
analysis. 
3.2.5. Data Analysis and Statistics  
All data was analyzed with Prism v5 (Graphpad) and electrophysiological recordings were also 
analyzed using Clampfit v10 (Molecular Devices). 2-way ANOVAs comparing isoform vs 
condition, unless otherwise noted, with an α = 0.05 were used for all experiments. Bonferroni 
post analysis test were used to compare between groups. Stars indicate a significant difference 
between groups as noted in the figure captions. EAAT mediated currents are defined here as 
the whole cell currents observed minus the currents observed in the presence of Na+ and 
saturating concentrations (100 µM) of the competitive EAAT channel and transporter antagonist 
DL-threo-β-benzoyloxyaspartate (DL-TBOA). Macroscopic currents are defined as the whole 
cell currents observed without any subtraction procedure.   
 
3.3. RESULTS 
3.3.1. Neuronal and Glial EAATs Diverge by Their Na+ Dependence of Anion Channel 
Activity 
Anion channel activity has been demonstrated to be gated by substrate interaction (10), 
however a comprehensive analysis of the ability of Na+ interaction to gate the anion channel in 
all isoforms has not been performed. In EAAT1, replacement of total extracellular Na+ with 
choline (Ch+) does not affect EAAT mediated NO3 current amplitudes (Figure 11A, C). The 
same Na+ replacement strategy reduces EAAT mediated current amplitudes in EAAT4 
expressing oocytes by 95.8 + 4.6% (equivalent to a 50.5 + 4.8% reduction in macroscopic 
current amplitude; p < 0.001; Figure 11B, C).  Interaction of either glu or DL-TBOA is dependent  
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Figure 11: Replacement of external Na+ with Ch+ abolishes anion flux in EAAT4 but not 
EAAT1. A-B) Conditions displayed are NaNO3 (closed circles), NaNO3 + 500 µM glu (closed 
squares), NaNO3 + 100 µM DL-TBOA (closed triangles), ChNO3 (open circles), and ChNO3 + 
100 µM DL-TBOA (open triangles). Currents were normalized to the response to application of 
saturating glu application at +60 mV and are represented by the mean and S.E.M. of 8 
individual oocytes from > 3 frogs. A) Plot of the current-voltage relationship (I-V plot) of 
Xenopus oocytes expressing EAAT1. B) I-V plot of the responses to conditions described in A) 
from oocytes expressing EAAT4. C) Bar graph of the currents amplitudes at +60 mV in oocytes 
expressing EAAT1 and EAAT4 in response to applications of NaNO3 (black), NaNO3 + 100 µM 
TBOA (white), ChNO3 (grey), and ChNO3 + 100 µM TBOA (dark grey). Data are normalized to 
the cellular response to perfusion of NaNO3 alone at +60 mV and is expressed as the mean and 
S.E.M. for 10-12 oocytes from > 3 frogs. D) Radiolabeled accumulation of 200 nM 3,4-3H-L-glu 
and 10 µM glu in oocytes expressing EAAT1 or EAAT4 in the presence of NaNO3 (black) or 
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ChNO3 (white) buffers as described in the experimental procedures. Data in CPMs were 
normalized to transport activity for the NaNO3 conditions and is displayed as the mean and 
S.E.M. for 8-12 oocytes from > 3 frogs. Stars indicate statistical significant difference with a 
Bonferroni post-analysis after a significant 2-way ANOVA comparing isoform and condition.   
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on the ordered binding of 1 or 2 Na+ ions and replacement of extracellular Na+ with Ch+ 
abolishes all substrate or inhibitor interactions. This is demonstrated by the loss of inhibition of 
EAAT1 mediated current amplitudes in the presence of saturating DL-TBOA when co-applied 
with a ChNO3 buffer (Figure 11A). Current amplitudes mediated by EAAT4 were already 
reduced by over 95% with the removal of Na+ and therefore DL-TBOA co-application did not 
significantly alter the loss of these currents (Figure 11B).  Also, co-application of glu in ChNO3 
buffers does not significantly alter current amplitudes above application of ChNO3 alone (Figure 
1C; p < 0.001). Consistent with the loss of glutamate mediated channel activity in the absence 
of Na+, radiolabeled transport in EAAT1 is reduced after Ch+ substitutions by 96.4 + 0.7% (p < 
0.001) and uptake is abolished after removal of Na+ in EAAT4 by 90.9 + 2.8% (Figure 11D; p < 
0.001). These data all suggest that substrate interactions are disrupted by Na+ replacement. 
Taken together, these data support the hypothesis that EAAT4 anion channel activity is 
dependent on the presence of Na+ ions but EAAT1 demonstrates Na+ independent conducting 
states. 
One of the apparent differences between EAAT1 and EAAT4 is their cell type expression 
in tissue. EAAT1 is exclusively glial while EAAT4 is restricted to neurons (13,134,135). 
Therefore to test if the functional difference in Na+ gating activity is related to this divergence in 
expression in the nervous system, we examined EAAT2, a glial isoform, and EAAT3, another 
neuronal isoform. As demonstrated for EAAT1, the replacement of extracellular Na+ for Ch+ 
resulted in no significant alteration in NO3 current amplitudes for EAAT2 expressing oocytes 
(Figure 12A, C). A 59.7 + 4.6% decrease in macroscopic amplitudes (p < 0.001) was observed 
in EAAT3 expressing oocytes in Ch+ buffer as compared to the 72.6 + 1.8% decrease in 
macroscopic current amplitudes in the presence of 100 µM DL-TBOA. Therefore the removal of 
extracellular Na+ results in an 82.2% decrease in EAAT3 mediated current amplitudes, with 17.8 
% of channel activity remaining (Figure 12B, C). These results are consistent with the data  
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Figure 12: Replacement of external Na+ affects EAAT3 but not EAAT2. A-B) Conditions 
displayed are NaNO3 (closed circles), NaNO3 + 500 µM glu (closed squares), NaNO3 + 100 µM 
DL-TBOA (closed triangles), and ChNO3 (open circles). Currents were normalized to the 
response to application of saturating glu application at +60 mV and are represented by the 
mean and S.E.M. of 9-17 individual oocytes from > 3 frogs. A) Plot of the current-voltage 
relationship (I-V plot) of Xenopus oocytes expressing EAAT2. B) I-V plot of the responses to 
conditions described in A) from oocytes expressing EAAT3. C) Bar graph of the currents 
amplitudes from +60 mV in oocytes expressing EAAT2 and EAAT3 in response to applications 
of NaNO3 (black), NaNO3 + 100 µM DL-TBOA (white), ChNO3 (grey), and ChNO3 + 500 µM glu 
(dark grey). Data are normalized to the cellular response to perfusion of NaNO3 alone at +60 
mV and is expressed as the mean and S.E.M. for 6-20 oocytes from > 3 frogs. D) Radiolabeled 
accumulation of 200 nM 3,4-3H-L-glu and 10 µM glu in oocytes expressing EAAT1 or EAAT4 in 
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the presence of NaNO3 (black) or ChNO3 (white) buffers. Data in CPMs were normalized to 
transport activity for the NaNO3 conditions and is displayed as the mean and S.E.M. for 15-25 
oocytes from > 3 frogs. Stars indicate statistical significant difference with a Bonferroni post-
analysis after a significant 2-way ANOVA comparing isoform and condition.   
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observed with EAAT1 and EAAT4, radiolabeled glu uptake in the presence of Ch+ buffers was 
significantly decreased by 98.3 + 3.3% and 95.7 + 1.2% (p < 0.001) for EAAT2 and EAAT3, 
respectively. Thus, glial isoforms EAAT1 and EAAT2 display Na+ independent anion channel 
activity while neuronal isoforms display a strong Na+ dependence of anion channel activity. 
3.3.2. Choline Buffers do not Support Transporter Activity 
Although glu addition to ChNO3 didn’t significantly increase current amplitudes at +60 mV, 
suggesting that Ch+ is not binding to the Na+ binding site (Fig 11C and 12C). It could be argued 
that Ch+ may be binding allosterically to EAAT1 and EAAT2 and this could support channel 
activity in some manner. To control for this possibility, we repeated the previous Na+ 
replacement experiments using N-methyl-D-glucamine (NMDG+) instead of Ch+. As 
demonstrated for the Ch+ substitution experiments, replacement of extracellular Na+ with 
NMDG+ caused a significant reduction in channel activity in oocytes expressing EAAT3 and 
EAAT4 but not EAAT1 or EAAT2 (Figure 13A-D). Interestingly, EAAT3 current amplitudes were 
not reduced to background levels as observed with application of 100 µM DL-TBOA. Indeed 
EAAT3 mediated currents were only reduced by 61.0 + 1.8% in the presence of NMDG+. EAAT4 
expressing oocytes displayed a 103 + 1.9% decrease in EAAT mediated current amplitudes in 
response to Na+ replacement with NMDG+. Interestingly, the incomplete loss of channel activity 
observed with EAAT3 in the presence of ChNO3 as well as NMDG
+ (Figures 11C, 12B, C) might 
indicate the presence of both Na+ gated and Na+ independent open states. This is in contrast to 
the other isoforms which display either a complete retention (EAATs 1 and 2) or abolishment 
(EAAT4) of current amplitudes in the presence of either Ch+ or NMDG+.  
The application of saturating (500 µM) glu concentrations in the presence of NMDG+ did 
not significantly alter current amplitudes in any of the EAAT isoforms tested (Figure 13D) as 
opposed to Na+ and glu co-applications (Figure 13E). In addition to NMDG+ not supporting the 
gating mechanism induced by glu binding, NMDG+ substitution also does not support glu  
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Figure 13: NMDG+ replacement of Na+ mimics Choline substation on EAATs 1-4. A-D) 
Conditions displayed are NaNO3 (closed circles), NaNO3 + 500 µM glu (closed squares), 
NaNO3 + 100 µM DL-TBOA (closed triangles), NMDGNO3 (open circles). Currents were 
normalized to the response to application of saturating L-glu application at +60 mV and are 
represented by the mean and S.E.M. of 6-14 individual oocytes from > 3 frogs. A) Plot of the 
current-voltage relationship (I-V plot) of Xenopus oocytes expressing EAAT1. B) I-V plot of the 
responses to conditions described from oocytes expressing EAAT2. C) I-V plot of the responses 
to conditions described from oocytes expressing EAAT3. D) I-V plot of the responses to 
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conditions described from oocytes expressing EAAT4. E) Bar graph of the currents amplitudes 
from +60 mV in oocytes expressing EAAT1, EAAT2, EAAT3, and EAAT4 in response to 
applications of NaNO3 (black), NaNO3 + 100 µM DL-TBOA (white), NMDGNO3 (grey), and 
NMDGNO3 + 500 µM glu (dark grey). Data are normalized to the cellular response to perfusion 
of NaNO3 alone at +60 mV and is expressed as the mean and S.E.M. for 5-12 oocytes from > 3 
experiments. F) Radiolabeled accumulation of 200 nM 3,4-3H-L-glu and 10 µM L-glu in oocytes 
expressing EAATs 1-4 in the presence of NaNO3 (black) or NMDGNO3 (white) buffers. Data in 
CPMs were normalized to transport activity for the NaNO3 conditions and is displayed as the 
mean and S.E.M. for 6-20 oocytes from > 3 experiments. 
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transport activity. Radiolabeled transport is significantly reduced in EAATs 1-4 with EAAT1 
demonstrating a 92.2 + 0.9% decrease in transport capabilities, EAAT2 a 94.6 + 2.0% 
reduction, EAAT3 a 94.6 + 0.4% reduction, and EAAT4 a 103 + 14.9% reduction (Figure 13F; p 
< 0.001 for all conditions). Therefore, the loss of anion channel activity in neuronal EAAT 
isoforms 3 and 4 is due to the loss of Na+ interactions when we replace all external Na+ with 
either Ch+ or NMDG
+. Likewise, the persistence of currents in EAAT1 and EAAT2 are due to Na+ 
independent conducting states. Since the macroscopic amplitudes of the leak states are similar 
or the same as the channel states in the presence of Na+, these EAAT1 and EAAT2 leak open 
channels states are possibly of the same single channel conductance and open probability as 
the channel states in the presence of Na+. Alternatively these properties would have to be 
altered in the opposite but equal manner to mediate an unaltered macroscopic current.  
3.3.3. Na+ Mediated Channel Gating in EAAT3 and EAAT4 is Concentration-dependent 
We next examined the nature of Na+ mediated channel gating in both glial and neuronal 
isoforms by assaying the relationship between Na+ concentration and channel activity. By 
systematically replacing increasing amounts of Na+ with equal molar concentrations of Ch+, we 
observed a significant dependence of EAAT4 channel activity on extracellular Na+ concentration 
(Figure 14A). EAAT4 demonstrated a concentration-dependent decrease in whole cell currents 
with a 73.5 + 8.9% reduction of macroscopic current amplitudes in 0 mM Na+ as compared to 98 
mM [Na+] (p <0.001). Channel activity in EAAT1 was not significantly altered at any 
concentration of Na+ (Figure 14A). Comparing EAAT2 and EAAT3 demonstrates the same 
patterns of responses. Macrocopic current amplitudes in EAAT3 expressing oocytes, in the 
absence of glu, are significantly reduced with systematic Na+ removal yet EAAT2 macroscopic 
current amplitudes do not significantly change at any concentration of Na+ (Figure 4B). EAAT3 
macroscopic currents were reduced by 68.6 + 5.3% in 0 mM Na+ (p < 0.001). Typically an 
estimation of Na+ affinity would be possible with the datum generated by this type of assay, 
however, without a saturation of currents with increasing Na+ concentrations, a curve fit would  
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Figure 14: Na+ gating of anion channel activity is concentration dependent in neuronal 
EAATs. A) Total cellular currents from oocytes expressing either EAAT1 (circles) or EAAT4 
(squares) in response to perfusions of varying concentrations of Na+. Na+ was replaced with 
equal molar concentrations of Ch+. B) Currents recorded from oocytes expressing EAAT2 
(circles) or EAAT3 (squares) in response to application of varying concentrations of Na+ as 
described in A). A-B) Currents were normalized to the response of application of NaNO3 at +60 
mV and represent the mean and S.E.M. from 5-12 oocytes for each condition and > 3 
experiments. (*) indicates a probability that the two isoforms are significantly different at each 
Na+ concentration point with a of p < 0.05, (**) indicates a p < 0.01, and (***) indicates a p < 
0.001 from a 2-way ANOVA with a Bonferroni post-analysis comparison as described under the 
experimental procedures.   
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Figure 15: Replacement of internal Na+ causes a loss of inward facing anion channel 
currents in neuronal isoforms only. A) Whole cell patch clamp recordings of I-V curves from 
tsA201 cells transiently expressing EAAT1. Cells were dialyzed with a ChCl pipette solution as 
described in the experimental procedures. Extracellular solutions used were NaSCN (closed 
circles), NaSCN + 500 µM L-glu (closed squares), NaSCN + 100 µM DL-TBOA (closed 
triangles), and KSCN buffer (open circles). Currents were normalized the response elicited by 
application of NaSCN alone at +150 mV and represent the mean and S.E.M. of 7 cells. B) 
Whole cell patch clamp recordings of I-V curves from tsA201 cells transiently expressing 
EAAT4. Conditions are the same as described for A) and are displayed as the mean and S.E.M. 
from 3 cells from 2 experiments. C) Bar graph displaying the quantitation of current amplitudes 
at +150 mV from cells as described in A) and B). Conditions displayed are NaSCN + 500 µM glu 
(white), NaSCN (black), NaSCN + 100 µM DL-TBOA (dark grey), and KSCN buffer (light grey).  
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not be accurate and therefore we did not attempt to estimate an affinity for Na+. Previous 
estimations place the effective concentration of Na+ which yields half maximal channel activity 
(EC50) for the empty, outward facing transporters at 98 mM for EAAT2 (35), 80 mM for EAAC1 
(EAAT3) (50), and 42 mM for EAAT4 (132), consistent with our partial data. 
3.3.4. The Channel Activity Mediated by the Inward Facings States of EAAT1 and EAAT4 
Display a Disparate Na+ Dependence 
EAATs operate through a reversible transport cycle. Therefore, exposure of EAATs to high 
extracellular K+ concentrations drives the carriers to the inward facing states during the reverse 
transport cycle (20,22,39,119). Inward facing transporters need to bind either intracellular K+ to 
complete the forward transport cycle or Na+ and glu to mediate reverse transport or an 
exchange cycle. Thus, without these intracellular conditions, the carriers will be locked in the 
inward facing states in the presence of high extracellular K+ solutions. Using whole-cell patch 
configurations of EAAT expressing tsA201 cells, we dialyzed the endogenous cytoplasmic K+ 
and Na+ and replaced these cations with Ch+. This allows for the persistence of the inward 
facing states and the determination of the Na+ dependence of the inward facing conducting 
states. Under these conditions we see no significant difference in current amplitudes from 
inward oriented open channels states, mediated by the KSCN extracellular solutions and the 
outward facing conformation-mediated open channel states observed in NaSCN extracellular 
solutions, in EAAT1 (Figure 15A, 15C). However, in the same experimental paradigm, EAAT4 
macroscopic currents, under high extracellular K+ buffers (KSCN), were significantly reduced in 
amplitude by 27.6 + 0.8 % (p < 0.001, student’s t-test; Figure 15B, 15C). Thus, the conducting 
states mediated by inward facing conformations show a similar Na+ dependence as the outward 
facing conducting states (Fig 11). The glial carrier EAAT1 mediates a Na+ independent anion 
“leak” conductance while the neuronal carrier EAAT4 displays Na+ dependent channel activity in 
both the outward and inward facing conformations of the transport cycle. 
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Figure 16: State diagrams for neuronal and glial EAATs differ in number of open channel 
states. A) State diagram representing the transport cycle and open channel states of glial 
glutamate carriers EAATs 1 and 2. Conformations of the transport cycle are colored black. Open 
channel states are depicted in various colors; Leak conducting states (red), glutamate gated 
open states (blue), glutamate gated states mediated by the inward facing transporter 
conformations (green). B) State diagram representing the transport cycle and open channel 
states of neuronal EAATs 3 and 4. Open channel states displayed are low conductance or open 
probability leak states (fuchsia, EAAT3 only), Na+ gated open states (red), glutamate gated 
open states (blue), glutamate gated states mediated by the inward facing transporter 
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conformations (green). Substrate binding order was adapted from (34). Inward facing open 
channel states were interpreted from (41,45). The [To2Na
+H+] conducting state was omitted for 
clarity of the diagram and would be a low open probability conducting state colored red. State 
diagrams were made using ChemBioDraw v13 (Perkin-Elmer).   
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3.3.1. Glial and Neuronal EAATs have a Different Number of Open Channel States  
These data presented here allows us to refine the EAAT state diagram to include novel open 
channel states and to separate glial and neuronal carriers. Our models are adapted from the 15 
state transport cycle originally proposed by Bergles et al. (34). Depicted for the glial carriers 
EAAT1 and EAAT2 are 12 open channel states of at least two different open probabilities or 
single channel amplitudes (Figure 16A). The “leak” or low open probability channel states are 
depicted in red and the glu gated open channel states are shown as blue (outward facing 
conformations) and green (inward facing conformations). As demonstrated by our model, the 
empty, outward facing carrier ([To]) mediates the same macroscopic currents as the Na
+ bound 
conformations ([ToNa
+] – [To2Na
+]) and thus are both colored red. Figure 16B depicts the open 
channel states for neuronal carriers EAAT3 and EAAT4. EAAT4 is diagramed with 10 open 
channel states in the presence of bound Na+ (red) and Na + glu (blue/green) (Figure 16B). 
EAAT3 is depicted to possess an additional open channel state mediated by the empty 
transporter that is a lower open probability and/or single channel conductance (fuchsia) then in 
the presence of extracellular Na+. The glu gated anion conducting states modeled in green for 
both glial and neuronal transport diagrams represent conducting states reported in previous 
publications (41,45).    
   
3.4. DISCUSSION 
Here we demonstrate a difference in the gating mechanism between neuronal and glial EAAT 
isoforms. The ability of EAATs to mediate an anion flux in the absence of glutamate binding, 
classically term the “leak” conductance, has been accepted for many years. Our data indicate 
that Na+ binding to EAAT3 and EAAT4 is necessary for channel opening but EAATs 1 and 2 
mediate a “leak” anion flux through the empty, unbound transporters. Initial studies into the 
EAAT mediated anion conductance displayed the loss of a tonic current in Muller glial cells 
when extracellular Na+ was replaced by Ch+ (49) Alternatively, the presence of the tonic or leak 
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currents in the presence of Na+ alone (glu free) were revealed when inhibitors such as DL-
TBOA were used to inhibit the tonic anion flux (46). The presence of currents in extracellular 
Na+ buffers (glu free) was subsequently demonstrated for all EAAT isoforms (11,33,40,48). 
Studies which described the Na+ dependence of these anion conducting states were, however, 
limited to neuronal EAAT3 and EAAT4 isoforms (50,130,132) or Müller glial cells from 
salamander (49), the latter of which displays some disparate properties from the mammalian 
EAATs (136). Therefore, attributes of neuronal carriers were assumed to apply to all isoforms 
which our data presented here refutes.  
One of the early kinetic models of the glutamate transport cycle described a 15 state 
transport cycle with 8 conducting states in GLT-1 (rat EAAT2). These conducting states were 
limited to Na+ bound and Na+ and glu bound states, in the outward facing conformations.  The 
only inward facing conformations that the model displayed with an associated conducting state 
was the 2Na+ bound state and the K+ bound conformations (34). The presence of the inward 
facing 2 Na+ bound conducting state was not directly experimentally determined (47). Recently, 
experimental data were combined with simulations to further refine our knowledge of the 
relationship between conducting states and transporter conformations in EAAT4 (118). These 
data support the hypothesis that there are additional conducting states which are associated 
with conformations not previously believed to mediate channel activity. Our data here partially 
support this hypothesis because we demonstrate that EAATs 1 and 2 mediate open channel 
states in the unbound transporters. We also demonstrate a partial or total loss of all channel 
activity with EAAT3 and EAAT4 with the removal of extracellular Na+.  One possible reason for 
the difference in our interpretation of the number of conducting states in EAAT4 compared with 
the results in Machtens et al. (2011) (118) is that our background is defined by currents in the 
presence of DL-TBOA. There is could be some residual open probability that exists even in the 
presence of saturating concentrations of this antagonist. Thus it is possible that our removal of 
Na+ from EAAT4, for example, may leave us with a small residual EAAT mediated current that 
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we do not recognize because it is equal to currents in the presence of saturating DL-TBOA. 
Despite these factors, we can now develop or refine individual state diagrams for glial and 
neuronal transporters.     
 It is intriguing that complete removal of extracellular Na+ from EAAT3 only causes a 
partial loss of channel currents in Xenopus oocytes. We interpret these data to indicate that 
EAAT3 is unique in that it has an open probability associated with both the unbound and Na+ 
bound states and that the open probability or single channel conductance is lower in the 
unbound state. Watzke et al. (2001) (50) assayed for channel activity in the presence or 
absence of extracellular Na+ similar to the experiment shown in Figure 14B. However, in their 
experiments, DL-TBOA was added in conjunction with the removal of Na+ and this might have 
blocked the residual currents which we observed with a similar Na+ replacement. Nonetheless, 
the Na+ independent channel activity seen with EAAT3, in addition to the Na
+ dependent 
channel activity, will need further examination in the future.  
It is unclear what role the neuronal or glial EAAT-mediated, channel activity plays in 
glutamatergic neurotransmission. The role of the anion channel in regulating cellular activity has 
been supported by EAAT5-mediated regulation of rod bipolar cells in the retina. However, 
similar experiments have not been performed examining the role of the anion channel with other 
EAAT isoforms. Additionally, experiments testing the ability for EAAT5 anion currents to effect 
cellular activity were always performed in the presence of glu and no data exist which support a 
role for the EAAT-mediated regulation of cellular activity in the absence of glu. Thus it is 
challenging to speculate on the impact of these low open probability conducting states in the 
presence of Na+ alone (EAAT3 and EAAT4) or in the unbound transporter (EAATs 1, 2, and 3). 
The difference in gating mechanism between glial and neuronal isoforms allows us to 
form better hypotheses surrounding the question of the role of the anion channel in regulating 
cellular activity in the absence of extracellular glu. For example, anoxic depolarization would 
significantly disrupt anion currents mediated by neuronal EAATs as the Na+ gradient would be 
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dissipated (4,39,57,137). This could lead to a loss of a neuroprotective hyperpolarization in 
EAAT3 and EAAT4 expressing neurons, which has been hypothesized to be caused by EAAT 
anion channel activity (44). Conversely, astrocytes would still mediate a steady Cl- flux through 
either EAAT1 or EAAT2 their channel activity is independent of extracellular Na+ concentrations 
(10,35). Although this hypothesis of glial regulation in the presence of an altered ion gradient is 
currently just speculative, the additional knowledge provided in this study will assist in 
generating more meaningful hypotheses for future studies.     
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4. CONCLUSIONS 
 
4.1. EXCITATORY AMINO ACID TRANSPORTERS AND ANION CONDUCTION 
EAATs are secondary active, electrogenic transporters which also possess a thermodynamically 
uncoupled anion channel. This anion channel functionality is ubiquitous in the EAAT containing, 
SLC1 family of transporters yet a significant role for this channel function has yet to be 
established in many of the EAAT isoforms. The anion channel function has been described 
since the early 90s (49) and was further elucidated in 1994 when the human EAAT4 isoform 
was cloned. In EAAT4, and subsequently all EAAT isoforms, it was demonstrated that channel 
function was integral to the EAAT4 protein (10). To characterize the anion flux, the temperature 
dependence of anion and substrate flux through EAAT2 was measured (40). Macroscopic 
currents at negative potentials, predominately transport processes, were highly temperature 
sensitive with a thermal coefficient (Q10) of > 3, while currents measured at various 
temperatures at positive potentials displayed a Q10 of ~ 1, indicating a passive diffusion 
mechanism for anions through an open pore. These types of experiments have been repeated 
for other EAAT isoforms with similar results (138). Additional data which support that this 
channel like activity is mediated by a pore came from noise analysis data which displays power 
spectra which can be fitted to a lorentzian function, indicative of a stochastic gating transition or 
channel mediated anion flux (40,51-53,139,140). The permeability of anions through this pore is 
akin to many promiscuous Cl- channels and generally follows a sequence of SCN
- > ClO4
-
 > NO3
- 
> I- > Br- > Cl- (10,44,45). The channel behaves in a manner consistent with a multi-ion pore for 
SCN- flux through EAAT4, although, a lack of anomalous mole fraction behavior, characteristic 
of single-file, multi-ion pores, has been described for the EAATs as well (43,52). Thus, it is 
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unclear if the EAATs possess a classical pore design which is similar in nature to many other 
anion channels. A notable difference between the EAAT anion channels and those of classical 
chloride channels, such as GABAA receptors or CLC channels, is that the EAAT channels have 
a particularly low conductance. Both stationary and non-stationary noise analysis has been 
performed on various EAAT isoforms and these data indicate a low conductance permeation 
pathway of between 0.3 fS to 700 fS (51-53). Many of these studies agree that the single 
channel conductance is not altered upon substrate interaction and that an increase of the open 
probability underlies the change in macroscopic currents in the presence of substrates. Melzer 
et al. (2003) reported that dissociation rate of the highly permeant anion SCN- to the channel 
was increased by increasing concentrations of substrates, although they concluded that this 
likely related by an increase in the unitary conductance of the channel (52).  
 
4.2. SUBSTRATE-MEDIATED CHANNEL GATING 
Since the discovery of the anion channel in the EAATs, the interaction of substrate translocation 
and the anion channel gating function has been thoroughly investigated. It is clear that substrate 
interaction mediates the increased macroscopic current above basal channel activity, but not all 
substrates act on the channel in the same way. The application of D-asp caused macroscopic 
reversal potential (Erev) to move close to the Cl
-
 reversal potential (ECl) then application of glu 
(43). The current/flux ratio (Φ Cl-/ Φ substrate) was different between the two substrates. In 
contrast, pre-steady state kinetic data have suggested that D-asp transport is less efficient in 
gating the anion flux then glu and that D-asp transport alters the rate limiting step of the 
transport cycle in EAAT3 from K+ mediated reorientation to a step earlier in the transport cycle 
(141). The decrease in transport rate could decrease the relative contribution of the 
stoichiometric transport current, thus shifting ERev closer to ECl. However, similar experiments in 
EAAT2 have yielded opposite results where application of D-asp led to an ~ 2 fold increase in 
steady state current amplitudes as compared to glu. Concentration jumps of D-asp elicited a 
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decay in current amplitudes with a significantly slower time course than those observed with 
application of glu (40). The binding of substrates and the relationship of binding to the gating 
function of the anion channel has been investigated using pre-steady state kinetics as well. 
Using photo-release of caged glu molecules, Grewer et al. (2000) demonstrated a rapid voltage 
independent binding of glu and a subsequent, voltage-dependent slow process, likely glu 
translocation. In addition, the formation of the anion conducting state is slightly delayed in 
comparison to the formation of glu bound states but does occur before glu translocation across 
the membrane (33). These data indicate that binding of the transporter is not sufficient to gate 
the anion channel and a secondary process after the binding comprises the gating mechanism. 
Consistent with these observations, mutation of R388 to acidic residues glu or asp eliminates 
substrate induced open channel states yet allows for the binding and translocation of those 
substrates (Appendix D). These data support the hypothesis that channel gating is not induced 
by substrate binding alone but is dependent on subsequent conformational changes that occur 
before the translocation of substrates.  
Two additional sets of data are worth considering when contemplating the gating 
mechanism in the EAATs. First, binding of DL-TBOA, a competitive and non-transportable 
inhibitor of the EAATs, has been demonstrated to block not only glutamate interactions and 
transport, but also anion channel activity, including the leak conducting states (142). The 
mechanism by which TBOA blocks all channel activity is unknown. Recent data have indicated 
that binding of TBOA locks HP2 into an open or intermediate-open state (31), but conversely 
modification of HP2, locking it into the open state, leads to heightened channel activity (115-
117). Thus it is not unreasonable to hypothesize that HP2 dynamics are involved in anion 
channel gating but at this point a concise mechanism has yet to emerge. Additional data 
supporting the role of HP2 in channel gating comes from double site-directed spin labeling 
electron paramagnetic resonance spectroscopy (DSDSL-EPR) demonstrated that Na+ binding 
to the empty transporter induced and stabilized an open conformation of spin labeled HP2 
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(143). Thus, gating of the anion channel may involve HP2 dynamics, possibly part of the 
occlusion mechanism that must occur between substrate binding and translocation. It is clear 
that lingering questions remain about the mechanism of substrate interactions and how these 
relate to the gating of the anion channel.    
 
4.3. THE ROLE OF THE ANION CONDUCTANCE IN CELLULAR FUNCTION 
The role of the EAAT anion channel in cellular function has yet to be clarified. However, the 
anion channel activity of EAAT5 has been demonstrated to influence cellular activity in rod 
bipolar cells in the retina. Veruki et al. (2006) demonstrated that the Cl- flux through EAAT5 was 
capable of modulating firing rates of the bipolar cell as well as influence the release probability 
of glu containing vesicles (58). EAAT5 was also able mediate a substantial Cl- flux from 
activation by adjacent bipolar cells through spillover of glu. Other work has substantiated the 
role of EAAT5 as a ligand gated receptor in the retina (59). Unfortunately, analogous data have 
not been demonstrated to date for the other EAAT isoforms. Like EAAT5, EAAT4 has a lower 
transport rate and thus has a prominent anion conductance in comparison to its transport 
capacity. Thus, many have speculated that EAAT4, which is ubiquitously expressed throughout 
the CNS in low levels, may be playing a similar role to a ligand gated receptor because it likely 
does not transport a significant amount of synaptically release glu. Indeed the majority of glu 
that is released to the synapse diffuses and is transported by the glial EAAT2 isoform (14,85). In 
addition to rapidly buffering released glu, roles for the neuronal isoform EAAT3 include providing 
avenues for GABA synthesis with the small amount of glu transport it mediates (112). Data from 
EAAT3 knock-out mice strongly suggest a role for EAAT3 mediating cysteine transport and 
influencing glutathione synthesis (111) (Appendix C). Because the majority of released glu is 
transported by glial EAAT isoforms, it is possible that anion channel activity is the predominate 
role for neuronal isoforms (84). Surprisingly, the enhanced expression of EAAT4 in the 
cerebellum has provided little insight into its role beyond that typical of glutamate carriers (144). 
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Experiments have described a significant role for neuronal EAATs in the cerebellum in 
regulating perisynaptic activation of ionotropic and metabotropic receptors but few studies have 
isolated the contributions of EAAT4 in these processes (105,106).  
The anion channel activity of glial isoforms EAATs 1 and 2 have not been thoroughly 
investigated for their role in regulating glial activity. The single channel properties of EAAT3 and 
EAAT4 measured by noise analysis indicated that the difference in macroscopic currents are 
due solely to differences in transport kinetics, more specifically time spent transporter 
conformations that can mediate open channel states (53,132). Since EAAT3 and EAAT4 
possess similar single channel properties, it is possible that glial isoforms do not differ in 
channel properties either. One difference in channel activity between glial and neuronal EAATs 
is the gating of the anion channel where we have demonstrated that glial isoforms have a basal 
open probability in the absence of Na+ in contrast to neuronal isoforms which are strongly Na+ 
dependent (Figure 11 and Figure 13).   
 
4.4. LEAK CONDUCTING STATES IN EAATS 
The anion conductance in the family of EAATs has been demonstrated to be gated by Na+ 
interaction and the anion channel activity increased upon subsequent glu binding (40,46,48). 
The Na+ gated channel activity has been classically referred to as the “leak” conductance 
because the mechanism of channel gating in the absence of glu was unresolved at that time. 
Initial estimations of the number of anion conducting states were limited to those readily 
observed; the outward Na+-bound conformations and the outward Na+ and glu-bound 
conformations. Additional conducting states were proposed based on minimal evidence. These 
included the inward 2Na+-bound conformation and the inward K+-bound conformation (34). The 
glutamate transport cycle last from approximately 8 – 66 msec. the majority of this time is spent 
during the inward facing steps because K+ reorientation is the rate limiting process. Thus, if the 
inward facing steps of the transport cycle had transitions to open channel states, the relative 
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contribution of the Na+ gated or leak anion conductance would be significantly greater than 
previously assumed. Indeed, our data demonstrate that when EAAT1 is restricted to the inward 
facing conformations through modification of HP1 while in the inward, HP1-open conformation, 
we readily observe anion conductances that mimic the outward Na+ bound states (Figure 7). 
This work was significant for two reasons. First, we developed a novel method for capturing the 
inward facing states. Initial strategies for accomplishing this goal were based on those used by 
Reyes et al (2009) involving crosslinking of HP2 to TM2 (32). Crosslinking of these two regions, 
however, did not yield results indicative of the inward facing state. If the inward facing state was 
captured, then the carriers would be insensitive to extracellular substrate application. 
Application of saturating concentrations of glu to the extracellular face of the 1,10-Cu2+-
Phenanthroline (CuPh) treated V454C-Q93C double mutant yielded ~125% of the channel 
activity as dithreoretinal (DTT) treated double mutant. Our current strategy was based on 
another set of observations. Modification of the external gate HP2 using cysteine point 
mutations and cysteine specific modifying reagents results in a transport state that is locked 
outward and open. Substrate transport is eliminated yet binding and channel activity are intact 
after this modification. Experiments which used inside-out patch clamp recording of EAATs 
demonstrated that substrates applied to the intracellular face of the transporters could readily 
bind and gate the substrate induced anion channel activity. It is likely that a significant fraction of 
the transporter population was in the inward, HP1-open conformation under conditions that drive 
carriers to inward facing states, i.e. high extracellular K+. Combining these data, we 
hypothesized that driving the transporter into the inward facing states, then modifying the 
proposed internal gate HP1, would likely restrict the transporter into the inward open state. 
Although we cannot say precisely which state was captured by our modification strategy, our 
modified transporters exhibit a complete loss of transport activity and have no response to 
extracellularly applied substrates or inhibitors. If the open (binding site accessible) and closing 
(occluded) transition of the internal gate is similar to the external gate, then a modified open 
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HP1 would be prevented from closing by steric hindrance, and thus prevent further 
conformational changes. With this strategy of hindering conformational changes after stabilizing 
one or more inward facing states, we observed a significant anion conductance. These data 
support our hypothesis that the inward facing conformations visited during the transport cycle 
can mediate transitions to open, conducting states (Figure 7).  
 We were curious why these inward facing open channel states mediated the same 
macroscopic current amplitudes as those observed with the outward facing conformations of the 
EAAT transport cycle. One possibility is that the channel can only exist with two different open 
probabilities, leak and substrate gated, which are accessible from multiple conformations in the 
transport cycle. Another explanation is that there are additional substrates present which could 
be binding and mediating this channel activity. To test the gating requirement of the EAAT anion 
channel in the absence of substrates, we used an ion replacement strategy where all the 
extracellular Na+ was replaced by choline (Ch+). For EAATs 1 and 2, the persistence of anion 
conducting states of the same macroscopic amplitudes in the absence of Na+ as in the presence 
of Na+ is indicative of leak conducting states (Figures 11 and 12). In contrast, the reduction in 
current amplitudes in the absence of external Na+ in EAAT3 and EAAT4 are consistent with 
previously published data indicating that the open channel states in the absence of substrates 
are Na+ mediated (50,130,132). Thus, we now possess a more accurate state diagram where 
glial EAAT isoforms have a basal open probability in the unbound and Na+ bound states, and 
this increases upon glutamate interaction. Once glutamate is translocated and released to the 
intracellular space, the channel returns to its lower open probability states. The only states 
which have not been investigated to date are the K+ interacting states. It is unclear if these 
states mediate an anion flux. Data recorded in EAAT4 demonstrated a current “overshoot” effect 
when fast application of glu caused a coordinated movement of the transporter population 
through the initial steps of the transport cycle involving Na+ and glu translocation across the 
membrane. Entry of the population of transporters into non-conducting states caused a transient 
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reduction or “overshoot” of anion channel mediated currents below background (Na+ alone) 
(47). This effect was absent in the EAAT2 isoform (34). The absence of anion conducting steps 
in the glu unbound conformational states in EAAT4 compared to the additional conducting 
states in the glu unbound EAAT2 could explain the presence of the current overshoot effect in 
EAAT4 alone. Although these data do not resolve the question of whether K+ interaction 
mediates anion channel activity, it is likely that such an overshoot effect would need additional 
non-conducting states visited during the transport cycle to mediate this phenomenon. Thus we 
speculate that the K+ interacting steps do not mediate channel activity in at least the neuronal 
isoforms, if not in all EAATs.          
 
4.5. SUMMARY 
The anion channel found in EAATs could be an important regulator of cellular activity. Its 
proposed roles have ranged from offsetting the depolarizing effect electrogenic transport 
mediates to regulating cellular excitability and neurotransmission as an ionotropic receptor. The 
work presented here pushes forward our understanding of not only the link between substrate 
transport and open channel states but also the gating mechanism of the anion channel. 
Although much of this work has elucidated low open probability conductance states classical 
termed “leak” states, the transport spends the majority of the duration of the transport cycle in 
conformations that are associated with such states. These data presented here will assist in 
resolving the role of EAAT associated anion channel and pave the way for future studies 
investigating dual transport-channel systems.  
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APPENDIX A: THE LOCATION OF THE ANION PORE OF EXCITATORY AMINO ACID 
TRANSPORTERS 
 
A.1 INTRODUCTION 
Glutamate is the major excitatory neurotransmitter in the central nervous system. The spatio-
temporal profile of synaptically released glutamate is regulated by a family of five excitatory 
amino acid transporters or EAATs. EAATs 1 and 2 are expressed in glia while EAATs 3-5 are 
expressed exclusively in neurons (1-5). Dysregulation of glutamate transport has been 
hypothesized to be involved in many diseases or disorders such as Alzheimer’s, Parkinson’s, 
Amyotrophic lateral sclerosis (ALS), and ischemic conditions mediating excitotoxicity (6). EAATs 
are secondary active, electrogenic transporters which couple the energetically uphill movement 
of anionic glutamate (glu) into the cell with co-transport of 3 Na+, 1 H+, and the counter transport 
of 1 K+ ion (7-9). Therefore, each transport cycle mediates the net inward movement of 2 
positive chargers. In addition, EAATs possess a thermodynamically uncoupled anion channel 
which is either a leak conductance in glial isoforms or is gated by Na+ interaction in neuronal 
carriers (4,10). The channel open probability is increased by subsequent glu binding to the 
binding site (11) located at the intersection of transmembrane domains 7 and 8 (TM7 and TM8) 
and the hairpin, re-entrant loops HP1 and HP2 (12,13).  
Initial investigations into the coupling of substrate interactions and channel activity 
demonstrated that modification of residues such as V449 or V452 in the outer hairpin loop, HP2, 
with methanesthiosulfonate (MTS) allowed for full or even enhanced anion channel activity while 
completely abolishing substrate transport (14,15). Thus, glutamate mediated gating of the 
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channel was dependent on substrate binding but not transport. This data also supported the 
hypothesis that the pore domain was in a location distinct from the substrate binding site. 
Further support for this hypothesis was reported by Vandenberg’s group which used site 
directed mutagenesis in the regions of transmembrane domain 2 and 5 (TM2 and TM5). 
Mutations of residues S102 (TM2), D112 (TM2), or D272 (TM5) were demonstrated to 
significantly alter channel properties while not affecting transport functionality (16,17). In 2004, 
the crystal structure of an archeal homolog of glutamate transporters, GltPh, revealed many 
properties of the carriers including residues which participate in substrate coordination in the 
ligand binding site (12). Unfortunately, the location or presence of a pore domain was not 
observable in the crystal structure and only limited evidence exist to support the presence of an 
uncouple chloride flux in GltPh (18). Beyond these initial studies no significant progress has been 
made to determine the exact location of the pore domain.  
 Efforts to determine the location of pore regions in other channels or transporters have 
been developed with similar strategies. Substituted cysteine accessibility methods or SCAM has 
been used to determine residues which display accessibility to extracellular or intracellular 
reagents, indicative of an aqueous pore region, as well as residues which influence channel 
function and ion flux after modification. These strategies have been used successfully to identify 
residues lining the pore of acetylcholine receptors (AChRs) (19,20), γ-aminobutyric acid 
(GABAA) receptors (21,22), as well as the palytoxin-modified pore of the Na
+-K+ ATPase 
(23,24).  Here we used as similar strategy in human EAAT1 to determine if the location of the 
pore region lies in the area of TM2. We used site directed mutagenesis to create cysteine point 
mutations at every position of TM2 as well as several other regions of EAAT1. We will 
determine which residues in these regions display accessibility to intracellular and extracellularly 
applied MTS reagents as well as the permeable non-reversible cysteine modifying reagent N-
ethylmaleimide (NEM). After modification, two-electrode voltage clamp recordings will determine  
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Figure A1. EAAT1 Homology Model Depicting Point Mutations. 
Homology model of hEAAT in the outward facing state based on the GltPh crystal structure from 
(12) (pdb file 3FXH). Helices are depicted in ribbon form (grey) with a stick model of mutated 
residues (green). L-aspartate is depicted by a space filling model placed over the electron 
density pattern of bound L-cysteine sulfinic acid (yellow). 
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which residues are important for anion flux through EAAT1. With this strategy, we will 
unambiguously determine if the pore regions lies in the region of surrounding TM2 as previously 
proposed (16).  
 
A.2. EXPERIMENTAL PROCEDURES 
A.2.1. Generation and Subcloning of EAAT1 Cysteine Mutations 
hEAAT1 was as previously described (25) and was subcloned into pOTV and pcDNA3.1 
(Invitrogen) using Kpn1 and Xba1 restriction sites. Quikchange site-directed mutagenesis 
(Stratagene) was used to create half of the cysteine point mutations and the other half was 
purchased from Genewiz Inc custom mutagenesis services. All mutations were confirmed by 
sequencing before use. 
A.2.2. Transient Transfection of COS-7 cells and cRNA injections into Xenopus Oocytes 
COS-7 cells were transiently transfected using Lipofectamine 2000 (Invitrogen) two days prior to 
use in assays. hDAT-GFP-pCDNA3.1 was transfected in parallel to estimate transfection 
efficiency and serve as a negative control for COS-7 experiments. cRNA was synthesized from 
linearized capped DNA using T7 mMessage mMachine kit (Ambion) from pOTV constructs. 50 
ng of cRNA was injected into store bought stage VI oocytes (Ecocyte). Oocytes were incubated 
for 2-3 days in ND96 buffer containing penicillin, streptomycin, gentamycin, and Na+ pyruvate at 
18oC.  
A.2.3. Radiolabeled Transport Assays 
COS-7 cells transiently transfected with hEAAT1 WT, hEAAT1 CSLS, and hEAAT1 mutations 
were washed 3 times with phosphate buffered saline containing 1.0 mM MgCl2 and 0.1 mM 
CaCl2 (PBSCM). 1 mM L-glutamate + 200 nM 3,4-
3H-L-glutamate was serially diluted to create 
the concentrations described. Glu was applied for 10 min and then washed out using ice cold 
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PBSCM. Cells were washed a total of 3 times before being lysed using 0.1 N NaOH and 1% 
SDS. The accumulated radiolabeled substrate was counted using liquid scintillation counting.  
A.2.4. Electrophysiology 
 Two-electrode voltage clamp recordings were performed on hEAAT1 constructs 
expressed in stage VI Xenopus oocytes as previously described (4). 500 msec voltage pulses 
were applied every 15 mV ranging from -150 mV to +60 mV. Isochronal current amplitudes were 
taken from the last 100 msec of the sweep. All currents were recorded using a Geneclamp 500 
(Molecular Devices) and pClamp10 software (Molecular Devices). Data was digitized using a 
Digidata 1440A and was filtered using a Bessel filter at 1 kHz and sampled at 50 kHz. Solutions 
were applied using a gravity fed perfusion system and for basic experiments were 96 mM 
NaNO3, 2 mM KCl, 1.8 mM MgCl2, 1 mM CaCl2, and 10 mM HEPES, pH 7.4 (NDNO3). For 
permeability studies, the 96 mM NaNO3 was replaced with 96 mM NaX (where X is Cl, I, Br, or 
SCN). MTS reagents, dithrioretinol (DTT), and NEM are applied for 5 min and then washed out 
with ND96 for 2 min before recordings. 
 
A.3. RESULTS 
A.3.1. Transport Kinetics of Cysteine Point Mutations in EAAT1 
TM2 contains residues which, when altered through mutagenesis can affect anion flux. In order 
to fully characterize the role of TM2 in the flux of anions, we designed a series of point 
mutations to comprehensively map out amino acid positions which affect anion flux in order to 
determine which residues line the pore of the anion channel (Figure 1). In order to determine the 
basic transport functions of mutant EAATs, radiolabeled glutamate dose-response curves were 
performed on EAAT residues altered to cysteine side chains. The apparent affinity (KM) and 
maximal velocity (Vmax) of residues altered to cysteine in comparison to CSLS EAAT1 controls   
are presented in Table 1. None of the 11 residues tested thus far demonstrate a significantly 
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Table 1. Kinetic Data of EAAT1 Cysteine Point Mutations in COS-7 Cells 
Mutant Km µM (CI95) % Activity* 
Number of 
Samples (N) 
Location 
WT 
   
- 
CSLS 53.4 (0 – 108.0) 100 6 - 
R76C 94.6 (48.0 - 141.3) 55.2 6 TM1-2 loop 
E77C 71.5 (46.3 - 96.7) 66.3 6 TM2 
V78C 76.2 (45.2 - 107.2) N.D. 6 TM2 
K79C 110.1 (0 – 361.3) N.D. 6 TM2 
Y80C 5.64 (0 – 18.1) N.D. 6 TM2 
F81C 
   
TM2 
S82C 34.0 (0 - 80.0) N.D. 6 TM2 
F83C 
   
TM2 
P84C 
   
TM2 
G85C 
   
TM2 
E86C 
   
TM2 
L87C 
   
TM2 
L88C 
   
TM2 
M89C 
   
TM2 
R90C 70.6 (53.4 – 87.8) 60.1 9 TM2 
M91C 
   
TM2 
L92C 
   
TM2 
Q93C 78.6 (0-177.6) 104.7 6 TM2 
M94C 
   
TM2 
L95C 
   
TM2 
V96C 
   
TM2 
L97C 
   
TM2 
P98C 
   
TM2 
L99C 
   
TM2 
I100C 
   
TM2 
I101C 
   
TM2 
S102C 
   
TM2 
S103C    TM2 
L104C    TM2 
V105C    TM2 
T106C    TM2 
G107C    TM2 
M108C    TM2-3 loop 
R342C 120.7 (98.3 – 143.1) 54.6 5 TM6-HP1 loop 
K343C 130.4 (56.5 – 204.4) 60.2 5 TM6-HP1 loop 
N344C 105.0 (39.7 – 170.3) 31.3 5 TM6-HP1 loop 
Normalized to WT uptake but not controlled for expression levels;  
* N.D. describes active mutants whose kinetics parameters couldn’t be accurately 
determined; 
** N.E. describes mutants whose activity was < 10% of WT; Blank spaces indicate 
residues not yet assayed. 
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different KM from EAAT constructs lacking any cysteine residues (CSLS). Maximal transport 
rates, however, were significantly lower for all mutants tested except for Q93C which showed 
normal Vmax compared to CSLS. This data does not take into consideration changes to 
membrane expression and therefore could be any combination of a loss of transport velocity or 
surface expression. Semi-quantitative membrane biotinylation experiments will be needed in 
order to estimate the change in surface expression.     
A.3.2. Transport Kinetics of Non-cysteine Point Mutations in EAAT1 
Modification of cysteine point mutations by specific cysteine modification reagents will assist in 
determining which residues line the pore domain. However, at locations in the pore region which 
might restrict accessibility to even the smallest of the cysteine modifying reagents, further 
mutational analysis is needed. Therefore, we also mutated a series of residues to glu side 
chains so that anion flux could be disrupted without the need for accessibility of exogenous 
modifying reagents to the residues. Table 2 depicts the KM and Vmax of residues altered to non-
cysteine residues in comparison to CSLS EAAT1 controls. Of the mutants tested, only D172R 
(TM4), R342E (TM6-HP1 loop), K343E (TM6-HP1a loop), and T358E (HP1a) showed a 
significantly lower apparent affinity, KM, then WT EAAT1 controls. However, almost all point 
mutations displayed a Vmax below 80% except for R76E, K188E, and R122E. This loss of 
transport capacity could either be due to loss of transport velocity or surface expression as is 
the case for the cysteine point mutations.  
 
A.4. DISCUSSION 
The location of the anion pore is one of the most significant questions left in the field of EAAT 
biology and also one of the most elusive questions. Channel-like functionality has been 
demonstrated for not only the EAATs but also many other isoforms and families of 
neurotransmitter transporters such as the ASCTs (26-30) and the monoamine carriers (31-34).  
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Table 2. Kinetic Data for Non-cysteine EAAT1 Point Mutations in COS-7 Cells 
Mutant Km µM (CI95) % Activity* 
Number of 
Samples (N) 
Location 
WT 26.9 (14.8 – 39.1) 100 12 - 
CSLS 47.1 (0.79- 93.1) 82.8 5 - 
R76E 29.9 (16.1 – 43.7) 98.2 6 TM1-TM2 loop 
R79E    TM2 
Y80E    TM2 
F81E    TM2 
S82E    TM2 
E86R    TM2 
R90E 81.1 (32.8 – 129.3) 42.7 12 TM2 
P98A 85.1 (0 - 176.0) 20.3 12 TM2 
G107A    TM2 
K118E 26.5 (3.85-49.2) 109.8 6 TM2-TM3 loop 
R122E 37.5 (0-80.9) 112.1 6 TM3 
D172R 358.2 (99.7 – 616.8) 25.9 6 TM4a 
E276K 19.2 (12.1 – 26.4) 30.3 6 TM5 
M279A N.E. N.E. N.E. TM5 
R280E 21.7 (12.6 – 30.7) 33.2 11 TM5 
K300E 118.3 (10.8-225.8) 52.2 4 TM5 
E303R N.E. N.E. N.E. TM5 
H328E 36.7 (32.0 - 41.4) 31.5 5 TM6 
R342E 90.4 (76.1 - 106.6) 62.4 5 TM6-HP1 loop 
K343E 256.1 (N.D.) 41.6 4 TM6-HP1 loop 
T358E 61.1 (45.8 - 76.4) 25.6 10 HP1a 
K374E 29.5 (15.5 - 43.5) 45.6 5 TM7a 
R385E 30.8 (25.4 - 36.2) 20 5 TM7a 
Normalized to WT uptake but not controlled for expression levels; 
* N.D. describes active mutants whose kinetics parameters couldn’t be accurately 
determined;  
** N.E. describes mutants whose activity was < 10% of WT; Blank spaces indicate not yet 
assayed. 
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To date, the exact location of the pores which are thought to mediate such conductances has 
not been resolved. Therefore, it is likely that extraordinary efforts are needed to define the pore 
region in these systems. Site-directed mutagenesis is valuable tool to determine the location of 
channel lining residues and been used as a successful strategy in the past (19,23,24). Here we 
developed a series of point mutations in the TM2 region of the transporter which has been 
demonstrated to alter anion channel function after mutation (16,17). 
Through initial screening of transport activity in each of these mutants, we will be able to 
clearly exclude residues which demonstrate a loss of all transport functionality when mutated. 
These residues will be excluded from electrophysiological analysis since we would not be able 
to determine if changes to anion flux were due to large structural perturbations and/or loss of all 
surface expression. Second, kinetic analysis of transport will allow us to identify mutations which 
may have altered affinity for glutamate and allow for appropriate adjustments since we will apply 
saturating concentrations of glu during subsequent experiments. 
 Two-electrode voltage clamp recordings will be divided into three phases. First, the 
maximal current amplitudes from non-cysteine point mutations (Table 2) will be recorded in the 
presence of Cl-, I-, NO3
-, and SCN- buffers in order to determine if any point mutation has altered 
the permeability sequence or maximal anion flux of the EAAT-mediated anion channel. Next, 
cysteine point mutations will be assayed using the same experimental paradigm. Additionally, 
various anion containing buffers will be applied to cysteine point mutations before and after a 5 
min perfusion of 1 mM 2-(trimethylammonium)ethylmethanethiosulfonate (MTSET), 10 mM 2-
aminoethylmethanethiosulfonate (MTSEA), 10 mM 2-sulfonatoethylmethanethiosulfonate 
(MTSES), or 1 mM NEM. Experiments with modification of residues can be combined using 5 
mM DTT perfusions to reverse modifications by MTS reagents. These data will be used to 
examine the role of each residue position in affecting the permeability of various anions through 
EAAT1. Together these data should allow for a comprehensive mapping of residues which show 
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a significant alteration to anion flux to form a contiguous pore region in the EAAT1 structural 
model (Figure 1). This approach has the strength of non-biasing positions or side chains and 
should be comprehensive enough to capture a structural trend in anion flux even with regions or 
inaccessibility to modifying reagents such as the selectivity filter.  
EAATs are not the only neurotransmitter transports which possess dual transport and 
channel-like functionality. The SLC16 family or neurotransmitter Na+ symporters (NSS) have 
shown channel like activity and although its exact role in cellular function for many of the NSS 
members is unclear, evidence supports the flux of anions through the dopamine transporter can 
influence cellular excitability (32-35). These preliminary data presented here are the first steps 
into a comprehensive screen designed to delineate the pore lining residues of EAAT1. The 
location of the pore in EAATs is a major question in the field and elucidation of this question will 
allow for a new era of investigations resolving the role of channel like states in transporters.           
 
A.5. REFERENCES 
1. Kanai, Y., and Hediger, M. A. (1992) Primary structure and functional characterization of 
a high-affinity glutamate transporter. Nature 360, 467-471 
2. Pines, G., Danbolt, N. C., Bjoras, M., Zhang, Y., Bendahan, A., Eide, L., Koepsell, H., 
Storm-Mathisen, J., Seeberg, E., and Kanner, B. I. (1992) Cloning and expression of a 
rat brain L-glutamate transporter. Nature 360, 464-467 
3. Storck, T., Schulte, S., Hofmann, K., and Stoffel, W. (1992) Structure, expression, and 
functional analysis of a Na(+)-dependent glutamate/aspartate transporter from rat brain. 
Proc Natl Acad Sci U S A 89, 10955-10959 
4. Fairman, W. A., Vandenberg, R. J., Arriza, J. L., Kavanaugh, M. P., and Amara, S. G. 
(1995) An excitatory amino-acid transporter with properties of a ligand-gated chloride 
channel Nature 375, 599-603 
A11 
 
5. Arriza, J. L., Eliasof, S., Kavanaugh, M. P., and Amara, S. G. (1997) Excitatory amino 
acid transporter 5, a retinal glutamate transporter coupled to a chloride conductance 
Proc Natl Acad Sci U S A 94, 4155-4160 
6. Danbolt, N. C. (2001) Glutamate uptake. Prog Neurobiol 65, 1-105 
7. Zerangue, N., and Kavanaugh, M. P. (1996) Flux coupling in a neuronal glutamate 
transporter. Nature 383, 634-637 
8. Kanner, B. I., and Sharon, I. (1978) Active transport of L-glutamate by membrane 
vesicles isolated from rat brain. Biochemistry 17, 3949-3953 
9. Brew, H., and Attwell, D. (1987) Electrogenic glutamate uptake is a major current carrier 
in the membrane of axolotl retinal glial cells. Nature 327, 707-709 
10. Wadiche, J. I., Amara, S. G., and Kavanaugh, M. P. (1995) Ion fluxes associated with 
excitatory amino acid transport Neuron 15, 721-728 
11. Torres-Salazar, D., and Fahlke, C. (2007) Neuronal Glutamate Transporters Vary in 
Substrate Transport Rate but Not in Unitary Anion Channel Conductance in The Journal 
of Biological Chemistry  
12. Yernool, D., Boudker, O., Jin, Y., and Gouaux, E. (2004) Structure of a glutamate 
transporter homologue from Pyrococcus horikoshii. Nature 431, 811-818 
13. Boudker, O., Ryan, R. M., Yernool, D., Shimamoto, K., and Gouaux, E. (2007) Coupling 
substrate and ion binding to extracellular gate of a sodium-dependent aspartate 
transporter. Nature 445, 387-393 
14. Seal, R. P., Shigeri, Y., Eliasof, S., Leighton, B. H., and Amara, S. G. (2001) Sulfhydryl 
modification of V449C in the glutamate transporter EAAT1 abolishes substrate transport 
but not the substrate-gated anion conductance Proc Natl Acad Sci U S A 98, 15324-
15329 
A12 
 
15. Ryan, R. M., and Vandenberg, R. J. (2002) Distinct conformational states mediate the 
transport and anion channel properties of the glutamate transporter EAAT-1 J Biol Chem 
277, 13494-13500 
16. Ryan, R. M., Mitrovic, A. D., and Vandenberg, R. J. (2004) The chloride permeation 
pathway of a glutamate transporter and its proximity to the glutamate translocation 
pathway J Biol Chem 279, 20742-20751 
17. Huang, S., and Vandenberg, R. J. (2007) Mutations in transmembrane domains 5 and 7 
of the human excitatory amino acid transporter 1 affect the substrate-activated anion 
channel Biochemistry 46, 9685-9692 
18. Ryan, R. M., and Mindell, J. A. (2007) The uncoupled chloride conductance of a 
bacterial glutamate transporter homolog. Nat Struct Mol Biol 14, 365-371 
19. Akabas, M. H., and Karlin, A. (1995) Identification of acetylcholine receptor channel-
lining residues in the M1 segment of the alpha-subunit. Biochemistry 34, 12496-12500 
20. Parikh, R., Bali, M., and Akabas, M. H. (2011) Structure of M2 transmembrane segment 
of GLIC, a prokaryotic Cys-loop receptor homologue from Gloeobacter violaceus, probed 
by substituted cysteine accessibility. J Biol Chem  
21. Filippova, N., Wotring, V. E., and Weiss, D. S. (2004) Evidence that the TM1-TM2 loop 
contributes to the rho1 GABA receptor pore. J Biol Chem 279, 20906-20914 
22. Horenstein, J., Wagner, D. A., Czajkowski, C., and Akabas, M. H. (2001) Protein mobility 
and GABA-induced conformational changes in GABA(A) receptor pore-lining M2 
segment. Nat Neurosci 4, 477-485 
23. Takeuchi, A., Reyes, N., Artigas, P., and Gadsby, D. C. (2008) The ion pathway through 
the opened Na(+),K(+)-ATPase pump. Nature  
24. Reyes, N., and Gadsby, D. C. (2006) Ion permeation through the Na+,K+-ATPase. 
Nature 443, 470-474 
A13 
 
25. Arriza, J. L., Fairman, W. A., Wadiche, J. I., Murdoch, G. H., Kavanaugh, M. P., and 
Amara, S. G. (1994) Functional comparisons of three glutamate transporter subtypes 
cloned from human motor cortex. J Neurosci 14, 5559-5569 
26. Arriza, J. L., Kavanaugh, M. P., Fairman, W. A., Wu, Y. N., Murdoch, G. H., North, R. A., 
and Amara, S. G. (1993) Cloning and expression of a human neutral amino acid 
transporter with structural similarity to the glutamate transporter gene family. J Biol 
Chem 268, 15329-15332 
27. Zerangue, N., and Kavanaugh, M. P. (1996) ASCT-1 is a neutral amino acid exchanger 
with chloride channel activity J Biol Chem 271, 27991-27994 
28. Broer, A., Wagner, C., Lang, F., and Broer, S. (2000) Neutral amino acid transporter 
ASCT2 displays substrate-induced Na+ exchange and a substrate-gated anion 
conductance. Biochem J 346 Pt 3, 705-710 
29. Grewer, C., and Grabsch, E. (2004) New inhibitors for the neutral amino acid transporter 
ASCT2 reveal its Na+-dependent anion leak. J Physiol 557, 747-759 
30. Scopelliti, A. J., Ryan, R. M., and Vandenberg, R. J. (2013) Molecular determinants for 
functional differences between alanine-serine-cysteine transporter 1 and other glutamate 
transporter family members. J Biol Chem 288, 8250-8257 
31. Galli, A., DeFelice, L. J., Duke, B. J., Moore, K. R., and Blakely, R. D. (1995) Sodium-
dependent norepinephrine-induced currents in norepinephrine-transporter-transfected 
HEK-293 cells blocked by cocaine and antidepressants. J Exp Biol 198, 2197-2212 
32. Sonders, M. S., Zhu, S. J., Zahniser, N. R., Kavanaugh, M. P., and Amara, S. G. (1997) 
Multiple ionic conductances of the human dopamine transporter: the actions of 
dopamine and psychostimulants. J Neurosci 17, 960-974 
A14 
 
33. Galli, A., Blakely, R. D., and DeFelice, L. J. (1998) Patch-clamp and amperometric 
recordings from norepinephrine transporters: channel activity and voltage-dependent 
uptake. Proc Natl Acad Sci U S A 95, 13260-13265 
34. Ingram, S. L., Prasad, B. M., and Amara, S. G. (2002) Dopamine transporter-mediated 
conductances increase excitability of midbrain dopamine neurons. Nat Neurosci 5, 971-
978 
35. Mager, S., Min, C., Henry, D. J., Chavkin, C., Hoffman, B. J., Davidson, N., and Lester, 
H. A. (1994) Conducting states of a mammalian serotonin transporter. Neuron 12, 845-
859 
 
 
B1 
 
 
 
APPENDIX B: CLOSE ENCOUNTERS OF THE OILY KIND: REGULATION OF 
TRANSPORTERS BY LIPIDS 
 
 
252
Christopher B. Divito and Susan G. Amara 
University of Pittsburgh, Department of Neurobiology, Pittsburgh, PA 15260
Neurotransmitter transporters are membrane proteins that serve as key regulators of extracellular neurotransmitter concentrations and have been long viewed as important targets for drug devel-opment by the pharmaceutical industry. Although many cellular signaling systems are known to 
modulate transport activity, much less is known about how transporters communicate with and are regu-
lated by the various components of the lipid sea in which they reside. Variations in lipid content clearly 
affect the activity of a variety of transport systems, and with advances in techniques for lipid analysis 
and a clearer vision of carrier structure, this area of research appears poised for major advances.
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Introduction
Neurotransmitter transporters are essential to the homeostatic 
regulation of synaptic signaling throughout the nervous system. 
The extensive amount of research that has been devoted over the 
past few decades to these integral membrane proteins is an apt 
reflection of this importance. Transport mechanisms have been a 
prime target of the pharmaceutical industry, prompting the invest-
ment of billions of dollars into the development of drugs, such as 
the selective reuptake inhibitors, several of which have achieved 
blockbuster status in the treatment of depression and anxiety. 
The functions of many carriers are influenced by a variety of fac-
tors such as temperature, membrane voltage, pH, ion gradients, 
ligands, and accessory proteins. One mechanism for regulating 
membrane protein function that has only started to make the 
list has been the impact of lipid environment. Over the last few 
decades, lipids, the unsung heroes of regulation, have begun 
to emerge as critical modulators of membrane protein function 
through their direct actions on proteins, through their influence 
on the lipid milieu, and through their roles in signaling pathways.
A variety of mechanisms have been identified through which 
transporters act to regulate the storage, subcellular localization, 
and synaptic availability of neurotransmitters. Physiological fac-
tors that influence transporter function include temperature, 
membrane voltage, pH, ion gradients, endogenous ligands, and 
accessory proteins. The degree to which any particular mecha-
nism contributes to transporter function or might be exploited for 
improved drug development is not always clear. But the impor-
tance of transporters in basic neurobiology and translational medi-
cine certainly mandates investigation from a variety of approaches. 
The advent of lipidomics in past years has enriched our under-
standing of signal transduction in many contexts, including neu-
rotransmission. The versatility of lipids in signaling has proven 
remarkable, and one aspect of this signaling is the role of lipids as 
modulators of regulatory proteins in the cell membrane. 
Lipids, once viewed simply as building blocks of the mem-
brane, have for many years now been appreciated for their role 
in signal transduction at the cell surface. Receptor- and enzyme-
mediated hydrolysis of PIP
2
, producing DAG and IP
3
, has become 
a canonical feature of signaling cascades. Fatty acid amides and 
arachidonate metabolic products, including a fascinating array 
of endocannabinoids, are involved in regulating physiological 
and basic behavioral states through the activation of specific cell 
surface receptors. [For an excellent review of the contributions of 
lipids to cellular signaling, see (1).] The direct binding and allos-
teric modulation of proteins by lipid molecules has been proposed 
in many systems, yet additional subtle effects of lipids on protein 
function can also occur through variations in the structure, rigid-
ity, or lateral pressure of the lipid components affecting protein 
conformation or dynamics.
This review will emphasize the direct effects of membrane 
lipids on transport proteins relevant to the central nervous system. 
[For a review of the actions of lipids on ion channel properties, 
see (2–4)]. We will attempt to complement traditional concepts of 
the neural cell membrane with data focusing on the interaction of 
both cholesterol and fatty acids with plasma membrane carriers. 
We will provide common names to discuss particular lipids (see 
Table 1), but we will also rely on the LIPID MAPS initiative, with 
its more precise nomenclature and comprehensive systematization 
of lipids and their metabolism (5). In accordance with much of 
the literature, we occasionally refer to “simple” lipids as those that 
produce only one or two products upon hydrolysis, as opposed 
to “complex” lipids, which yield a larger number of hydrolysis 
products. 
Lipid Composition of Cellular Membranes
Many initial efforts to characterize the “lipidome” of neural tis-
sues were limited in resolution to only a few of the predomi-
nant membrane constituents. For example, lateral vestibular 
neurons were reported to contain cholesterol [ST01010001], 
phosphatidylethanolamine [GP02], phosphatidylserine [GP03], 
oleic acid [FA01030002], stearic acid [FA01010018], palmitic 
acid [FA01010001], as well as phosphoinositols [GP06] (6). 
Differences in lipid composition between axonal plasma mem-
branes and the surrounding myelin were in a sense some of the 
earliest “lipidomics” data: axonal membrane was reported as 
20.1 % cholesterol, 20.1 % galactolipid [SP06], 14.6% phos-
phatidylethanolamine, 18.3% phosphatidylcholine [GP01], 9.3% 
sphingomyelin [SP0301], 5.6% phosphatidylserine, and 3.4% 
phosphatidylinositol [GP06]). Ceramides [SP02] and sulfogly-
cosphingolipids [SP0602] predominated as the 24:1 unsaturated 
form. In myelin, the saturated version of sphingolipid (i.e., 24:0) 
predominated (7–9). From this early work, it became clear that 
the plasma membrane of neurons (and indeed of most mammalian 
cells) is comprised of a combination of cholesterol, phosphatidyle-
thanolamine, phosphatidylserine, phosphatidylcholine, sphingo-
myelin, and glycolipids in an asymmetrical leaflet distribution. 
[For a comprehensive review of history of early neuronal lipidom-
ics, see (10).]
To understand how the lipid environment influences protein 
function it is imperative to define not only the lipid components 
of the membrane, but their organization in the membrane. It was 
shown almost fifty years ago that artificial lipid monolayers can 
transition from a gel-like state to a liquid-crystalline state with 
increasing temperature (11). In the gel phase, acyl chains in a 
predominately all-trans configuration undergo orderly packing, 
whereas in the liquid crystalline state acyl chains with disordered 
or random orientations predominate (Figure 1). Lipid bilayers can 
also transition between these states, and the plasma membrane is 
best modeled as a liquid-disordered state (12). Although the study 
of lipid monolayers and pure or controlled lipid environments has 
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Table 1. Eight Lipid Catagories and Subclassification According to LIPID MAPSa
Category Subclassification and identification in LIPID MAPS structure database
Fatty Acyls
Fatty Acids and Conjugates [FA01]b Fatty amides [FA08]
Octadecanoids [FA02] Fatty nitriles [FA09]
Eicosanoids [FA03] Fatty ethers [FA10]
Docosanoids [FA04] Hydrocarbons [FA11]
Fatty alcohols [FA05] Oxygenated hydrocarbons [FA12]
Fatty aldehydes [FA06] Fatty acyl glycosides [FA13]
Fatty esters [FA07]
Glycerolipids
Monoradylglycerols [GL01] Triradylglycerols [GL03]
Diradylglycerols [GL02] Glycosylmonoradylglycerols [GL04]
Glycosyldiradylglycerols [GL05]
Glycerophosphocholines [GP01] Glycerophosphates [GP10]
Glycerophosphoethanolamines [GP02] Glyceropyrophosphates [GP11]
Glycerophosphoserines [GP03] Glycerophosphoglycerophosphoglycerols [GP12]
Glycerophosphoglycerols [GP04] CDP-Glycerols [GP13]
Glycerophosphoglycerophosphates [GP05] Glycosylglycerophospholipids [GP14]
Glycerophosphoinositols [GP06] Glycerophosphoinositolglycans [GP15]
Glycerophosphoinositol monophosphates [GP07] Glycerophosphonocholines [GP16]
Glycerophosphoinositol bisphosphates [GP08] Glycerophosphonoethanolamines [GP17]
Glycerophosphoinositol trisphosphates [GP09] Diglycerol tetraether phospholipids (caldarchaeols) [GP18]
Sphingolipids
Sphingoid bases [SP01] Neutral glycosphingolipids [SP05]
Ceramides [SP02] Acidic glycosphingolipids [SP06]
Phosphosphingolipids [SP03] Basic glycosphingolipids [SP07]
Phosphonosphingolipids [SP04] Amphoteric glycosphingolipids [SP08]
Arsenosphingolipids [SP09]
Sterol Lipids
Sterols [ST01] Bile acids and derivatives [ST04]
Steroids [ST02] Steroid conjugates [ST05] 
Secosteroids [ST03]
Prenol Lipids
Isoprenoids [PR01] Polyprenols [PR03]
Quinones and hydroquinones [PR02] Hopanoids [PR04]
Saccharolipids
Acylaminosugars [SL01] Acyltrehaloses [SL03]
Acylaminosugar glycans [SL02] Acyltrehalose glycans [SL04]
Other acyl sugars [SL05]
Polyketides
Linear polyketides [PK01] Angucyclines [PK08]
Halogenated acetogenins [PK02] Polyether antibiotics [PK09]
Annonaceae acetogenins [PK03] Aflatoxins and related substances [PK10]
Macrolides and lactone polyketides [PK04] Cytochalasins [PK11]
Ansamycins and related polyketides [PK05] Flavonoids [PK12]
Polyenes [PK06] Aromatic polyketides [PK13]
Linear tetracyclines [PK07] Non-ribosomal peptide/polyketide hybrids [PK14]
a The LIPID Metabolites and Pathways Strategy (LIPID MAPS) classifies eight broad categories, developed through chemical characteristics, that are subdivided into 
classes and subclasses. 
b Subsequent organization of lipids into subclasses can be identified by the root number shown followed by additional numbering for subclass and specific molecule 
within that subclass. This system allowed for universal inclusion of new lipids compounds discovered through high-throughput lipidomics analysis. Adapted from Fahy 
et al. 2005 and http://lipidmaps.org/.
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revealed much about dynamics of lipids in general, such studies 
cannot offer a comprehensive model of a biological membrane that 
contains integral membrane proteins. In 1972, Singer described 
a model of the plasma membrane as a two-dimensional dynamic 
viscous solution in which integral membrane proteins maximize 
their hydrophobic and hydrophilic interactions in accordance 
with the surrounding lipid matrix and aqueous environment (13). 
Singer’s “fluid mosaic model” has been well supported for over 
thirty years (14), and an extensive literature reveals that variability 
in lipid composition affects viscosity, depth, curvature, and lateral 
pressure (15–19). 
Singer also recognized, in certain membrane regions, the pos-
sibility of liquid-ordered phases, characterized by restriction in the 
lateral movement of lipids. The emergence of lipid rafts as a field 
of study, although not without its share of debate, has established 
that local lipid composition can have profound impacts on integral 
protein structure and activity. Lipid rafts, or detergent resistant 
microdomains (DRMs), are defined as cholesterol- and sphingo-
myelin-rich membrane regions that impose an ordered state to the 
surrounding lipid environment (20, 21). Although not considered 
in detail here, this area of research has brought an exciting new 
focus of research and discussion that will further our understand-
ing of lipids and membrane dynamics and how they relate to bio-
logical function.
Influence of Fatty Acids on  
Transporter Function
Polyunsaturated fatty acids (PUFAs; [FA0103]), such as arachi-
donic acid [FA01030001], comprise twenty to thirty percent of 
free fatty acids in the human brain (22). Typically derived from 
diet, polyunsaturated fatty acids in the brain are either transported 
from plasma and esterified into complex lipids or are released 
from membrane glycerophospholipids (23). Levels of brain PUFAs 
can increase with neuronal activity (e.g. activation of NMDA-
type glutamate receptors) and area subsequently metabolized by 
lipases, typically phospholipase A2 (PLA
2
) (24). Arachidonic acid 
(and other PUFAs) can modulate both the electrical and biochemi-
cal properties of a variety of membrane proteins involved in cel-
lular signaling mechanisms, including ion channels, receptors, and 
transporters. A critical question in all these examples is whether 
arachidonic acid modulates protein activity through a direct inter-
action with the protein or whether it indirectly modulates the pro-
tein either by altering membrane fluidity or through the actions 
of metabolites (e.g., mediated by cyclooxygense and lipoxygenase 
pathways).
The effects of arachidonic acid on brain transporter activ-
ity were initially examined in assays of glutamate uptake, 
γ-aminobutyric acid (GABA) uptake, and Na+/K+-ATPase activ-
ity (25). Incubation of rat cortical slices with arachidonic acid 
caused a dose-dependent reduction in the Na+-dependent 
transport of GABA and glutamate but did not affect transport 
of α-aminoisobutyric acid. Na+/K+-ATPase activity was reduced 
not only by arachidonic acid but also by docosahexaenoic acid 
[FA01030185]; the basis for these responses did not appear to 
stem from any detergent-like actions, as the addition of sodium 
dodecylsulfate at low concentrations had no effect. Similarly, in rat 
primary neuronal cultures, uptake of both glutamate and GABA 
was significantly inhibited by the two PUFAs, whereas glutamate 
transport alone was altered in astrocytes (26). The saturated fatty 
acid palmitate had no effect on transport in either neurons or glial 
cells. Taken together, these studies suggested that PUFAs modulate 
transport systems in a cell-type specific manner, perhaps related to 
intrinsic differences in membrane composition.
Melittin, a phospholipase A
2
 activator, has been used to 
increase cellular production of arachidonic acid from endogenous 
glycerophospholipid precursors. In one study, the addition of 
melittin together with an acyltransferase inhibitor to cultured 
astrocytes increased arachidonic acid levels in a dose-dependent 
manner and concomitantly inhibited glutamate uptake (27). 
This inhibition is insensitive to the cyclooxygenase inhibitor 
indomethacin but is abolished upon application of bovine serum 
albumin, which binds free fatty acids. These experiments were 
not able to determine whether arachidonic acid affects the gluta-
mate transporter through a direct interaction with the protein or 
whether it inhibits glutamate transport through an indirect mecha-
nism. The metabolism of arachidonic acid generates free radicals 
and reactive oxygen species (ROS), which are reported to inhibit 
glutamate transport in cells; thus, ROS were examined as potential 
indirect means for arachidonic acid–mediated inhibition of gluta-
mate transport (28–31). In astrocyte cultures treated with an ROS-
producing agent, saturating doses of arachidonic acid produced 
further inhibition of glutamate uptake. In addition, transport 
inhibition was fully prevented in cultures treated with both BSA 
(to sequester arachidonic acid) and superoxide dismutase/catalase 
(to prevent the accumulation of ROS). Application of either agent 
alone recovered only a portion of the inhibition, confirming that 
arachidonic acid mediates transport in an ROS-independent man-
ner. These investigations elegantly demonstrated that PUFA modu-
lation is a distinct mechanism and not dependent on oxidative 
stress or related processes. 
In isolated salamander retinal glial cells, arachidonic acid can 
inhibit the glutamate-evoked currents that arise from electrogenic 
glutamate uptake. Whole cell patch recordings of salamander 
Muller cells reveal that arachidonic, docosahexaenoic, and oleic 
acids reduce maximal transport currents without dramatically 
affecting glutamate affinity (32). These inhibitory effects did not 
appear to depend on metabolic turnover of the PUFAs, as the 
inhibition was affected by neither nordihydroguaiaretic acid nor 
indomethacin, inhibitors of lipoxegenase and cycooxygenase, 
respectively. Using a different model system, Trotti and colleagues 
investigated the effects of a series of fatty acids on the uptake of 
radiolabeled glutamate in reconstituted proteoliposomes enriched 
in the glutamate transporter isoforms Glt-1 (33). They showed 
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that oleic acid, methyl ester-arachidonic acid, α-linolenic acid 
[FA01030152], docosahexaeonic acid, and eicosapentaenoic acid 
[FA01030181] all inhibited glutamate transport, and interestingly, 
eicosapentaenoic acid inhibited uptake significantly more than 
did arachidonic acid. A major finding from this work was that 
arachidonic acid present in the aqueous but not the lipid phase 
was essential for the inhibitory effect. This observation supports 
the intriguing possibility that the inhibition of glutamate transport 
is the consequence of a direct interaction between arachidonic 
acid from the aqueous medium and the transporter protein. 
Remarkably, in 2004, the crystal structure of an archaeal ortholog 
of mammalian glutamate transporters revealed the presence of a 
lipid moiety bound within the solvent-filled basin. In this struc-
ture the lipid extends down into a hydrophobic crevice that is 
observed only in the substrate-bound carrier (34) (Figure 2A). 
This state-dependent lipid interaction at the aqueous interface 
of a glutamate transporter is intriguing and may provide a struc-
tural link to the lipid-mediated inhibition of carrier activity noted 
above.
The question of whether PUFAs act directly or indirectly to 
modulate transporter function was further addressed in investiga-
tions of the effects of arachidonic acid and other fatty acids on 
transport currents associated with human excitatory amino acid 
transporters (EAATs) (35). Because transport of glutamate by 
EAATs is coupled thermodynamically to the co-transport of one 
proton and two to three sodium ions, and to the counter-transport 
of one potassium ion, the process is electrogenic and can be stud-
ied using electrophysiological techniques in Xenopus oocytes. 
With all EAAT subtypes, most notably EAAT4 and EAAT5, sub-
strates can additionally activate a thermodynamically uncoupled 
anion flux. Three glutamate transporter isoforms were expressed 
in Xenopus oocytes and tested for their sensitivity to arachidonic 
acid: EAAT1, a glial carrier; EAAT2, an abundant, predominantly 
astrocytic carrier; and EAAT3, a widely expressed neuronal carrier. 
The effects of PUFAs were distinct for each transporter subtype: 
maximal transport activity of EAAT 1 was decreased without alter-
ation of glutamate affinity; the activity of EAAT2 was increased by 
decreasing its apparent K
m
 for glutamate; and little or no effect was 
observed on the activity of EAAT3. These results, together with 
synaptosomal studies reporting different arachidonic acid effects 
on glutamate transport in various regions of the rat central ner-
vous system (36), first illustrated the subtype-selective actions of 
arachidonic acid on glutamate transporters. Proteoliposomal prep-
arations further corroborate these observations, raising again the 
possibility that PUFAs such as arachidonic acid regulate transport 
through direct interactions with the carriers themselves, rather 
than through indirect effects on membrane organization or fluidity. 
Moreover, the rapid onset of modulation, along with its insensitiv-
ity to cyclooxygenase and lipoxygenase inhibitors, suggests that 
the effects on glutamate transport are mediated directly by arachi-
donic acid itself, rather than via a metabolite. 
Solid gel
A
B
C
Liquid crystalline/disordered
Liquid-ordered
Figure 1. The dynamic lipid bilayer and membrane phases. Three different 
phases are generally described for membrane lipids. A) In the “solid gel state,” 
or “solid crystalline state,” hydrocarbon chains are typically found in the trans 
configuration and are highly ordered. Low temperatures can favor the solid 
gel phase. B) This “liquid crystalline state,” or “liquid disordered state,” is typi-
cal of high temperature and shows a disordered configuration of acyl chains. 
High lateral mobility is associated with the liquid disordered state; most pure 
fatty acid, detergent, or phospholipid liposomes are found in this state at room 
temperature. C) The “liquid ordered state” occurs in the presence of high lev-
els of sphingolipids and cholesterol and results in mobility slightly under that 
of the pure liquid disorderd state. Detergent-resistant microdomains or lipid 
rafts are endogenous liquid-ordered membrane patches. See text for details. 
Adapted from (63).
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Further insight into the 
ability of arachidonic acid to 
differentially modulate the 
activity of glutamate trans-
porters comes from inves-
tigation of human EAAT4, 
a carrier that possesses a 
prominent substrate-activated 
anion current (37). Although 
arachidonic acid does not 
significantly affect substrate 
transport, it causes a large 
increase in substrate-activated 
EAAT4-mediated currents. Ion 
substitution experiments have 
revealed that EAAT4 generates 
a distinctive substrate-gated 
proton-selective current that 
is PUFA-dependent. The pro-
ton conductance, activated at 
low, physiologically relevant, 
concentrations of arachi-
donic acid (EC
50
 ≈2µM), is 
not associated with changes 
in substrate flux, PUFA 
metabolism, ion coupling, 
or the well-established anion 
conductance. The phenom-
enon is characteristic of rat as 
well as human EAAT4 (38). 
Thus, several lines of data indicate that arachidonic acid and other 
PUFAs alter the channel-like signaling properties of the EAAT4. 
[For reviews of EAAT modulation by PUFAs, see (39, 40)]. 
In addition to the excitatory amino acid family of carriers, 
which belong to solute carrier family 1 (SLC1), a second family 
of transporters, the biogenic amine carriers, are also regulated 
by PUFAs. These carriers are members of the neurotransmitter–
sodium symporter family (SLC6). For example, arachidonic acid 
inhibits the uptake of L-dopamine into rat striatal synaptosomes in 
a dose-dependent manner (41). In contrast, C6 glioma cells stably 
expressing the dopamine transporter respond to arachidonic acid 
(20–160µM) in a biphasic manner: dopamine transport is acti-
vated in the short term, but at later time points (incubations > 45 
min), transport is inhibited relative to control (42). Thus, within 
a single cell line, arachidonic acid may have multiple modes of 
action on the dopamine transporter. 
In addition to the electrogenic co-transport of Na+, Cl– and 
dopamine, the dopamine transporter mediates a sodium-depen-
dent cation leak conductance (43), which is relevant in determin-
ing the specific effects of PUFAs upon the transporter. Indeed, like 
the excitatory amino acid transporter discussed above (EAAT4), 
the dopamine transporter responds to arachidonic acid by display-
ing unique conductances. The application of arachidonic acid 
(1–100 µM) to Xenopus oocytes expressing the human dopamine 
transporter stimulates an inward current that is potentiated by 
dopamine and can be blocked by transport inhibitors such as 
cocaine (44). The current is qualitatively and quantitatively differ-
ent from the currents typically associated with dopamine transport 
in several ways: it shows a distinctive selectivity for cations; its 
amplitude can be up to fiftyfold larger than current arising from 
electrogenic transport; and it is more pH-sensitive than transport. 
In voltage-clamped oocytes, arachidonic acid inhibits dopamine 
transport. Interestingly, dopamine, even in the absence of its co-
substrate sodium, can potentiate the arachidonic acid–induced 
current. These effects appear to be produced by a direct action 
of arachidonic acid on the carrier, as they are not mimicked by 
non-metabolizable analogs and they are insensitive to a variety of 
inhibitors of fatty acid metabolism.
Because many studies have ruled out changes in fluidity or 
other membrane dynamics as contributors to the effect of PUFA 
actions on transporters, the observation that a range of these lipid 
molecules can mediate similar effects may well reflect a generally 
accommodating binding site. Nonselective binding is unlikely to 
be as energetically favorable as the binding of ligand to a more 
B
Figure 2. Lipid moieties found within high-resolution structures of integral membrane proteins. A) A high-affinity 
aspartate transporter (GltTph) from Pyrococcus hirokoshii resolved at 3.2Å. Surface representation of a single GltTph 
monomer, colored by atom type, with the interacting palmitate molecule colored green. At right, the hydrophobic residues 
that are positioned to interact with the lipid molecule are shown. B) Membrane topology of the human β2-adrenergic 
receptor based on the crystal structure resolved at 2.4 Å. Intriguingly, association of the two receptor molecules (blue) 
appears to be mediated by cholesterol (orange). [Adapted from (34, 64).]
A
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specific binding site. Nevertheless, the presence of lipid moieties 
within a number of high-resolution membrane protein structures 
lends additional credence to the possibility of allosteric lipid mod-
ulation (Figure 2). 
Cholesterol and Transporter Function
Cholesterol is another con-
stituent of the membrane 
that has been shown to have 
a major effect on protein 
dynamics and function. 
Increases in membrane cho-
lesterol content have been 
shown to affect lipid fluidity 
and to increase the viscos-
ity of the membrane (45). 
The Na+/K+-ATPase is one of 
the most extensively studied 
carriers in biology, and early 
studies indicated that mem-
brane cholesterol depletion 
increases pump activity. To 
establish whether cholesterol 
depletion alters maximal 
transport rates through a 
general change in membrane 
lipid fluidity or through a 
more direct mechanism, 
the effect of several addi-
tional amphiphilic molecules 
that enhance membrane 
fluidity were tested (46). 
Electronic spin resonance 
and fluorescence polariza-
tion measurements with 
these compounds revealed 
a membrane-disordering 
effect that mimicked choles-
terol removal. All treatments 
decreased the apparent inter-
nal Na+ affinity but increased 
maximal transport velocity of 
the ATPase. In addition, the 
supplementation of bovine 
kidney membrane vesicles 
with phosphatidylcholine 
and sterols evoked a biphasic 
response in pump activity, 
in which low levels of cho-
lesterol stimulated activity, whereas high concentrations inhibited 
ATP hydrolysis (47).
Although initial studies consistently demonstrate a biphasic 
action of cholesterol on ATPase activity, the magnitude of inhibi-
tion observed varied widely among the various artificial membrane 
and tissue preparations studied. A comprehensive series of experi-
Table 2. Transporter Regulation by Polyunsaturated Fatty Acidsa
Transporter Fatty acid (structure) Regulationb Ref.
Rat GAT
Arachidonic acid
O
OH
O
OH
O
OH
O
OH
O
OH
O
OH
Transport inhibited
25, 26, 
33
Rat GLT-1/ 
GLAST/EAAC1
Arachidonic acid Vmax decreased
25–31, 
36
Rat GLT-1
Oleic acid O
OH
O
OH
O
OH
O
OH
O
OH
O
OH
Vmax decreased 33
A-Linolenic acid
O
OH
O
OH
O
OH
O
OH
O
OH
O
OH
Eicosapentaenoic acid
O
OH
O
OH
O
OH
O
OH
O
OH
O
OH
Docosahexanoeic acid
O
OH
O
OH
O
OH
O
OH
O
OH
O
OH
Rat EAAT4 Arachidonic acid
I increased,  
H+ conductance
38
Human EAAT1
Arachidonic acid
A-Linolenic acid ITransport decreased 35
Linoleic acid
O
OH
O
OH
O
OH
O
OH
O
OH
O
OH
Human EAAT2
Arachidonic acid
ITransport increased,  
Km decreased
35A-Linolenic acid
Linoleic acid
Human EAAT3 Arachidonic acid
ITransport increased,  
Km decreased
35
Human EAAT4
Arachidonic acid
I increased,  
H+ conductance
37
A-Linolenic acid
Linoleic acid
Docosahexanoeic acid
Oleic acid
Salamander 
GLT1/GLAST
Arachidonic acid
Vmax decreased 32
Oleic acid
Rat DAT Arachidonic acid Transport inhibited 41
Human DAT Arachidonic acid
Vmax decrease,  
Km decrease
42, 44
I increased, 
Cation conductance
Rat Na+/K+- 
ATPase
Arachidonic acid Transport inhibited 25
a Data reflect effects of fatty acids added to different membrane transport systems in different tissues and species  
as indicated. 
b Regulatory effects of the fatty acid addition.
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ments addressed the effects of cholesterol on the kinetic properties 
of the Na+/K+-ATPase isolated from the shark rectal gland; pump 
activity was reconstituted in liposomes consisting of phosphati-
dylcholine, phosphatidylinositol, and phosphatidylethanolamine. 
The addition of cholesterol to these liposomes caused a significant 
increase in steady-state rate of Na+/K+-exchange activity, Na+/Na+-
exchange, and on Na+ uncoupled transport (48). Additionally, 
cholesterol increased the rates of ATPase phosphorylation and 
dephosphorylation by as much as forty percent. These data sup-
ported a model in which the incorporation of cholesterol into lipo-
somes shifts the equilibrium of ATPase conformers, accounting for 
kinetic effects observed for the potassium deocclusion reaction as 
well as for the observed change in phosphoenzyme levels (49). 
The fatty acid composition of the lipid bilayer can also affect 
Na+/K+-ATPase activity. Unsaturated fatty acids, which display 
fewer packing interactions and higher fluidity than saturated 
fatty acids, give rise to higher levels of ATPase activity in proteo-
liposome preparations (50). Additionally, acyl chain length is a 
variable that has been demonstrated to impact protein activity 
with optimal functioning of the ATPase in lipid vesicles contain-
ing between 16- and 20-carbon atom phosphatidylcholine acyl 
chains (51). When the Na+/K+-ATPase was assessed in a reconsti-
tuted liposome system in the 
absence of cholesterol, the 
optimal acyl chain length for 
a monounsaturated phos-
pholipid was twenty-two 
carbons, whereas the optimal 
length in the presence of 
cholesterol was shifted to 18 
carbons (52). No significant 
effect on pump activity was 
seen in response to tempera-
ture alteration supporting 
the notion that that bilayer 
thickness is a more critical 
variable for regulating activ-
ity than membrane fluid-
ity. Subsequent work also 
revealed that interactions 
between cholesterol and the 
polyunsaturated acyl chains 
of lipids can significantly 
influence Na+/K+-ATPase 
activity. Specifically, the addi-
tion of phosphatidylcholine 
molecules containing doco-
sahexaenoic acid acyl groups 
lowers pump activity and 
decreases Na+ binding (53), 
effects that vary inversely 
with the amount of choles-
terol incorporated into the membrane. The docosahexaenoic acid 
moiety, with its six double bonds, induces a high degree of dis-
order within the membrane, whereas cholesterol favors a liquid-
ordered state. Docosahexaenoic acid-containing phospholipids 
thus tend to segregate laterally away from cholesterol and establish 
liquid-disordered domains. These experiments demonstrate a fun-
damental effect of membrane properties on integral protein func-
tion, and also reveal more specific interactions of cholesterol and 
phospholipids with the ATPase. 
Clearly, studies of Na+/K+-ATPase activity have established 
that the activity of an integral membrane protein can be regulated 
by membrane lipid composition, bilayer thickness, and general 
fluidity. Membrane cholesterol has also been shown to modulate 
the activity of neurotransmitter transporters. Transport by a rat 
brain GABA transporter reconstituted into liposomes was signifi-
cantly impaired when the lipid bilayer consisted solely of asolectin 
(soybean phospholipids), but transport activity was restored upon 
addition of brain lipids containing cholesterol (54). This stimula-
tion was specific in that it could not be replicated by cholesterol 
analogs. Brain glutamate transport in proteoliposomes is similarly 
cholesterol-dependent, and the stimulatory effect of cholesterol in 
this case could not be explained by any changes in ion coupling 
Table 3. Transporter Responses to Alteration of Membrane Cholesterol Contenta
Transporter Cholesterol treatment Effect Ref.
Na/K-ATPase
(Human)
Removalb Decreased Na affinity,
Increased Vmax
46
Na/K-ATPase
(Bovine)
Minimal additionc
Maximal addition
Increased ATPase 
Decreased ATPase 
47
Na/K-ATPase 
(Shark)
Addition Stimulated ATPase activity,  
Na transport, K release
48, 49, 
52
GAT (Rat) Removal Decreased activity 54
Glt-1 (Rat) Removal Decreased activity 54
EAAT2 (Human) Removal Decreased activity 56
SERT
(Rat)
Removal Decreased Vmax,
Decreased Km
57, 58
EAAC1 (EAAT3) 
(Rat)
Addition Increased Vmax,  
Increased expression
55
DAT 
(Human)
Removal Decreased Vmax,
Decreased Km,
Increased lateral mobility
59
DAT (Rat) Removal Decreased activity 60
GLYT2 (Rat) Removal Decreased activity 61
GLYT1 (Human) Removal Decreased activity 62
GLYT2v (Human) Removal Increased activity 62
a Data compiled from reviewed references demonstrate the effect of cholesterol manipulation on different transport systems  
across several species. 
b Removal is typically treatment with methyl-β-cyclodextran (MβCD) or incubation of the transporter-encompassed  
membrane with cholesterol-free liposomes. 
c Addition is either treatment with water-soluble cholesterol bound in MβCD as a carrier or incubation within high  
cholesterol concentrations in liposomes.
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or carrier surface expression. Remarkably, very modest amounts 
of cholesterol are required to restore GABA or glutamate trans-
port activity, implying that a direct interaction of cholesterol with 
the carriers may mediate this effect. A more recent study has 
explored a distinct effect of cholesterol in primary neuronal cul-
tures from rat cortex. The intrinsic glutamate transport activity of 
pure neuronal cultures is lower than that of neurons co-cultured 
with astrocytes (55). The transport deficiency manifested by pure 
neuronal cultures can be rescued by astrocyte-conditioned media, 
and cholesterol itself was identified as the molecule responsible for 
the observed increase in transport function. One additional study 
of the effect of cholesterol depletion on glutamate transport in rat 
cortical cultures showed that when the sterol chelator methyl-β-
cyclodextrin (MβCD) was used to remove cholesterol, radiolabeled 
glutamate uptake was significantly reduced. Additional experiments 
showed that EAAT2 resides in detergent-resistant lipid microdo-
mains and that MβCD treatment altered this localization (56).
Membrane cholesterol content can also regulate the activ-
ity of the serotonin transporter, which also belongs to the 
Neurotransmitter–Sodium Symporter family (NSS or SLC6 fam-
ily). Treatment of HEK293 cells stably expressing the rat serotonin 
transporter with MβCD decreases maximal transport rate, lowers 
the apparent affinity for serotonin, and abolishes binding of the 
antagonist citalopram (57). These effects were specific for cho-
lesterol and not due to alterations in membrane fluidity, because 
analogs of cholesterol that alter membrane fluidity had no effect 
on transport activity. In addition, disruption of lipid microdo-
mains upon removal of cholesterol with MβCD has been linked to 
reduced SERT activity (58).
The human dopamine transporter is also regulated by its 
association with membrane lipid microdomains and by changes in 
cholesterol content (59). Based on fluorescence recovery after pho-
tobleaching (FRAP) experiments, an association of the dopamine 
transporter (tagged with yellow fluorescent protein) with lipid 
microdomains was reported in HEK293 cells. With the depletion 
of membrane cholesterol by MβCD treatment, the lateral mobility 
the dopamine transporter was increased, and this effect was associ-
ated with a decline in the transporter Vmax as well as its apparent 
affinity for dopamine. Interestingly, the disruption of the cytoskel-
eton by cytochalasin D also disrupted the localization of the dop-
amine transporter in this system, although it was unclear whether 
this effect alone was sufficient to alter transporter activity. Another 
study of the dopamine transporter, in which the effect of protein 
kinase C on dopamine transport was examined with respect for 
the distribution of the transporter at lipid microdomains (60), 
concluded that 1) the regulation of the dopamine transporter by 
cholesterol occurred within lipid rafts; and 2) that cholesterol-
dependent regulation of dopamine transport was not mediated 
through alterations in cell surface expression of the transporter. 
In addition, studies examining the accessibility of cysteine resi-
dues introduced into the carrier sequence have demonstrated an 
increase in the number of cocaine binding sites when cells are pro-
vided with medium enriched with water-soluble cholesterol (Hong 
and Amara, unpublished data). These results support the notion 
that membrane cholesterol affects the conformational equilibrium 
of the transporter domains to favor an outward-facing state.
Two additional members of the SLC6 family, the glycine 
transporters GLYT1 and GLYT2, regulate glycine concentrations 
near central nervous system synapses. The neuronal carrier, 
GLYT2, localizes to detergent-resistant microdomains that are 
required to maintain full activity, and both cholesterol removal 
and sphingomyelinase treatment reduce GLYT activity (61). In 
contrast, a second study, using human GLYT1 and GLYT2 stably 
expressed in Chinese hamster ovary cells, reported that MβCD-
mediated depletion of cholesterol reduced GLYT1 activity but 
actually increased GLYT2 activity (62). The same experiments, 
repeated in Xenopus laevis oocytes, revealed that although GLYT1 
catalytic activity was reduced, GLYT2 activity was unaltered. 
Differences among these observations could arise from cell-specific 
differences in membrane thickness, fluidity, composition, or the 
presence of specific regulators.
Conclusions
The precise mechanisms for regulation of both primary and sec-
ondary carriers by lipids have remained elusive, in part reflecting 
the diversity of pathways and settings in which lipids can alter the 
structure and function of membrane proteins. Emerging data on 
the functional impact of lipids on membrane proteins, together 
with new high-resolution structures of protein–lipid complexes, 
support the idea that direct interactions of lipids and proteins will 
be found in many different transport systems. Nonetheless, the 
indirect effects of fatty acid composition, membrane fluidity, lateral 
segregation of membrane components, and bilayer dimensions in 
complex membrane environments will undoubtedly be part of the 
picture, too. Despite all the possibilities, the intimate association 
of membrane proteins with the lipid milieu guarantees that their 
functions will be shaped and regulated by a diverse, but essential 
cadre of oily characters.  doi:10.1124/mi.9.5.8
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APPENDIX C: MECHANISM OF CYSTEINE INTERACTION IN EXCITATORY AMINO ACID 
TRANSPORTERS 
 
C.1. SUMMARY OF CONTRIBUTIONS 
My contributions to this manuscript, which is in preparation, are significant in number. I 
developed the electrophysiological experiments and performed them in conjunction with Dr. 
Delany Torres-Salazar. I designed the use of L-selenocysteine as a cys congener and, along 
with Dr. Spencer Watts, interpreted all the data collected for the manuscript. I also attempted 
several challenging experiments looking at flux coupling ratios at various pHs and attempted to 
use deuterium containing buffers to modulate the mechanism of cysteine interaction with the 
EAATs. I also significantly assisted in the writing of this document.  
   
C.2. INTRODUCTION 
Excitatory amino acid transporters (EAATs) regulated the spatio-temporal profile of synaptically 
released glutamate (glu). Regulation of extracellular glu controls activation of synaptic and peri-
synaptic ionotropic and metabotropic glutamate receptors (iGluRs and mGluRs) (1). EAATs are 
secondary active, electrogenic transporters of L-glu and L- and D-aspartate (asp) (2). This 
family of carriers is organized as homotrimers in the membrane and is comprised of 8 
transmembrane domains (TM1-8) and two reentrant or hairpin loops (HP1 and HP2) (3-5). The 
translocation of 1 glu molecule is against its concentration gradient and therefore is co-
transported with 3 Na+, 1 H+, and counter-transport of 1 K+ ion. This allows the net influx of ~2 
positive charges per transported glu (6). In addition to this electrogenic activity, EAATs mediate 
a thermodynamically uncoupled anion conductance (7). This channel activity is open in the 
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empty transporter in glia (unpublished observation) and is gated by Na+ interaction in neuronal 
isoforms (8,9). The binding of substrates such as glu or asp occurs in an ordered manner after 
the initial binding of 1 or 2 Na+ and substrate interaction increases the open probability of the 
channel (10-12).   
The mechanism of substrate interaction has been studied thoroughly for ligands such as 
glu or asp, yet many of the EAAT isoforms are capable of transporting a wide range of acidic 
species (2,13). One of the most atypical endogenous substrates for an EAAT family member is 
the transport of L-cysteine (cys) by EAAT3 (or EAAC1) (14). This carrier-substrate interaction 
was highlighted when EAAC1 KO mice showed a significant loss of neuronal viability, increased 
presence of reactive oxygen species, and a distinct decrease in glutathione levels (15). Thus, it 
is possible that EAAT3 influences glutathione levels through transport of cys, the rate limiting 
precursor to glutathione synthesis (16). The role of EAAT3 as a transporter of released 
glutamate is somewhat unclear. Although EAAT3 may influence the initial concentration of 
glutamate seen by post- and peri-synaptic receptors through rapid binding of released glu 
(17,18), the majority (> 90%) of glu transport is mediated by EAAT2 isoforms (19,20). Therefore, 
it has been proposed that EAAT3 uses the small amount of glu it transports as a precursor for γ-
aminobutyric acid (GABA) synthesis (21). Thus, it is not surprising that EAAT3 has also been 
proposed to mediate the synthesis of glutathione (GSH) through transport of cys. This 
hypothesis is support by a number of studies in addition to the initial EAAC1 knockout data. 
GSH levels are significantly affected by knockdown of GTRAP3-18, an interacting protein of 
EAAT3 (22,23). Also, application of N-acetylcysteine, a membrane permeable cysteine 
precursor, recovered GSH levels in EAAC1 -/- mice, suggesting that EAAT3 is the active 
transport protein for cysteine in the nervous system (24). These data together warrant the 
further investigation of cysteine interactions with this family of glutamate transporters.  
Here we elucidate the mechanism of cys interaction with the family of EAATs. Through a 
combination of experimental techniques such as biochemistry, optical imaging, and 
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electrophysiology, we demonstrate that the transport of cysteine is dependent on a de-
protonation mechanism mediated by EAAT3 alone among the EAATs. Our data support the 
potential neuronal transport of cys and aid in this field of investigation by providing critical insight 
into the mechanism of substrate interactions in the family of glutamate transporter.  
 
C.3. EXPERIMENTAL PROCEDURES 
C.3.1. Generation of Constructs 
hEAAT1, hEAAT2, hEAAT3, and rEAAT4 were all subcloned into pOTV or pcDNA3.1 constructs 
using Kpn1 and Xba1 restriction sites (2). The EGFP-pH was constructed starting with pEGFP-
N3 (Clonetech) and using site directed mutagenesis to create the H148D substitution with 
primers (5' to 3') CTGGAGTACAACTACAACAGCGACAACGTCTATATCATGGCCGAC (sense) 
and GTCGGCCATGATATAGACGTTGTCGCTGTTGTAGTTGTACTCCAG (antisense) (C to G 
base change to create the CAC to GAC codon change) (25).  Membrane targeting was 
accomplished by insertion of the coding sequence for the palmitoylation signal peptide from 
neuromodulin (GAP-43), MLCCMRRTKQVEKNDEDQKI, immediately 5' of the ATG start codon 
for EGFP-pH using the DNA sequence (ATGCTGTGCTGTATG 
AGAAGAACCAAACAGGTTGAAAAGAATGATGAGGACCAAAAGATC)(26). 
C.3.1. Transfection of HEK293 and cRNA Injection into Xenopus oocytes 
HEK293 cells were cultured at 37°C in a humidified 5% CO2 incubator in DMEM (Lifetech, Gibco 
BRL, Invitrogen) supplemented with 10% FBS, penicillin (100 U/mL) and streptomycin (100 
µg/mL).    For imaging, 1 x 105 cells/mL were batch transfected using 6 µL Lipofectamine 2000 
(Invitrogen) and 1 µg DNA (0.5 µg EAAT and 0.5 µg mEGFPpH) with 2 x 104 cells plated on 
poly-L-lysine coated 15mm coverslips. For radiolabeled transport experiments, cells were 
transfected as above with 1 µg EAAT DNA and plated at 5 x 104 cells/well in 24 well Costar 
(Corning) plates.  Following transfection and plating, cells were cultured 2-3 days prior to 
imaging or [3H]-L-glutamate transport experiments.   
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C.3.2. Radiolabeled Transport Assays 
Radiolabeled transport assays were conducted using hEAAT1, hEAAT2, hEAAT3, or rEAAT4 
transiently transfected into HEK293 cells or Xenopus oocytes. Briefly, 20 nM 35S-L-cystiene 
(Perkin Elmer) was diluted with various concentrations of L-cysteine as described in the figure 
captions. 200 nM 3,4-3H-L-glu was combined with various concentrations of L-glutamate as 
described in the figure captions. All cells were washed 3 times before application of substrates 
with phosphate-buffered saline + 1 mM MgCl2 and 0.1 mM CaCl3 (PBSCM) for HEK293 cells or 
with ND96 buffer for oocytes. Cells were washed 3 times with their respective buffer after 10 
min incubation with labeled substrates. Cell were lysed with 0.1 N NaOH + 1% SDS. HEK293 
were counted by well using liquid scintillation counting (LSC) and oocytes were counted by 
individual cell by LSC. 
C.3.3. Electrophysiology 
Two-electrode voltage clamp recordings were performed on Xenopus oocytes 2-3 days after 
injection using a Geneclamp 500 (Molecular Devices) and were digitized using a 1440A 
Digidata (Molecular Devices). Various concentrations of substrates were perfused with a gravity 
fed perfusion system with a flow rate of 5-10 ml/min. Electrodes with a resistance between 0.5-
2.0 were used to minimize voltage errors and were filled with 3 M KCl. A 3 M KCl agar bridge 
was used for all experiments. Samples were filtered at 1 kHz and were sampled at 50 kHz. 
Current-voltage (I-V) relationships were determined by applying voltage sweeps between -150 
mV and +60 mV for 500 msec each. Isochronal current amplitudes were taken from the last 100 
msec to ensure steady state conditions.   
C.3.4. Cell Imaging Experiments 
Cells were imaged with a Zeiss Axiovert 135T inverted microscope with a 40X NeoFluoar oil 
immersion objective (NA1.3).  A Lambda DG4 (Sutter Instrument Co.) equipped with a xenon 
arc lamp was used for high-speed excitation wavelength switching.  Images were collected 
using either a Quantix (Roper Scientific, Tucson, AZ) or an Orca ER (Hammamatsu Co.) cooled 
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CCD. For pH imaging experiments, the fluorescence filters (Omega Optical) were: excitation 
405 ± 20 and 485 ± 7.5 nm; dichroic 400-480-585 DLRP; emission 510 ± 11.5 nm.  Software 
control and data acquisition were accomplished using Axon Imaging Workbench (INDEC 
Biosystems) or OpenLab acquisition software (Improvision, Perkin Elmer). Cells were incubated 
at room temperature with continuous perfusion using buffer containing (in mM): 146 NaCl, 5 
KCl, 5 HEPES, 2.5 CaCl2 and 1.2 MgCl2 at pH 7.35 with additions (substrates etc.) as indicated 
in figure legends. 
C.4. RESULTS 
C.4.1. EAATs Readily Transport the Deprotonated Cysteine Analog Selenocysteine 
It has been previously demonstrated that EAAT3 can mediate the transport of cys with an 
apparent affinity of approximately 200 µM. However, EAATs 1 and 2 made an affinity for cys > 1 
mM. This led us to the hypothesis that EAAT3 possessed a special mechanism for the transport 
of cysteine. We further hypothesized that this was due to the ability of EAAT3 to mediate the 
deprotonation of cys at physiological pH. To test if EAAT3 can readily mediate the deprotonation 
of cys, we used selenocysteine (Secys) as a model for deprotonated cysteine transport. With a 
pKa of 5.5, Secys should be present in it’s negatively charged form at physiological pH. 
Application of various concentrations of Secys to Xenopus oocytes expressing EAAT1, 2, or 3 
demonstrate that deprotonated Secys is readily transported by all EAAT isoforms. The apparent 
affinity of Secys for EAAT3 is 7.1 + 2.0 µM (Figure C1A). The maximal current generated by 
transport of substrates is compared in oocytes expressing EAAT1, EAAT2, and EAAT3 (Figure 
C1B). Compared to saturating concentrations of glu, cysteine transport was significantly lower in 
both EAAT1 and EAAT2 (p < 0.001) while maximal transport currents in response to Secys 
were not significantly lower for EAATs 1, 2, or 3 (p > 0.5). Thus, selenocysteine is transported 
with a similar affinity and maximal velocity as glu. These data strongly suggest that any EAAT 
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Figure C1.  Selenocysteine is transported by EAATs 1-3 in oocytes. A) Perfusion of 
increasing concentrations of L-Selenocysteine (bars) induced increasing currents in voltage 
clamped oocytes expressing hEAAT3 (Upper panel). Normalized currents as a function of L-
Selenocysteine concentration in hEAAT3 expressing oocytes (Lower panel).  Data are 
presented as the mean and Std. dev.  and were fit with a sigmoidal dose-response curve to 
estimate the KM for transport. B) Comparison of the maximal transport currents for L-
selenocysteine (Secys) and L-cysteine (Cys) by hEAAT1 (white), hEAAT2 (black), or hEAAT3 
(grey) normalized to the maximal currents induced by L-glutamate (Glu) measured in the same 
oocytes.   
 
 
 
 
 
 
 
 
B 
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isoform tested here is capable of transporting a deprotonated cys but only EAAT3 can readily 
accomplish this at physiological pH, suggesting a mechanism present for cys deprotonation in 
EAAT3 but not EAATs 1 or 2.  
C.4.2. Selenocysteine Binding Competes for Glutamate Interaction in EAATs 
The transport of Secys in the EAATs could be indicative of the mechanism of cys binding in 
EAAT3 but further characterization is needed. The presence of increasing concentrations of 
Secys caused a specific decrease in transport of radiolabeled glu in HEK293 cells expressing 
EAAT2 with an IC50 of 37.2 + 2.0 µM (Figure C2B), indicating that these substrates were 
competitive. In contrast, the IC50 of cys for glu transport in EAAT2 was > 5 mM (Figure C2B). 
EAAT3 showed competitive inhibition of glu transport with both Secys (IC50 = 68.3 + 10.7 µM) 
and cys (IC50 = 399 + 48.7 µM). These data are consistent with both cys and Secys binding to 
the glu binding site in all of the EAAT isoforms tested and the affinity of the interaction is 
dependent on charged state for EAAT2 but not for EAAT3 as only the deprotonated Secys, and 
not cys, was readily transported by EAAT2.  
C.4.3 Optical Observation of Proton Coupled EAAT Transport Processes.  
One interpretation is that EAAT3 can mediate a binding mechanism that involves a 
deprotonation step of cys which the other EAAT isoforms cannot readily mediate. An alternative 
hypothesis is that EAAT3 can mediate the transport of the protonated from of cys as previously 
hypothesized (14). To differentiate between these two possibilities we developed an EGFP-pH 
sensor as a monitor for proton coupled substrate transport through the EAATs. To serve as a 
sensitive measure of proton influx mediated by EAAT transport processes, the EGFPpH sensor 
was membrane bound by adding a myristolation sequence to anchor it after translation. 
Transient transfection of HEK293 cells with the mEGFPpH sensor resulted in fluorescent 
signals indicative of membrane expression and localization (Figure C3A). Application of NH4Cl 
caused cells to significantly, transiently alkylate but then the cells rapidly acidified in response. 
The response of the mEGFPpH sensor demonstrates this behavior and, thus, would act as a 
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Figure C2. Comparison of [3H]-L-Glutamate transport inhibition by L-Selenocysteine and 
L-Cysteine for EAAT2 and EAAT3. Inhibition of 10 µM [3H]-L-glutamate with increasing 
concentrations of L-cysteine (circles) or L-selenocysteine (triangles) in HEK293 cells expressing 
hEAAT2 (A) or hEAAT3 (B). Data are represented as the mean and S.E.M. with non-linear 
curve fit to calculate the IC50.   
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Figure C3. mEGFPpH detects intracellular pH changes induced by glutamate transport. 
A) Representative fluorescent image of HEK293 cells transiently expressing the membrane 
bound (myristolated) EGFPpH sensor. B) Representative fluorescence traces of mEGFPpH 
transfected HEK293 cells (inset) perfused with 50 mM NH4Cl.  Left axis indicates the ratio of 
fluorescence from excitation at 488 nm to fluorescence of excitation 410 nm (F488/F410).   Arrows 
in inset indicate cells from which traces were recorded.  C) Perfusion of increasing 
concentrations of L-Glu results in increased rate and amplitude of mEGFPpH fluorescence 
decrease in HEK293 cells co-transfected with hEAAT3 and mEGFPpH.  D) Comparison plot of 
the magnitude of the slope of EGFPpH F488/F410 decrease (left y-axis) as a function of the 
applied L-glutamate concentration and that obtained for [3H]-L-glutamate transport activity (right 
y-axis) in similarly transfected cells.  L-glutamate induced a concentration dependent and 
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saturatable increase in the rate of mEGFPpH F488/F410 decrease that was similar to the rate of 
[3H]-L-Glu transport over the same range. 
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reliable sensor for monitoring pH dependent transport processes (Figure C3B). As predicted, 
perfusion of increasing concentrations of the substrate glu caused a concentration-dependent 
decrease in 488/405 fluorescent ratio in HEK293 cells transfected with both EAAT3 and the 
mEGFPpH sensor indicative of a net acidic transport process. These data support the use of 
this sensor as readout for proton coupled transport.    
C.4.4. Cysteine is Transported as a Thiolate Anion Through EAAT3 
If cys is transported in the neutral zwitterionic form, then the carrier would need to bind a proton 
from the extracellular milieu to complete the coupling normal for transport of a substrate. This 
would create a net acidic transport cycle as demonstrated for the transport of glu (Figure C3C). 
Alternatively, if EAAT3 is mediating a deprotonation mechanism for bound cysteine, then at 
physiological pH, the negatively charged cysteine would rebind a proton once released to the 
intracellular space (assuming a normal pKa for cys of 8.3). Therefore, our mEGFPpH sensor 
should delineate between these two processes. With HEK293 cells transiently expressing either 
EAAT2 or EAAT3 and the mEGFPpH sensor, application of 100 µM caused a decrease in the 
fluorescent ratio indicative of a net intracellular accumulation of protons, as previously described 
for glu transport (Figure C4A and C4B, left) (6). Likewise, application of 200 µM Secys also 
caused the net influx of protons in a mechanism indistinguishable from glu transport (Figure 
C4A and C4B, right). In contrast, application of 1 mM cys did not elicit any transport response in 
EAAT2, but elicited a small increase in the fluorescent ratio, consistent with a transport cycle 
which did not mediate the net influx of protons. These data indicate that cys is transported as 
the negatively charged thiolate which presumably rebinds intracellular protons after deocclusion 
from the EAATs. With the elimination of alternative hypotheses, it is most likely that EAAT3 
mediates the deprotonation of bound cysteine, completing the stoichiometric coupling of the 
transport cycle  
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Figure C4 Transport of substrates in cells expressing hEAAT2 and hEAAT3 differentially 
affects intracellular pH.  A) In cells co-expressing hEAAT2, 1 mM L-Cys induces no change in 
mEGFPpH fluorescence while 100 µM L-Glu and 100 µM L-Selenocysteine induce intracellular 
acidification (decreasing fluorescence).  B) In cells co-expressing hEAAT3, 1 mM L-Cys induces 
intracellular alkalinization (increasing fluorescence) while 100 µM L-Glu and 100 µM L-
Selenocysteine both induce intracellular acidification (decreasing fluorescence). 
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Figure C5. Effect of pH on L-cysteine transport properties of hEAAT3. A) Concentration 
dependent [35S]-L-Cys transport in hEAAT3 expressing oocytes at pH 6.9 and pH 8.5 with 
Michaelis-Menten curve fit, with calculated Km of > 2 mM and 660 µM for pH 6.9 and pH 8.5 
respectively.  B) and C) Inhibition of [35S]-L-cysteine transport  (30 µM, 300 µM, or 1000 µM L-
cys) at varying concentrations of L-glutamate in hEAAT3 expressing oocytes measured at pH 
6.9 (B) and pH 8.5 (C).  
  
 
 
 
 
 
 
 
 
 
 
 
[35]-Cys, µM 
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either with the proton gained from the cys substrate itself, or by shuffling the cys side chain 
proton to the extracellular milieu if a proton is already bound to the carrier (27). 
C.4.5. pH Dependence of Cysteine Interactions in EAAT3 
Our hypothesis is that EAAT3 is capable of a cys deprotonation scheme as part of the cys 
binding mechanism. If true, one would expect to see a pH dependence to cysteine interactions. 
We measured the transport kinetics of 35S-cys through EAAT3 expressed in Xenopus oocytes 
and, as predicted, transport velocity was drastically increased at pH 6.9 as compared to 
transport at pH 8.5. Additionally, the competitive binding of glu and cys to EAAT3 displayed 
interesting pH dependences. The IC50 for glu inhibition of cys at high pH (8.5), where > 50% of 
the cys present is in its deprotonated form, was dependent on the concentration of cys present. 
With 30 µM cys, IC50 of glu was 31.5 + 7.13 µM (Figure C5B). At higher concentrations of cys, 
the IC50 was shifted to 267.1 + 12.1 µM and 455.5 + 157.8 µM for 300 µM and 1 mM cys, 
respectively. When these experiments were replicated with a pH of 6.9, where the cys present is 
in its protonated form, the IC50 of glu inhibition of cys was 42.8 + 9.8 µM and 42.5 + 12.1 for 30 
µM and 300 µM cys, but only at the highest concentration of 1 mM was the IC50 right shifted to 
210.3 + 58.8 µM. We interpret this data to signify that cys behaves as two different substrates in 
its competition to glu, depending on the protonation of its side chain thiol group. These complex 
kinetic behaviors support that EAAT3 has a different relative affinity and therefore molecular 
interaction with cys when deprotonated. After the induced fit of binding, likely satisfaction of the 
R477 (EAAT3) side chain, does the thiolate form of cys translocate across the membrane.        
 
C.5. DISCUSSION 
Here we investigated the mechanism of cys transport by the SLC1 family of glutamate 
transporters. The EAAC1 (EAAT3) knockout animal model displayed a distinct phenotype where 
glutathione production was severely hindered and there was a significant increase in reactive 
oxygen species and loss of neurons in these mice (15). Several other lines of evidence support 
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the role of EAAT3 mediated cys transport in the central nervous system (22,23,28,29). 
Therefore, if EAAT3 is the sole source of cys for neurons in the nervous system, it would be of 
great importance for future investigations.  
The role of EAAT3 in cys transport is hard to resolve since there are several known 
transport machinery that are capable of cys translocation across the membrane. For example, 
the alanine/serine/cysteine transporters (ASCTs) are neutral amino acid exchangers which can 
readily mediate the flux of cysteine and are strongly expressed in the CNS.(30-33). These 
carriers are members of the SLC1 family of transporter and share ~35 % homology to the 
EAATs. The role of ASCTs have not been confirmed with knockout studies yet it has been 
proposed that ASCT2 plays a role in glutamine translocation and is involved in the glutamate-
glutamine pathway (34,35). In contrast, ASCT1 does not transport gln and, thus, may play a role 
in the exchange of cys in neurons (30). There are two other transport systems which may play a 
role in the translocation of cys in vivo. System N and A transporters of sodium coupled neutral 
amino acid transporters (SNATs) can mediate the transport of cysteine but their roles have been 
limited to regulating glutamine transport in the glutamate-glutamine cycle similar to ASCT2 (36). 
Additionally cysteine-glutamate exchangers (XCTs) are also present and may be another 
candidate for cysteine accumulation in neurons. Indeed, it has been proposed that XCTs and 
EAATs 3 and 4 may work together to drive GSH production (37). Thus with so many different 
transporters co-localized in the same systems, it is challenging to resolve the individual roles of 
each carrier or how they coordinate to mediate cysteine metabolism in the CNS.        
Zerangue and Kavanaugh (1996) originally proposed that cysteine transport occurred 
through EAAT3 as the neutral zwitterionic form of cysteine due to a lack of alteration to the EC50 
at pH higher than 7.5. This is not surprising because our data suggest that the transporter can 
readily mediate the deprotonation of cys and so shifting the equilibrium toward the thiolate 
species in solution would not necessarily reveal any insight into the mechanism of transport. 
Our data supports the transport of cys as a negatively charged species for multiple reasons. 
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First, a recent series of crystal structures from an archeal homolog of the EAATs, GltPh, depicts 
several substrate and inhibitor interactions (38,39). In these structures, substrates are 
demonstrated to be coordinated by several residues which have been previously substantiated 
to have a role in substrate interactions.  For example, mutation of R447 (EAAC1) drastically 
alters the substrate specificity of EAATs from a preference for acidic substrates to neutral 
substrates. The GltPh crystal structure also depicts the coordination of the side chain carboxylic 
group by R397 (the equivalent residue to R447). Thus, it is highly likely that EAATs can only 
mediate the interaction with anionic species due to the necessary interaction with the positively 
charged R447 residue. The only manner in which cys could satisfy the charge of this 
coordinating residue is if cys is transported as the negatively charge thiolate form. Second, 
Secys is an excellent congener for cys and is readily transported by all EAAT isoforms with an 
apparent affinity and velocity similar to glu. The structure of cys and Secys are near identical 
and the only major difference between these two substrates is the pKa of the side chain. Secys, 
with a pKa ~5.3, would be predominately deprotonated and negatively charged at physiological 
pH. This charged species can readily interact with the EAAT binding sites of any isoform. 
However, only EAAT3 can readily mediate transport of cys, suggesting that there is a particular 
mechanism in place for the deprotonation of glu by EAAT3 alone. Additional evidence which 
supports this mechanism is the lack of net acidic transport with the translocation of cys by 
EAAT3. Both glu and Secys mediate the net influx of a proton during the transport cycle yet cys 
does not demonstrate this property. The only mechanism which explains this phenomenon is 
that cys is transported as a thiolate which then rebinds a proton once it is released to the 
intracellular milieu.  
It is unclear exactly how the deprotonation of cys is mediated by EAAT3. Work done by 
Watzke et al. (2000) resolved the lingering question at the time of wether the pH altering 
species in the EAAT transport cycle was a proton or a hydroxyl ion (27,40,41). Additionally, the 
authors demonstrated that the ordered binding of substrates to the outward-open conformation 
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of EAAC1 would occur with glu (or cys) binding after the proton (42). Furthermore, 
investigations in the residue E373 (EAAC1) revealed its involvement with the protonation 
mechanism in some manner, due to the loss of pH dependent transport with mutations at this 
position. The role of E373, however, is not entirely clear as it also forces the transporter into the 
obligate exchange mode of glu translocation and this phenomena is replicated with Y374 
(EAAC1) mutations which show a loss of K+ interaction (43). It is possible that the sites of K+ 
and H+ interaction are the same but clearly more research will be needed to unravel these 
interactions further. Our data does not dispute the ordered binding of substrates as we cannot 
distinguish the order in our experimental models, nonetheless, our data do support a 
mechanism that is dependent on pH. In order to resolve our data with those previously 
published, our model involves a proton shuffle mechanism with the transfer of the cys side chain 
proton, releasing a previously bound proton to the extracellular space, allowing for the induced 
fit or lower energy interaction of the cysteine thiolate side chain with R447. Although this 
mechanism is speculative currently, it does fit with all available data. To further resolve the 
exact binding mechanism and downstream steps, additional experiments would be necessary 
which employ higher resolution techniques.  
Here we resolved the mechanism of substrate interactions in the family of EAATs. Cys is 
a rate limiting precursor for GSH synthesis and the mechanism of cys regulation and transport 
remains unclear. Although there are a number of carriers which have been demonstrated to be 
capable of cys transport in vitro, EAAT3 has been demonstrated to modulate GSH levels and 
neuronal viability in vivo. One remaining question is how EAAT3 mediates cys transport in vivo, 
especially considering the exposure of EAAT3 to glu during excitatory neurotransmission. It is 
possible that while EAAT2 mediates the majority of glu transport during neurotransmission, 
EAAT3 is responsible for a basal level of cys transport which can mediate the necessary 
synthesis of GSH, protecting neurons from oxidative stress. Our data here clarify the role of 
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EAAT3 in cysteine transport and resolve disparate data in the field concerning this substrate-
carrier interaction.     
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APPENDIX D: COUPLING BETWEEN SUBSTRATE TRANSPORT AND ANION CHANNEL 
GATING IN EXCITATORY AMINO ACID TRANSORTERS 
 
D.1. SUMMARY OF CONTRIBUTIONS 
My contribution to the document below warrant both inclusion as a co-author as well as 
inclusion in my thesis document. Since the inception of the study I have provided significant 
input in both the development of experiments, interpretation of results, writing of the document, 
as well as addressing outside readers concerns. Specifically, I significantly helped in 
interpretation of R388 transport activity, L376C mediated structural changes, TBOA mediated 
stabilization of outward facing states, and many aspects of the project that were not included in 
the manuscript as written here. For example, I designed and executed several experiments 
aimed at how R388C could be used to further our understanding of the role of this residue in 
mediating substrate transport and channel gating mechanism although these data was not 
included in the final drafts of the manuscript for issues of clarity. 
 
D.2. ABSTRACT 
In the mammalian central nervous system, excitatory amino acid transporters (EAATs) are 
responsible for the binding and reuptake of glutamate after release into the synapse. This 
activity is crucial for precise neuronal communication and for maintaining extracellular glutamate 
concentrations below neurotoxic levels. In addition to their ability to transport glutamate from the 
extracellular space, EAATs also have a thermodynamically-uncoupled anion conductance. 
Using site directed mutagenesis and electrophysiological recordings in Xenopus oocytes, we 
have identified a highly conserved, positively charged residue in transmembrane domain 7 
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(TM7) that when substituted for a negative charged amino acid eliminates both substrate gated 
anion conductance and substrate transport current. Our data suggest that this mutation locks 
the chloride channel in the Na-bound conducting state and therefore no increase in the anion 
current is observed upon application of saturating concentrations of glutamate.  This is the first 
evidence of a residue that directly modulates both substrate transport and substrate-dependent 
gating of the anion conductance. The data presented here suggest that arginine 388 (EAAT1) 
may be playing a crucial role in the coupling of substrate transport and substrate-dependent 
anion channel gating. We believe this mutant can be used as a tool to better understand the 
structural basis of anion permeation through EAATs, as well as the conformational changes 
involved in substrate-dependent anion channel opening.  
 
D.3. INTRODUCTION 
The major excitatory neurotransmitter glutamate is efficiently cleared from the extracellular 
space into surrounding neuronal and glial cells through a transport mechanism mediated by 
excitatory amino acid transporters (EAATs). This mechanism prevents sustained glutamate 
receptors activation which can cause neuronal death by excitotoxic mechanisms (1). EAATs 
couple the influx of one glutamate molecule to the inward movement of three sodium ions, one 
proton, and to the counter transport of one potassium ion (2,3). In addition, they mediate a 
thermodynamically-uncoupled anion conductance that is either a leak conductance or is gated 
by Na+ and substrate interactions (4-6). The EAAT-associated anion conductance has been 
suggested to support electrogenic glu uptake by holding the membrane potential to negative 
values (5,7) as well as dampening cell excitability and preventing additional glutamate release 
(8-10). 
EAATs quaternary structure are homotrimeric complexes of three identical subunits (11-
14) with 8 transmembrane (TM) domains and two reentrant hairpin loops (HP1 and HP2) 
(11,15-17). Although many studies have contributed to our understanding of the transport 
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mechanism in the EAATs, less is known about the structural-function relationship of the 
uncoupled anion conductance mediated by this class of proteins. Residues located on TM2 
have been reported to affect anion permeation and even anion selectivity (18), suggesting that 
the permeation pore may be formed by the residues from this region. Interpretation of data from 
experiments designed to elucidate the gating mechanism of the anion channel in the EAATs has 
proven challenging. Conserved residues in TM2 (19), TM5, TM7 (20), and HP2 (6) have been 
mutated and observed to impact anion permeation and/or gating. Interestingly, none of those 
mutant transporters showed a major effect on substrate transport (6,19-21). Therefore, it is likely 
that the pore domain is located in a region of the transporter that is distinct from the regions of 
substrate interactions. However, the substrate dependence of the gating mechanism would 
suggest that residues which couple these two processes would exist and mutations of such 
residues would impact the relationship between substrate binding, transport, and channel 
activity.  
In the present study, we identified a highly conserved basic residue in the N-terminal 
segment of TM7 (R388 in EAAT1) that affected both substrate transport and gating of the anion 
channel. The EAAT-associated anion conductance is a pore mediated anion permeation that 
has been demonstrated to have multiple conducting states. The leak conductance is activated 
by Na+ ions in the absence of glu (22-24) in neuronal isoforms and the substrate gated 
conductance state is reached upon application of glu or aspartate (asp) in the presence of Na+ 
(4,5,22). When the conserved residue R388 (EAAT1) is mutated to an acidic amino acid, the 
leak conductance is observed, but neither the EAAT-associated substrate gated anion current 
(Figure 2) nor the electrogenic transport current remains (Figure 1C and D). The physiological 
relevance of the EAAT-associated chloride conductance has been resolved only for the EAAT5 
isoform. Identification of regions involved in anion channel gating as well as the regions lining 
the aqueous permeation pore will provide strong tools for future exploration of the role of 
channel functionality in the EAATs.  
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D.4. EXPERIMENTAL PROCEDURE 
D.4.1. Heterologous Expression of hEAAT1  
Point mutations were introduced into the wild type (WT) hEAAT1, cysteineless hEAAT1 
(hEAAT1Cs) and WT rEAAT4 cDNAs using the QuikChange mutagenesis kit (Stratagene). 
EAAT1 and EAAT4 capped cRNA was synthesized from SmaI-linearized pOTV constructs 
through use of MESSAGE machine kits (Ambion, Austin, TX). Subsequently, cRNA was 
resuspended in 10 µl of water, and stored in 2-µl aliquots at –80 °C until use. 50 nl of cRNA 
were injected using a nanoliter injector (Nanoliter 2000, World Precision Instruments, Sarasota, 
FL, USA), and oocytes were kept at 18 °C in ND-96 solution supplemented with 2.5 mM sodium 
pyruvate and 100 µg/ml gentamycin sulfate until recording. Oocytes expressing hEAAT1 and 
rEAAT4 were measured 2 to 3 days after injection. Since we performed cysteine substitutions 
for cysteine modification experiments on hEAAT1, all the hEAAT1 mutant transporters were 
constructed on a cysteine-null transporter (hEAAT1Cs). 
D.4.2. Electrophysiology 
Glutamate transporter-associated currents were recorded in oocytes by two-electrode voltage 
clamp using a GeneClamp500B (Axon Instruments, Union City, CA, USA) amplifier. Recording 
solution contain (in mM): 96 NaCl, 4 KCl, 0.3 CaCl2, 1 MgCl2, 5 HEPES, pH 7.4. Oocytes were 
held at 0 mV, and currents elicited by 200 ms voltage steps between –100 mV and +60 mV 
were filtered at 2kHz (-3dB) and digitalized with a sampling rate of 10 kHz using a Digidata 1332 
AD/DA converter (Axon Instruments, Union City, CA, USA). Glutamate transport currents were 
measured by subtracting current amplitudes in a NaCl-based glutamate-free solution from 
current amplitudes in an external solution supplemented with 1 mM L-glutamate. Anion currents 
were determined after exchanging the external solution to (in mM):  96 NaNO3, 4 KCl, 0.3 
CaCl2, 1 MgCl2, 5 HEPES, pH 7.4 in the absence or in the presence of 1 mM external 
glutamate without any current subtraction procedure.  
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D.4.3. Radiolabeled Transport Assays 
Radiolabeled transport assays were performed in Xenopus oocytes 2-3 days after injection with 
EAAT cRNA. Oocytes were washed 3 times by transferring to wells containing ND96 buffers 
and with gentle agitation. Oocytes were then transferred to wells containing 200 nM 3,4,-3H-L-
glutamate (Perkin Elmer) for 10 min before transferring to wash wells to remove residual 
glutamate with ice cold ND96. Ooctyes were lysed with 0.1 N NaOH and 1% SDS and the 
accumulated radiolabeled substrate was counted in the individual oocytes by liquid scintillation 
counting.    
D.4.4. Data Analysis 
Data were analyzed with pClamp9 (Axon Instruments) and SigmaPlot (Jandel Scientific, San 
Rafael, CA, USA) programs. Current-voltage relationships at various substrate concentrations 
were constructed by plotting isochronal current amplitudes 5 ms after the voltage step versus 
the membrane potential.  
 
D.5. RESULTS 
D.5.1. Mutating Arginine 388 Affects Substrate Transport 
In order to investigate both anion channel activity as well as substrate transport properties of 
EAAT1, we mutated arginine 388 (R388 hEAAT1), a highly conserved residue located at the tip 
of TM7 (Figure 1A and B). When R388 is substituted by a small non-polar amino acid, both 
transport current and substrate gated anion permeation are reduced by about 80%. 
Nevertheless in these mutant transporters glu is still able to gate the substrate-gated anion 
conductance and its transport remains electrogenic (Supplementary Figure 1). On the other 
hand, when this positively charged residue is substituted by an acidic amino acid, the 
D6 
 
 
 
Figure D1. R388 has a significant role in substrate transport. (A) Localization of residue 
R388 (highlighted in blue) in the ribbon representation of a monomeric subunit of EAATs. 
Highlighted in colors are HP1 (yellow), TM7 (orange), HP2 (red) and TM8 (magenta). (B) 
Alignment of the region of the primary amino acid sequence containing R388 (boxed) in several 
EAAT isoforms. Totally conserved residues (yellow) and partially conserved residues (blue) are 
displayed in the alignment  (C) Representative current traces from oocytes expressing EAAT1 
R388, R388D, and R388E, as well as water-injected oocytes in response to a series of voltage 
pulses from -100 to +60 mV. (D) Current-voltage relationship obtained from oocytes expressing 
EAAT1 R388 (open circles, n=7), EAAT1 R388D (open squares, n=7) and EAAT1 R388E (open 
diamonds, n=8), as well as from water-injected oocytes (n=6). Na+ gated currents were 
subtracted from glu induced current amplitudes for clarity. (C) Radioactive glu uptake from the 
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same oocytes in B). Controls represent water injected oocytes. Error bars represent standard 
deviation of the mean. For statistical evaluation, Student’s t-Test was used. 
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mutant transporters are no longer able to elicit substrate transport currents nor glutamate gated 
anion permeation (Figure 1 and 2).  
Figure 1C and 1D show representative recordings and averaged current-voltage (I-V) 
relationships from oocytes expressing either hEAAT1 cysteine-less wild type (hEAAT1Cs) 
(black open circles), hEAAT1Cs R388D (green open squares) or hEAAT1Cs R388E (blue open 
diamonds) in a NaCl based extracellular solution. EAAT currents in the presence of glu at 
negative potentials are comprised of the glu transport currents and to a lesser degree the anion 
channel mediated currents. In physiological conditions, transport currents show a strong voltage 
dependent inward rectification while the glu gated anion conductance is predominant at positive 
potentials (4,5). After subtraction of the currents recorded in the absence of glutamate, no R388 
mutants displayed no significant currents which indicates that R388E/D mutants do no mediate 
an electrophysiological response to application of glu as compared to R388 (Figure 1C and 1D; 
n=5). No differences from background currents were observed in oocytes expressing 
hEAAT1Cs R388D or hEAAT1Cs R388E. The lack of transport currents in oocytes expressing 
the mutant transporters could be due to a failure of the mutant proteins to be synthesized, 
erroneous trafficking, a decreased expression in the plasma membrane, their incapacity to bind 
glutamate, or a disruption of the transport mechanism. To discriminate between these 
possibilities, we performed radiolabeled glu transport assays on the same oocytes after current 
measurements. Figure 1E demonstrates that although both mutants exhibit a reduced uptake 
activity compared with hEAAT1Cs WT, they do significantly accumulate glutamate more than 
tenfold above background (water injected oocytes), demonstrating that the mutant transporters 
are expressed and that glutamate not only can bind to these mutants but also can be 
translocated to the cytoplasm. The loss of transport currents in R388D and R388E while still 
exhibiting transport capacity for glu could be indicative of an exchange mechanism of transport. 
Without net glutamate translocation due to full cycle transport, EAAT do not generate transport 
currents (25-27). These results demonstrate that an acidic amino acid substitution in position 
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388 allows glutamate binding, but it causes a dramatic change in the transport mechanism, 
presumably preventing completion of the full transport cycle.    
D.5.2. Arginine 388 Plays a Crucial Role in Anion Channel Gating 
After measuring the transport currents in a NaCl-based solution (Figure 1), we perfused the 
same oocytes with a NaNO3-based solution to study the effects of these mutations on the 
substrate gated anion conductance. Figure 2 shows I-V relationships in response to a series of 
voltage pulses from -100 to +60 mV in the absence (closed black circles) and the presence 
(open red circles) of 1 mM L-glu from oocytes expressing hEAAT1Cs WT (A, n=10), hEAAT1Cs 
R388D (B, n=7) or hEAAT1Cs R388E (C, n=8). We observed that the current in the presence of 
glutamate (red open circles) was not significantly different from the current in the absence of glu 
(closed black circles; corresponding data points superimpose). No substrate induced current 
was observed using either SCN- as the main permeant anion in the presence of 1 mM glu or in 
the presence of 1 mM D-asp (Supplementary Figure 3). The currents recorded from hEAAT1Cs 
R388D and hEAAT1Cs R388E expressing oocytes are much larger than the currents obtained 
from water injected oocytes (Figure 2 B and C) and they are blocked by the competitive 
antagonist DL-threo-β-benzoyloxyaspartate (DL-TBOA) nearly to the background levels 
(Supplementary Figure 1), demonstrating that they are currents mediated by hEAAT1 
transporters. These data suggest that R388 plays an important role in the mechanism coupling 
substrate interactions to anion channel gating. 
D.5.3. Mutating Arginine 388 to an Acidic Amino acid, Shifts the Conformational 
Equilibrium of the Channel to the Leak Conducting States 
The lack of glutamate induced currents in oocytes expressing either acidic amino acid 
substitution in the R388 position could be due to the channel being locked or constrained in its 
maximal open probability state in the absence of substrate. Another possibility is that these 
mutant transporters cannot undergo the conformational changes subsequent to glutamate 
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Figure D2. R388 has a crucial role in activating the substrate gated anion conductance. 
(A-C) Current-Voltage relationship from oocytes expressing hEAAT1Cs WT (A, n=10), or 
R388D (B, n=7) or R388E (C, n=8) mutants perfused with a NO3-based solution in the absence 
(closed black circles) and in the presence (open red circles) of 1 mM glutamate. Solid lines 
represent currents recorded in a NO3-based solution in the presence of 1mM Glutamate from 
water-injected oocytes (n=6). 
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binding required to enter the substrate gated conducting state. In order to investigate the 
second of these two possibilities, we measured the relative anion conductance (which can be 
estimated by the ratio of the macroscopic current at a certain potential in the presence of one 
anion with respect to a different anion) of the wild type and mutant EAATs. As shown in Figure 
3E and 3F (white bars, n = 8), application of 500 µM glutamate in oocytes expressing 
hEAAT1Cs WT increases both the NO3
-/Cl- and the SCN-/Cl- relative conductances by 
approximately 3 fold as compared to Na+ alone. Since glutamate did not increase the 
macroscopic current amplitude in any of the buffer conditions applied to oocytes expressing 
hEAAT1Cs R338D or hEAAT1Cs R388E mutants (Figure 3C and 3D, n=6) compared with 
hEAAT1Cs WT (Figure 3A and 3B, n=8), we expected the relative conductance for the mutants 
to be similar to either the Na+ or Na+ + 500 µM glu conditions seen in hEAAT1Cs WT. As shown 
in Figure 3E and 3F (grey bars, N = 6) in Figure 3E and 3F (grey bars, n=6), the relative 
conductances measured from oocytes expressing R388D were identical to those corresponding 
to the Na+ only condition in WT transporters, suggesting that the asp or glu substitution in this 
position prevents the channel from transitioning into the glutamate gated conducting state.  
To further support our conclusion, we estimated and compared the relative permeability 
ratios between NO3
- and Cl-, as well as SNC- and Cl-. Since the relative permeability was 
previously demonstrated to be increased by glutamate application in the EAATs, we estimated 
the relative permeability ratios by measuring the reversal potential under different anion 
containing buffers in the presence of Na+ alone or with Na+ and 500 µM glu. Using the Goldman-
Hodking-Katz equation and assuming the intracellular Cl- concentration in the oocytes to be 
approximately 40 mM (20) one can calculate the relative permeability ratios for each of the 
conducting states. Unfortunately, due to the large transport current mediated by hEAAT1 
transporters and its contribution to the total macroscopic current, the reversal potential of the 
anion conductance in the presence of glutamate cannot be accurately measured in oocytes 
expressing this isoform. Therefore, we expressed rEAAT4 WT and mutant transporters in 
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Figure D3. Relative anion conductance in R388D EAAT1 is not affected by glutamate. (A-
D) Current-Voltage relationship from oocytes expressing R388 EAAT1 (A and B, n=7), or 
mutant R388D (C and D, n=8) in response to different anions (Cl, grey symbols, NO3 red 
symbols and SCN, blue symbols) in the absence (A and C, closed symbols) and in the presence 
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(B and D, open synmbols) of 1 mM Glutamate. (E and F) Relative conductances obtained from 
A-D.  
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Xenopus oocytes to look at the relative permeability ratios since EAAT4 has been demonstrated 
to have a dramatically lower rate of transport (4,28). First we determined whether the same 
phenotype was observed in the R388 homolog mutation on rEAAT4, R410E. As observed in 
oocytes expressing hEAAT1 R388E, no additional macroscopic current was observed upon 
glutamate application in oocytes expressing rEAAT4 R410E (Figure 4B, n=7) as compared to 
rEAAT4 WT (Figure 4A, n=7). These data are consistent with results seen in EAAT1. We next 
measured the relative anion permeability (PNO3/PCl) of EAAT4-associated anion channels. 
PNO3/PCl was increased after application of 1 mM glu, as previously described (6,24) (Figure 4C, 
white bar, n=9). In contrast, application of glu did not affect the NO3
-/Cl- nor the SCN-/Cl- 
permeability ratio in oocytes expressing rEAAT4 R410E and its value was similar to WT 
transporters in the absence of glu (Figure 4C, grey bar, n=7). As observed with hEAAT1, glu 
also increases the relative anion conductance of rEAAT4 WT transporters while leaving rEAAT4 
R410E values similar to the one in the absence of substrate (Figure 4D). Taken together, these 
data support that in both isoforms (hEAAT1 and rEAAT4), mutating this positively charged 
residue to an acidic amino acid prevents the channel from transitioning from the leak or Na+ 
gated conducting states into the glu gated conducting state and therefore glu binding and/or 
translocation is no longer able to increase anion permeation. 
D.5.4. R388E/D Alters Accessibility of HP1 Residues in the Outward-facing 
Conformations 
EAATs can exist in at least two structurally distinct conformations, outward- and inward-facing. 
A recent crystal structure solved has allowed for a proposed transport mechanism between 
these two states (29). A large segment of the protein (TM6, HP1, TM7, HP2, and TM8) 
classified as the transport domain, performs a significant movement between these two 
proposed conformations (11,29). The conformational changes that induces the substrate 
dependent anion conducting state may share overlap with conformational changes necessary 
for the transport process. Since our data suggest that the substitution of R388(R410 in EAAT4)  
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Figure D4 Relative anion permeability and relative anion conductance in R410E EAAT4 
mimic the leak conducting state of WT transporters. (A and B) Current-Voltage relationship 
from oocytes expressing WT EAAT4 (A, n=9), or mutant R410E (B, n=8) in the absence (black 
symbols) and the presence (red synmbols) of 1 mM Glutamate. Solid lines represent currents 
recorded in a NO3-based solution in the presence of 1mM Glutamate from water-injected 
oocytes (n=8). (C and D) Permeability ratios (C) and relative conductances (D) obtained from A 
and B.  
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by an acidic amino acid, prevents the channel from transitioning to the glutamate gated 
conducting state, we propose that the phenotype that results from this mutation may be due to 
some impairment of such a movement. To test our hypothesis, we used the accessibility of 
residues in HP1, which when substituted to cysteine, can only be modified when the transporter 
is in the inward facing state (30). The point mutation L376C was created on the hEAAT1Cs WT 
and hEAAT1Cs R388D and assayed channel activity. The single cysteine mutant hEAAT1Cs 
L376C showed a similar channel phenotype compared to WT (Figure 5A), while oocytes 
expressing the double mutant hEAAT1Cs L376C-R388D displayed the same impaired gating 
function of R388E/D alone (Figure 5B). Interestingly, incubation of oocytes expressing the 
double mutant transporters hEAAT1Cs L376C-R388D for 5 minutes with 100 µM NEM under 
physiological conditions (96 mM Na-based solution), was sufficient to cause a 50% reduction of 
the transport activity of the double mutant proteins (Figure 5D), but not in the L376C mutant 
alone (Figure 5C). These results suggest that when a negative charge is located at position 388, 
the L376 residue is more exposed to the intracellular milieu. Oocytes expressing L376C alone 
are exposed to a high extracellular K+ solution, L376C is accessible to modification from the 
cytoplasm by 100 µM of the permeable maleimide reagent NEM, causing a reduction of the 
uptake by 70% in oocytes expressing this mutant transporter (data not shown). One could claim 
that the modification at position 376 was caused by extracellular accessibility as a result of an 
aberrant structure caused by the mutations themselves. If the R388D mutation shifts the carrier 
equilibrium to an intermediate outward state, thus allowing L376C to become exposed to 
modification even in external Na+ conditions, then forcing the transporter into a fully outward 
conformation should preclude any modifications on the double mutant. In order to support our 
hypothesis we tested the effect of NEM in oocytes previously incubated with TBOA, which 
would trap the transporter in an outward, HP2-open conformation. Compared with vehicle 
treated controls, pre-treatment of the R388D-L376C double mutant with DL-TBOA blocked the 
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Figure D5. R388D mediates an altered accessibility of HP1 residues to modifying 
reagents. (A and B) Current-Voltage relationships from oocytes expressing L376C EAAT1 (A, 
n=6) and R388D-L376C (B, n=10) EAAT1 in the absence (black symbols) and the presence 
(red symbols) of 1mM Glutamate. Solid lines represent currents recorded in a NO3-based 
solution in the presence of 1mM Glutamate from water-injected oocytes (n=8). (C-H) 
Radioactive glutamate uptake from oocytes expressing L376C EAAT1 (C, E and G) or R388D-
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L376C EAAT1 (D, F and H). (C and D) Glutamate uptake from oocytes that were treated for 5 
minutes (white bars) or not (grey bars) with 0.25 mM NEM. The treatment was done in normal 
Na-based solution (96 mM NaCl) or in a K-based solution (96 mM KCl) (n>9 for each condition). 
(E and F) TBOA effect on glutamate uptake in oocytes that were or not previously incubated 
with 0.25 mM NEM in a Na-based solution (n>8 for each condition). (G and H) NEM 
modification effect on glutamate uptake on oocytes that were or not previously incubated with 
TBOA (n>10 for each condition). For comparison uptake was normalized by the uptake in 
normal conditions (96 mM NaCl and no incubation with NEM and/or TBOA). Error bars 
represent standard error of the mean and ** indicates a p < 0.01 with an ANOVA.  
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reduction in uptake observed with NEM modification in the L376C-R388D double mutant. These 
data suggest that the alteration of R388 to an acidic residue alters both the mechanism of anion 
channel gating as well as shifts the transporter equilibrium into an intermediate-outward state, 
displaying increased intracellular accessibility of HP1 residues.    
Our results demonstrate that when an acidic amino acid occupies position R388 in 
EAATs, the transport cycle cannot be completed and the substrate gated anion conductance is 
no longer activated. This is the first time that a residue has been demonstrated to play a role in 
both transport and gating processes and therefore is likely involved in their mechanistic 
coupling. In addition, our results indicates that this mutation may shift the transport domain 
lower into the membrane field, increasing HP1 accessibility to the intracellular milieu, a 
movement that might resemble the normal, physiological gating process for the anion 
conductance.  
   
D.6. DISCUSSION 
Here we investigate the functional consequences of mutating a highly conserved arginine 
residue in TM7 in both EAAT1 and EAAT4. R388 is a positive charged amino acid conserved 
among the whole EAAT family (Figure 1B), located at the tip of TM7, a region in close proximity 
to residues participating in substrate binding and translocation (31), as well as to regions 
proposed to play a role in anion permeation (20,32). During the last 10 years, major progress 
has been achieved in our understanding of the mechanism of substrate transport. Yet, the 
molecular determinants underlying anion channel gating and permeation remain poorly 
understood. These two different processes have been proven to be thermodynamically 
uncoupled (4,5) and modification of HP2 abolishes substrate transport while not reducing anion 
channel activity, highlighting their independent processes (33-35). However, the interaction of 
substrates such as Na+ and glu at the binding site influences channel activity, supporting a 
coupling mechanism between the two processes. Initially, a detailed noise analysis study of the 
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EAAT-mediated currents proposed a structural coupling between substrate transport and anion 
channel gating, suggesting that EAAT-associated anion conductance may be gated by 
conformational changes involved in substrate translocation (36). Analyses using pre-steady 
state kinetics have further supported that initial conformational changes associated with 
transport and anion channel gating are related (22,37,38). Additionally, data derived from a 
combination of electrophysiology and voltage clamp fluorometry also supports such a 
mechanism (39). Here, we reveal a conserved basic residue located in the tip of TM7, which 
plays a crucial role in the coupling mechanism of substrate interaction and anion channel gating. 
R388 is located adjacent to other basic residues, K384 and R385, which have been 
previously demonstrated to effect the glu mediated anion channel gating and ion permeation 
properties of EAATs (Figure 1B)(20). K384 and R385 mutations effect the substrate induced 
current amplitudes but not substrate transport, therefore it was hypothesized that these residues 
are involved in substrate induced channel gating. It was also proposed that these residues 
interact with other residues in TM2-TM3 loop and TM7 (19,20). However, because these 
residues which influence anion flux do not exhibit a significant effect on substrate transport, it is 
unlikely that they comprise part of the gating mechanism.  
In oocytes expressing the R388E/D mutants, no transport current could be readily 
measured (Figure 1C and D). In contrast, radiolabeled glu is still able to accumulate in those 
cells, demonstrating that glu can bind to the mutant transporters and the transport mechanism is 
still active although operates in an electroneutral fashion (Figure 1E). Recently crystallographic 
data was obtained using TM2 and HP2 crosslinking with double cysteine mutants in GltPh (29). 
The authors proposed that this structure depicts an inward oriented conformational state, which 
lead them to propose that the core domain (TM 7, TM 8, HP1, and HP2) undergoes a large 
movement of approximately 15 Ǻ toward the cytoplasm during substrate transport. In 2012, a 
smaller inward movement of the core domain of about 3.5 Ǻ, referred to as an intermediate 
outward facing conformation (iOFS) was observed in GltPh (32). Such a movement altered the 
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conformation of the N-terminal tip of TM7, near where R388 is located. These data suggests 
that this small amplitude conformational change results in the formation of a cavity lined by 
conserved hydrophobic residues in TM2 and TM5, regions previously propose to participate in 
anion permeation (19,20). Our data suggests that the inability of glutamate to gate the substrate 
induced anion conductance in the R388D and R388E mutant transporters may be a result of 
stabilization of the mutant transporters in such an intermediate conformation. If accurate, then it 
is likely that the significantly reduced transport capacity and lack of full cycle transport are due 
to this structural perturbation.   
EAAT-associated anion channels are multi-state channels (40,41), with two predominant 
open states mediated by several conformations accessed during the transport cycle; a leak or 
Na+ bound open state and the Na+ and glutamate bound open state. Both these open states 
exhibit different anion permeabilities (6,24) and open probabilities (24,40,42). Several stationary 
and non-stationary noise analysis studies in different EAAT isoforms, using different ionic 
conditions, agree that they share a maximum absolute open probability of ~0.6 at saturating Na+ 
and glutamate concentrations (24,40,42,43). The lack of substrate activated current in oocytes 
expressing the hEAAT1cs R388D, hEAAT1cs R388E, or rEAAT4 R410E mutants could be the 
result of the mutant channels having reached their maximum open probability state. 
Alternatively they might be trapped in the leak state and cannot undergo the transition to the glu 
induced open states. We measured the relative anion conductance and anion permeability 
ratios in oocytes expressing WT and mutant EAAT transporters from two different species and 
isoforms. Our results suggest that the mutant channels, although still able to bind Na+ and glu 
(Figure 2C), are not able to undergo the transition to the glutamate-gated state. Although these 
results do not necessarily rule out an altered single channel conductance or increased open 
probability for the leak or Na+ gated state, the data are indicative of channel characteristics 
disparate from the glu induced open states and identical to the leak channel state.   
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It is clear from the data presented here that the initial binding of glu is not sufficient to 
gate the substrate-gated anion conductance because R388E/D mutants display glutamate 
interaction without substrate induced gating of the channel. Although this loss of gating could be 
an unnatural by-product of mutation of R388, our interpretation is supported by data from pre-
steady-state kinetic experiments indicating multiple events occur in order to active the anion 
conductance (22,37).  
In an attempt to better understand the nature of the carrier with a R388D mutation, we 
assayed for markers indicative of an altered structural conformation. Our modification 
experiments using cysteine substitution mutants strongly suggest that when the R388D 
mutation is present, under physiological conditions where the carrier would be stabilized in the 
outward-open conformation, an intermediate conformation is favored with HP1 residues 
accessible to the intracellular space. It is interesting to note that due to the ability of R388 
mutants to still bind glu and TBOA, as well as complete at least partial transport cycles, 
indicates that these mutant carriers can still visit a range of conformational states (32). Indeed, 
inhibitor binding can re-stabilize the outward-open conformation similar to a WT transporter as 
indicated by the loss of NEM labeling of L376C-R388D in the presence of TBOA. Likely, R388 
mutants alter the energy profiles of conformational states, possibly mimicking the recent 
intermediate outward facing structure (iOFs), and have serendipitously revealed an intermediate 
open channel state. We believe our findings open new avenues toward the complete 
understanding of the complex interaction of substrate transport and anion channel activity 
possessed by the EAATs. 
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SUMMARY
Pentameric ligand-gated ion channels (pLGICs) are
targets of general anesthetics, but a structural under-
standing of anesthetic action on pLGICs remains
elusive. GLIC, a prokaryotic pLGIC, can be inhibited
by anesthetics, including ketamine. The ketamine
concentration leading to half-maximal inhibition of
GLIC (58 mM) is comparable to that on neuronal nico-
tinic acetylcholine receptors. A 2.99 A˚ resolution
X-ray structure of GLIC bound with ketamine re-
vealed ketamine binding to an intersubunit cavity
that partially overlaps with the homologous antago-
nist-binding site in pLGICs. The functional relevance
of the identified ketamine site was highlighted by
profound changes in GLIC activation upon cysteine
substitution of the cavity-lining residue N152. The
relevance is also evidenced by changes in ketamine
inhibition upon the subsequent chemical labeling of
N152C. The results provide structural insight into
the molecular recognition of ketamine and are valu-
able for understanding the actions of anesthetics
and other allosteric modulators on pLGICs.
INTRODUCTION
Clinical application of general anesthetics is indispensable in
modern medicine, but the molecular mechanisms of general
anesthesia remain unclear. The complexity of plausible anes-
thetic targets and the lack of accurate structural information of
these targets have hindered progress toward a mechanistic
understanding. Among all the receptors involved in neuronal
signal transduction, a family of pentameric ligand-gated ion
channels (pLGICs) has been identified as a target for general
anesthetics. Anesthetics often inhibit the agonist-activated cur-
rent in the excitatory nicotinic acetylcholine receptors (nAChRs)
or serotonin 5-HT3 receptors, but potentiate the inhibitory glycine
and GABAA receptors (Franks and Lieb, 1994; Hemmings et al.,
2005). Although our understanding of general anesthetic modu-
lation on these receptors has progressed dramatically in the
last decade (Forman and Miller, 2011), it remains a formative
challenge to resolve high-resolution structures of these pLGICs,
and to pinpoint where and how anesthetics act on these
channels to modulate their functions.
The structure of a bacterial homolog of pLGICs from Gloeo-
bacter violaceus (GLIC) has been solved by X-ray crystallog-
raphy (Bocquet et al., 2009; Hilf and Dutzler, 2009), showing
a similar architecture of extracellular (EC) and transmembrane
domains (TM) to that of the Torpedo marmorata nAChR solved
by electron microscopy (Unwin, 2005). The EC domain of GLIC
resembles the X-ray structures of the acetylcholine-binding
proteins (AChBPs) (Brejc et al., 2001; Celie et al., 2004; Hansen
et al., 2005) and the EC domain of a1-nAChR (Dellisanti et al.,
2007), presenting similar intersubunit cavities for agonist or
antagonist binding (Hansen et al., 2005). Despite the fact that
GLIC opens upon lowering pH (Bocquet et al., 2007) and does
not require agonist binding to the conventional site as for
pLGICs, its responses to general anesthetics resemble those
of nAChRs. A proton-activated Na+ current in GLIC can be
inhibited by anesthetics, as demonstrated previously (Nury
et al., 2011; Weng et al., 2010) and in this study. Anesthetic
binding sites in GLIC have been investigated by steady-state
fluorescence quenching experiments (Chen et al., 2010) and
X-ray crystallography (Nury et al., 2011). Whereas the crystal
structures of anesthetic desflurane- and propofol-bound GLIC
revealed an intrasubunit binding site in the TM domain, the
fluorescence experiments with halothane and thiopental sug-
gested additional sites in the EC and TM domains of GLIC. The
sensitivity to anesthetics and amenability to crystal structure
determination make GLIC ideally suited for revealing where
and how general anesthetics act on pLGICs.
Ketamine has been widely used for the induction and mainte-
nance of general anesthesia. Although ketamine is commonly
known as a dissociative anesthetic acting as a noncompetitive
antagonist on the N-methyl-D-aspartate (NMDA) receptor (Harri-
son and Simmonds, 1985), it is also a potent inhibitor of neuronal
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nAChRs (Coates and Flood, 2001; Yamakura et al., 2000). The
action sites of ketamine in these receptors have not been identi-
fied previously. Here, we show the crystal structure of ketamine-
bound GLIC. A preexisting cavity in the EC domain of GLIC is
found to be the site for ketamine binding. Functional relevance
of the site is evidenced by electrophysiology measurements in
combination with site-directed mutations and subsequent
chemical labeling to mimic anesthetic binding. Combined with
the previous knowledge of anesthetic binding to the TM domain
of GLIC (Nury et al., 2011), the anesthetic binding site discovered
in the EC domain provides an additional structural template for
the future design and evaluation of novel general anesthetics
and therapeutic allosteric modulators of pLGICs.
RESULTS
Ketamine Inhibition on GLIC
We found that the anesthetic ketamine inhibited currents of
the Xenopus oocytes expressing GLIC in a concentration-
dependent manner (Figure 1). At the proton concentration near
EC20 (pH 5.5) for GLIC activation, inhibition concentration with
half-maximal response (IC50) for ketamine on GLIC is 58 mM,
which is comparable to the ketamine IC50 values on the a7
nAChR (20 mM) and the a4b2 nAChR (50-72 mM) (Coates and
Flood, 2001; Yamakura et al., 2000).
The Crystal Structure of Ketamine-Bound GLIC
To identify ketamine binding site(s) in GLIC, we co-crystallized
ketamine with GLIC and solved the structure to a resolution of
2.99 A˚. Crystallographic and refinement parameters are summa-
rized in Table 1. Strong electron densities for ketamine were
found in all five equivalent pockets in the Fo-Fc omit electron
density map (see Figure S1 available online). Figure 2 shows
the refined structure and a stereo view of the 2Fo-Fc electron
density map for the ketamine binding site, revealing ketamine
in a pre-existing cavity between adjacent subunits in the EC
domain of GLIC. The ketamine site in GLIC is near the homolo-
gous orthosteric agonist site in Cys-loop receptors, but it is
9–10 A˚ closer to the TM domain (Figure S2). It partially overlaps
with the binding interface of large antagonists in Cys-loop recep-
tors (Bourne et al., 2010; Hansen et al., 2005).
Interactions Stabilizing Ketamine in the Binding Pocket
Positively charged at a low pH, ketamine is stabilized in an
amphipathic pocket, where it contacts mostly hydrophilic resi-
dues to form electrostatic interactions with these residues, in
addition to van der Waals interactions with some hydrophobic
residues. As depicted in Figure 3, on one side of the pocket,
the chloro group of ketamine points to the positively charged
amine of K183 of b10 and the phenyl ring faces F174 and L176
of loop C. On a different side of the pocket, the aminium of
ketamine makes electrostatic interactions with side chains of
N152, D153, and D154 of the b8–b9 loop (loop F). The carbonyl
group of ketamine can potentially form a hydrogen bond with
the hydroxyl group of Y23 on b1. The amide carbonyl oxygen
of N152 is 3 A˚ away from the aminium of ketamine. GLIC is
activated at low pH and the protonation states of titratable
residues are responsible for channel activities. K183 of the
Figure 1. Ketamine Inhibition of GLIC at EC20
(A) Representative current traces of GLIC expressed in Xenopus oocytes in the
absence and presence of 100 mM ketamine.
(B) Inhibition of the GLIC current by ketamine. Response to inhibition is
expressed as a fraction of current induced at EC20 in the presence of an
indicated concentration of ketamine relative to that in the absence of ketamine.
The data are reported as the mean ± SEM from nR 8 oocytes and fit to the Hill
equation. Error bars less than the symbol size are not visible.
Table 1. Data Collection and Refinement Statistics
Data Collection and Process
Beamline SSRL BL 12-2
Wavelength (A˚) 0.9795
Space group C2
Unit cell (A˚) 184.1, 132.7, 162.1
b () 103.6
Resolution (A˚) 25-2.99
Rmerge (%)
a 8.3 (59.8)
Completeness (%)a 97.6 (92.3)
<I/s >a 12.6 (2.2)
Unique reflectionsa 74,604 (1,0257)
Redundancya 3.9 (3.9)
Refinement statistics
Resolution (A˚) 24.8-2.99
No. Reflections (test set) 68,525 (3,452)
Rwork/Rfeee 0.187/0.219
Non-H protein (ligand) atoms 13,358 (675)
B-factors (A˚2)
Protein 70.6
Detergents 125.0
Lipids 119.1
Solvent 51.7
Ketamine 122.3
Rms deviations
Bond lengths (A˚) 0.008
Bond angles (degrees) 1.22
Rotamer outliers (%) 8.3
Ramachandran outliers (%) 0.97
Ramachandran favored (%) 93.3
PDB code 4F8H
aValues in the parentheses are for highest resolution shell.
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principal side carries a positive charge on its side chain, whereas
the side chains of D153 and D154 of the complementary side
are likely negatively charged. Thus, electrostatic interactions
have contributed significantly to stabilizing ketamine binding
(Figure S3).
Functional Relevance of the Ketamine-Binding Pocket
The functional relevance of the identified ketamine site was
validated by site-directed mutations and subsequent chemical
labeling of a pocket residue to mimic anesthetic binding. As
shown in Figure 4, the ketamine-binding pocket is involved in
the GLIC activation. A single mutation in the pocket, N152C,
shifted EC50 from pH 5.0 in the wild-type (WT) GLIC to pH 5.4
in the N152Cmutant (Figure 4A). Ketamine binding to the pocket
is evidenced by a higher IC50 value for the N152C mutant
(110 mM) in comparison to IC50 of the WT GLIC (58 mM) (Fig-
ure 4B). Removal of a favorable electrostatic interaction between
the aminium of ketamine and the amide carbonyl oxygen of N152
in the mutant may account for the reduced ketamine inhibition.
The functional relevance of the ketamine binding site is further
substantiated by the results of labeling 8-(chloromercuri)-2-
dibenzofuransulfonic acid (CBFS) to N152C after mutating the
only native cysteine residue in GLIC (C27A). Covalent labeling
of the introduced cysteines with reagents like CBFS has been
used previously to mimic alcohol binding to specific residues in
pLGICs (Howard et al., 2011). The CBFS bonding to N152C
mimicked the ketamine effect and resulted in inhibition to the
mutant current (Figure 4C). The residual current from the CBFS
bonding could be completely inhibited by ketamine, but with a
higher IC50 of 180 mM (Figure S4). The weakening of ketamine’s
inhibition is somewhat expected, considering the interruption of
CBFS to the pocket and to potential interactions between
ketamine and its surrounding residues. The channel resumed
a normal function once CBFS was removed from N152C after
treatment with 10 mM DTT. Collectively, these data indisputably
demonstrate functional significance of the ketamine-binding
pocket revealed in the crystal structure.
DISCUSSION
The functional importance of the EC domain in pLGICs has been
well established based on the data that agonist or antagonist
binding to the orthosteric site regulates channel activities alloste-
rically (Changeux and Edelstein, 2005; Sine and Engel, 2006).
Our structure reveals a drug-binding pocket in the EC domain,
showing that ketamine is not in, but 9–10 A˚ below, the orthosteric
agonist-binding site. In the superimposed crystal structures of
the ketamine-bound GLIC and the agonist- or antagonist-bound
AChBP (Bourne et al., 2010; Celie et al., 2004; Hansen et al.,
2005; Hibbs et al., 2009; Ihara et al., 2008; Talley et al., 2008),
one can see clearly that ketamine is outside the binding loci for
agonists (Figure S2). However, the ketamine binding site over-
laps partially with the extended interaction surface of bulky
antagonists bound to AChBP (Figure S2), suggesting that ket-
amine may inhibit GLIC in a way similar to how competitive
antagonists inhibit the functions of nAChRs. No agonist other
than protons has been found for GLIC so far. It is unclear if the
EC domain, especially the region for agonist or antagonist
binding, plays any functional role in GLIC as in other pLGICs.
Our data highlight the functional importance of the EC domain
of GLIC. The functional relevance of the identified ketamine
site has been established by compelling data of mutations and
the CBFS labeling in combination with electrophysiology mea-
surements. Several residues lining the ketamine pocket in
GLIC are from the b8–b9 loop and b10. Their interplay with the
TM2–TM3 loop from the channel domain is thought to be essen-
tial for communication between agonist binding and channel
activation in pLGICs (Sine and Engel, 2006). Both our structural
and functional results suggest that the pre-existing cavity in
the EC domain, other than the conventional agonist-binding
site, can accommodate a drug molecule and modulate the func-
tions of the GLIC channel.
Despite a profound inhibition effect on GLIC upon ketamine
binding, our crystal structure shows little difference from the
apo GLIC structure (Bocquet et al., 2009; Hilf and Dutzler,
2009). For residues within 4 A˚ from the bound ketamine, their
root-mean-square deviation (rmsd) relative to the apo structure
is only 0.4 A˚. The structural resilience to anesthetic binding was
also observed in the desflurane- and propofol-bound GLIC
structures (Nury et al., 2011). Whether a structural response to
ligand binding can be observed under crystallization may
depend on binding sites, ligands, crystallization conditions, or
other factors. The crystal structure of ELIC, the pentameric
ligand-gated ion channel from Erwinia chrysanthemi, shows
significant conformational changes near and beyond the binding
site of acetylcholine (Pan et al., 2012), while agonist binding to
the homologous site of the pentameric Caenorhabditis elegans
glutamate-gated chloride channel alpha (GluCl) results in little
conformational changes in the crystal structures (Hibbs and
Gouaux, 2011). It remains a challenge to capture different con-
formations crystallographically for a given pLGIC (Gonzalez-
Gutierrez et al., 2012).
The structural and functional results of ketamine binding to
GLIC present a compelling case for the allosteric action of
Figure 2. The Crystal Structure of GLIC
Bound with Five Ketamine Molecules
(A) A side view of the structure with ketamine
molecules in purple color. A pair of principal and
complementary subunits for ketamine binding is
depicted in yellow and cyan, respectively. Note
that ketamine is a few A˚ below loop C.
(B) A stereo view of the 2Fo-Fc electron density
map, contoured at 1.0 s level, for the ketamine
binding site. See also Figures S1 and S2.
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anesthetics. The ketamine pocket is nearly 30 A˚ away from the
channel gate. The previously identified site for propofol or des-
flurane is in the upper part of the TM domain within a subunit
of GLIC (Nury et al., 2011), distinct from the ketamine binding
site. Two factors may have contributed to different sites of allo-
steric action for these drugs. First, ketamine is more soluble in
the aqueous phase than propofol and desflurane. It is more
attractive to the solvent-exposed pocket offering electrostatic,
hydrogen bonding, and van de Waals interactions (Figure S3).
Second, ketamine has a larger molecular size than either propo-
fol or desflurane. The ketamine pocket in GLIC is comprised of
flexible loops and has a volume of 248 A˚3, compatible with
a ketamine volume of 219 A˚3 (Table S1). Crystal structures of
anesthetic bound GLIC reported here and previously (Nury
et al., 2011) reveal at least two sets of sites for anesthetic
binding. Existence of multiple anesthetic binding sites in GLIC
has been suggested by several studies. Tryptophan fluores-
cence quenching experiments showed halothane and thiopental
binding in the EC domain, TM domain, and the EC-TM interface
of GLIC (Chen et al., 2010). Molecular dynamic simulations sug-
gested that in addition to EC and TM domains, isoflurane could
also migrate into the GLIC channel (Brannigan et al., 2010;
Willenbring et al., 2011). Multiple anesthetic sites were also iden-
tified in other pLGICs. In Torpedo nAChR, azietomidate photola-
beled not only some pore-lining residues, but also the agonist-
binding site in the EC domain (Ziebell et al., 2004). The volatile
anesthetic halothane was also found to photolabel both the TM
and EC domains (Chiara et al., 2003). Some halothane-labeled
residues in the EC domain of nAChR were from the b9 and b10
strands (Chiara et al., 2003), suggesting that the ketamine site
in our structure represents a homologous site for anesthetic
binding in other pLGICs.
Ketamine has been traditionally classified as an NMDA
receptor antagonist (Harrison and Simmonds, 1985). Our struc-
tural and functional data reported here, along with previous func-
tional studies of ketamine on nAChRs, may aid in a paradigm
shift and call for a comprehensive examination of ketamine
action on pLGICs. Ketamine inhibited the recombinant neuronal
nAChRs in a subunit-dependent manner (Coates and Flood,
2001; Yamakura et al., 2000). IC50 values of ketamine measured
from Xenopus oocyte expressing human a7 and a4b2 nAChRs
(Coates and Flood, 2001; Yamakura et al., 2000) were close to
our measured value with GLIC in this study. From the modeled
structures of the a7 and a4b2 nAChRs (Haddadian et al., 2008;
Figure 4. Functional Relevance of the Ketamine-Binding Site
(A) A single mutation of N152C in the binding pocket altered pH activation of
the channel. Currents of the N152C mutant (solid circle) and the wide type
GLIC (open circle) expressed in Xenopus oocytes were normalized to the
maximum current at pH 3.8 or 3.5, respectively.
(B) The N152C mutation weakened the ketamine inhibition. Responses of the
N152 mutant (solid circle) and the wild-type GLIC (open circle) are expressed
as the fraction of current induced at EC20 in the presence of the indicated
concentrations of ketamine relative to that in the absence of ketamine.
(C) Representative current traces of the N152C_C27A mutant at different pH
values, before and after labeling of 8-(chloromercuri)-2-dibenzofuransulfonic
acid (CBFS) at a concentration of 20 mM, and after the treatment of 10 mM
dithiothreitol (DTT). The application of CBFS or DTT to Xenopus oocytes lasted
for 2 min and was followed by the subsequent application of pH 7.4 buffer
before a newmeasurement. The data in (A) and (B) are reported as the mean ±
SEM from n R 8 oocytes and fit to the Hill equation. Error bars less than the
symbol size are not visible. See also Figure S4.
Figure 3. Stereo View of Atomic Details of the Ketamine Binding
Pocket
Dashed lines indicate distances in A˚ between the ketamine atoms and the
relating residues for electrostatic interactions. Residues on the principal and
complementary sites of the pocket are colored in yellow and cyan, respec-
tively. Note the position of ketamine relative to N152, in which the mutation
affected GLIC activation and ketamine inhibition. See also Figures S3 and S5
and Table S1.
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Mowrey et al., 2010), it is notable that both proteins have apocket
similar to the ketamine pocket in GLIC, where several acidic
residues are on one side of the pocket (Figure S5). These nega-
tively charged residues could attract ketamine and stabilize
the ketamine binding. A greater number of negatively charged
residues in the pocket of a7 than a4b2 nAChRs seem to be
consistent with the observation that the a7 nAChR is more sensi-
tive to ketamine inhibition than the a4b2 nAChR (Coates and
Flood, 2001).
The discovery of the ketamine-binding pocket expands the
scope of the drug-binding mode and is particularly valuable for
the understanding of functional data related to drug action in
the EC domain of pLGICs. There may also be other sites for
ligand binding in the EC domain of heteromeric nAChRs and
GABAA receptors (Hansen and Taylor, 2007). For a long time,
the search for targets of soluble drugs, such as benzodiazepine
and its derivatives, was focused on sites equivalent to but not the
orthosteric ligand site in GABAA receptors (Boileau et al., 1998;
Morlock and Czajkowski, 2011; Sigel and Buhr, 1997). Residue
selection for mutagenesis and subsequent functional studies
have relied heavily on structures of ligand-bound AChBPs (Celie
et al., 2004; Hansen et al., 2005) because of the limited number of
high-resolution structures with ligand binding to pLGICs
(Dellisanti et al., 2007; Li et al., 2011; Pan et al., 2012) and the
lack of experimental structures for GABAA receptors. The atomic
binding mode of ketamine in GLIC provides an additional struc-
tural template, which is invaluable for the design of novel modu-
lators or the search for optimal bindingmodes of benzodiazepine
derivatives at the interfaces of various subtype subunits (Richter
et al., 2012).
EXPERIMENTAL PROCEDURES
Protein Expression and Purification
GLIC was expressed as a fusion of Maltose-binding protein (MBP) using
a plasmid generously provided by Professor Raimund Dutzler’s group. The
protocol for GLIC expression and purification wasmodified from the published
protocols (Bocquet et al., 2009; Hilf and Dutzler, 2009) and detailed in the
Supplemental Experimental Procedures. The purified GLIC was concentrated
to 10 mg/ml and used for crystallization.
Crystallization
Crystallization was performed using the sitting-drop method at 4C. GLIC was
pre-equilibrated with 0.5 mg/ml E. coli polar lipids (Avanti Polar Lipids) and
1 mM ketamine (Fort Dodge) for at least 1 hr at 4C before being mixed
in a 1:1 ratio with the reservoir solution containing 10%–12% PEG 4000,
225 mM ammonium sulfate, and 50 mM sodium acetate buffer (pH 3.9–4.1).
Crystals of GLIC containing ketamine usually appeared within 1 week. For
cryoprotection, the crystals were flash frozen in liquid nitrogen after soaking
for 30 min in the reservoir solution supplemented with 20% glycerol and
10 mM ketamine.
Structural Data Collection and Analysis
The X-ray diffraction data were acquired on beamline 12-2 at the Stanford
Synchrotron Radiation Lightsource and processed using the XDS program
(Kabsch, 2010). The structure was determined by molecular replacement
using the apo-GLIC structure (PDB code 3EAM) without detergent, lipid, and
water molecules, as the starting model. Phenix (version: 1.6.4-486) (Adams
et al., 2010) and COOT (Emsley et al., 2010) were used for structure refinement
and model building. After several cycles of refinement, six detergent and ten
lipid molecules were built into well-defined extra electron densities using
COOT (Emsley et al., 2010). Noncrystallographic symmetry (NCS) restraints
were applied for five subunits in each unit cell. Automatic solvent detection,
update, and refinement were used for the placement of water molecules.
Manual inspection and adjustment were performed at a later stage. Finally,
ketamine binding sites were determined based on the Fo-Fc difference map
and ketamine molecules were built into five equivalent sites showing signifi-
cant electron densities. Initial ketamine geometry was obtained using
Gaussian 03 at the HF/6-31G level of theory (Frisch et al., 2003). Both R-
and S-ketamine enantiomers were used in structural refinements. R-ketamine
showed interactions with surrounding residues more energetically favorable
and was used in the final structure. The final structure was obtained after
additional refinement cycles. Crystal structure analysis was performed using
Phenix and CCP4 (Winn et al., 2011). PyMOL (Schrodinger, 2010) and VMD
(Humphrey et al., 1996) programs were used for structural analysis and figure
preparation.
Molecular Biology and GLIC Expression in Xenopus laevis Oocytes
Plasmids encoding GLIC in the pTLN vector for GLIC expression in Xenopus
laevis oocytes was a generous gift from Professor Raimund Dutzler of
University of Zu¨rich, Zu¨rich, Switzerland. Site-directed mutagenesis was intro-
duced with the QuikChange Lightning Kit (Stratagene) and confirmed by
sequencing. The plasmid DNA was linearized with MluI enzyme (New England
BioLabs). Capped complementary RNA was transcribed with the mMessage
mMachine SP6 kit (Ambion) and purified with the RNeasy kit (QIAGEN).
The defolliculated stage V-VI oocytes were injected with cRNA (10–25 ng
each) and maintained at 18C in modified Barth’s solution (MBS) containing
88 mM NaCl, 1 mM KCl, 2.4 mM NaHCO3, 15 mM HEPES, 0.3 mM
Ca(NO3)2, 0.41 mM CaCl2, 0.82 mM MgSO4, 10 mg/ml sodium penicillin,
10 mg/ml streptomycin sulfate, 100 mg/ml gentamycin sulfate (pH 6.7). Func-
tional measurements were performed on oocytes 16–40 hr after the injection.
Oocyte Electrophysiology
Two-electrode voltage clamp experiments were performed at room tempera-
ture with a model OC-725C amplifier (Warner Instruments) and a 20 ml oocyte
recording chamber (Automate Scientific). Oocytes were perfused with ND96
buffer (96 mM NaCl, 2 mM KCl, 1.8 mM CaCl2, 1 mM MgCl2, 5 mM HEPES
[pH7.4]) and clamped to a holding potential of –40 to –60 mV. Data were
collected and processed using Clampex 10 (Molecular Devices). Nonlinear
regressions were performed using Prism software (Graphpad). Ketamine
(Sigma-Aldrich) was prepared as a 100 mM stock at a specific pH and diluted
with freshly prepared ND96 to a desired concentration. 8-(chloromercuri)-2-
dibenzofuransulfonic acid (CBFS) was purchased as sodium salt (Sigma-
Aldrich). The stock solution of CBFS (200 mM) was prepared with ND96 and
diluted to a desired concentration before application. To measure CBFS
labeling effects, data were collected at various pH or various ketamine
concentrations at pEC20, followed by 2 min washout using ND96 (pH 7.4),
1–2 min treatment with 20 ml CBFS, 2 min to washout free CBFS, and data
collection at various pH or various ketamine concentrations at a new pEC20.
Covalent bonding of CBFS to GLIC mutants was confirmed by comparing
currents at pEC20 before and after applying the reducing reagent, 10 mM
dithiothreitol (DTT), to the CBFS-treated oocytes.
ACCESSION NUMBERS
Atomic coordinates and structure factors for the ketamine bound GLIC have
been deposited in the Protein Data Bank (http://www.pdb.org) with the acces-
sion code 4F8H.
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